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Regulation of Stem Cell Metabolism by the Lin28/let-7 Axis 
 
Abstract 
 
This thesis is focused on two fundamental aspects of stem cell metabolism: (1) the role of Lin28 
in  programming  stem  cell  metabolism,  and  (2)  how  metabolism  in  turn  fuels  and  governs 
pluripotency.  Our  studies  led  us  to  discover  that  the  stem  cell  factor  Lin28a  promotes 
organismal overgrowth  by enhancing glucose metabolism in mice,  corroborating  discoveries 
that  LIN28B  polymorphisms  influence  human  height.  Subsequently,  we  discovered  that  the 
Lin28/let-7 pathway controls glucose metabolism by orchestrating the upregulation of multiple 
components of the insulin-PI3K-mTORsignaling pathway, particularly in skeletal muscle. Since 
let-7 accumulates with aging, our discoveries suggest that antagonism of let-7 could represent a 
new strategy for treating insulin resistance and type 2 diabetes. During these studies, we also 
observed  that  Lin28a  enhances  tissue  regeneration  when expression  is  reactivated  in  adult 
tissues. Regeneration capacity has long been known to decline with aging, but why juvenile 
organisms  show  enhanced  tissue  repair  has  been  unexplained.  We  found  that  Lin28a 
reactivation improved the regrowth of skin, hair, cartilage, bone and mesenchyme after injuries. 
Let-7 repression was necessary but insufficient to explain these phenotypes. In parallel, Lin28a 
bound  to  and  enhanced  the  translation  of  mRNAs  for  several  oxidative  enzymes,  thereby 
increasing OxPhos. Lin28a-mediated tissue repair was negated by OxPhos inhibition, whereas 
a  pharmacologically-induced  increase  in  OxPhos  promoted  wound  repair.  Thus,  Lin28a iv 
 
enhanced tissue regeneration in adults by reprogramming cellular bioenergetics. My interest in 
the  central  principles  of  stem  cell  metabolism  also  led  us  to  map  the  metabolic  pathways 
associated with pluripotency during  somatic cell reprogramming and Lin28/let-7 perturbation. 
Surprisingly,  we  found  that  Thr-Gly-S-adenosylmethionine  (SAM)  metabolism  consistently 
showed the best correlation with pluripotency. 
13Carbon isotope metabolomics further revealed 
that Thr was catabolized to generate Gly and acetyl-CoA, and ultimately SAM - essential for all 
methylation reactions. Thr is required for SAM and histone H3K4 methylation in mouse ESCs, 
thus regulating the open euchromatin and pluripotency of ESCs. Our study shed light on a novel 
amino acid pathway in stem cells, and demonstrated that metabolic conditions can direct cell 
fate. In summary, my work has helped us to understand how we can reprogram and manipulate 
metabolic networks to regulate stem cell homeostasis.  
 v 
 
Table of Contents 
Chapter 1: Prologue - Lin28, a regulator of growth and metabolism in stem cells 
  1 
 
Chapter 2: The Lin28/let-7 axis regulates glucose metabolism in mammals   27 
 
Chapter 3: Lin28 enhances adult tissue regeneration by reprogramming cellular 
metabolism   59 
 
Chapter  4:  Lin28  promotes  threonine  metabolism  to  regulate  S-adenosyl-
methionine levels and histone methylation in pluripotent stem cells    94 
 
Chapter 5: Epilogue - Stem cell metabolism in tissue development and aging   126 
 
Chapter 6: Bibliography   157 
 
Appendix   188 
   vi 
 
Table of Figures 
Figure 1.1: Overview of Molecular Mechanisms Underlying Lin28 Function.  8 
Figure 1.2: Signals Upstream and Targets Downstream of Lin28.  12 
Figure 1.3: Potential of Lin28 in Re-Engineering Adult Mammalian Physiology.  26 
Figure 2.1: Lin28a Tg and iLIN28B Tg mice are resistant to obesity and diabetes and 
Lin28a is physiologically required for normal glucose homeostasis.  37 
Figure 2.2: iLet-7 mice are glucose intolerant.  41 
Figure 2.3: Insulin-PI3K-mTOR signaling is activated by Lin28, suppressed by let-7  44 
Figure 2.4: Lin28a/b and let-7 regulate genes in the insulin-PI3K-mTOR pathway.  48 
Figure 2.5: mTOR required for Lin28a’s effects on growth and metabolism in vivo.  51 
Figure 2.6: Let-7 target genes are associated with type 2 diabetes mellitus and a model 
of the Lin28/let-7 pathway in glucose metabolism.  55 
Figure 3.1: Lin28a reactivation promotes hair regrowth.  68 
Figure 3.2: Lin28a reactivation promotes digit regrowth after amputation.  71 
Figure 3.3: Lin28a reactivation promotes pinnal tissue repair.  74 
Figure 3.4: Let-7 repression is necessary but insufficient for tissue repair.  76 
Figure 3.5: Lin28a alters the bioenergetic state during tissue repair.  79 
Figure 3.6: Lin28 promotes wound healing by enhancing bioenergetic metabolism.  85 
Figure 3.7: Lin28 promotes tissue repair by enhancing bioenergetic metabolism.  89 
Figure 4.1: Pluripotency factors upregulate Threonine-Methionine metabolism.  103 
Figure 4.2: Threonine is catabolized to maintain the SAM/SAH ratio in mESCs.   107 
Figure 4.3: Threonine-methionine metabolism controls H3K4 methylation levels.   113 
Figure 4.4: Threonine dehydrogenase regulates the pluripotency of mESCs.   118 vii 
 
Figure 5.1: Totipotent stem cell (TSC) metabolism.   127 
Figure 5.2: Metabolism in pluripotent stem cells.  130 
Figure 5.3: Metabolism in differentiating ESCs.   134 
Figure 5.4: Metabolism in quiescent long-term hematopoietic stem cells (LT-HSCs)  136 
Figure 5.5: Proliferative hematopoietic stem and progenitor cell metabolism.   141 
Figure 5.6: Metabolism in neural stem cells and progenitors.  142 
Figure 5.7: Metabolism in mesenchymal stem cell (MSCs) and progenitors.   145 
Figure 5.8. Metabolism in skeletal myoblasts and myotubes.   146 
 
List of Tables 
Table 2.1: MAGENTA analysis of T2D and fasting glucose associations in different let-7 
target gene sets.  53 
Table 5.1: Metabolic Pathways in Respective Stem and Progenitor Cells  140 
   viii 
 
Acknowledgements 
Completing my PhD thesis would have been impossible without the help and support 
from my mentors, lab-mates, friends and family. 
Right from day one, my mentor Prof. George Daley has been teaching me to think big. 
“Think of a really big problem”, he said, “Then grab it by the horns and tackle it.” I have 
strove to make that my approach to science ever since! From my happy days of playing 
around ideas of what I wanted to work on during rotations, to the exhilarating years of 
discovering the roles of Lin28 in stem cell metabolism and tissue repair, to the painful 
months of struggling with harsh reviewers, then finally the sweet crescendo towards 
publications and graduation – George has always been supportive of my myriad ideas, 
and guiding me to see them through even when I thought it was impossible. I know this 
is a rare privilege for a PhD student, uncommon even in Harvard. I want to sincerely 
thank  him  for  providing  me  these  opportunities  and  trusting  me  to  shoulder  these 
projects. It was a blast! George is also my role model in his fearless leadership, his 
superhuman energy, his electric charisma, and his passion for life - be it risottos, wine, 
skiing,  or  karaoke.  He  has  been  awe-inspiring.  It  makes  me  want  to  live  up  to  his 
brilliant example.  
My co-mentor and dissertation chair, Prof. Lewis Cantley, moulded the other half of my 
PhD training. Watching him think about science is literally like watching a wizard at work 
sometimes.  His  effusive  energy for  scientific  ideas  (day or  night),  his rebelliousness 
against convention, and his uncanny speed at tearing through the morass of data to see 
connections between seemingly unrelated observations at the biochemical level, never 
fail to astonish me. Every lab meeting I try to best Lew at it, and every lab meeting I fail ix 
 
miserably. But that is what makes lab meeting with him such great fun, something we 
look forward to every time! It is leadership by example. He has set an incredibly high bar 
for scientific originality, curiosity, and rigor. A bar that I have sworn I will keep training 
and trying to cross. Another high bar that Lew has set, is for partying. He works hard, 
but plays even harder with us. Yet despite such sheer intensity, Lew is also one of the 
nicest people I have ever had the privilege of working with. I want to thank him for taking 
me under his wings as well, teaching me his values, inspiring me to greater heights than 
I had ever imagined, and imparting to me an amazing example of the scientific life.  
I am incredibly humbled and proud to have both George and Lew as my mentors for life. 
I also want to thank all my Daley lab colleagues and Cantley lab colleagues for their 
great camaraderie and helping me along this journey. Special thanks to my buddies in 
the  Lin28  subgroup,  aka  the  “Honey  Badgers”.  Especially  Hao  Zhu,  my  long-time 
collaborator, friend, and big brother, and also Michael Kharas, Harith Rajagopalan, Gen 
Shinoda,  John  Powers,  Kaloyan  Tsanov,  Sutheera  Ratanasirintrawoot  ‘Mam’,  Alena 
Yermalovich, Tarja Yvanka de Soysa, Marc Seligson, Samar Shah, Will Einhorn, and 
Mathew Lensch ‘Willy’. Also huge thanks to my buddies in the Cantley lab, especially 
Costas  Lyssiotis,  Jason  Locasale,  Jihye  Yun,  Edouard  Mullarky,  Hye  Seok  Shim, 
Yuxiang Zheng, Hai Hu, Hui Liu, Ning Wu, Min Yuan, and John Asara. They have all 
become my friends for life.    
Finally, I want to thank my family. My parents, especially, for letting their only son run so 
far away from our home in Singapore – for 8 years – to pursue his dreams of becoming 
a scientist. My father’s faith and my mother’s support have fueled me throughout my x 
 
journey. And most importantly, my wife Rachel Wang whom I married while at Harvard. 
Over the past 6 years, Rachel has become my closest friend, confidante, partner and 
lover. Together, we've helped each other withstand numerous trials – from little things 
like suffering experimental failures in our PhD work – to bigger things like surviving the 
Boston Marathon terrorist attack. And we kept emerging stronger from every trial and 
tribulation. I want to thank Rachel for understanding my workaholism, encouraging my 
passions, and fighting alongside me. I would not have done it without her. 
 1 
 
Chapter 1: Lin28, A Primal Regulator of Growth and Metabolism in Stem Cells 
Introduction 
A  central  question  in  stem  cell  biology  is  whether  common  factors  exist  to  define 
“stemness” in multiple tissue lineages. Arguably, one such candidate is the RNA-binding 
protein Lin28, which was first identified in the nematode C. elegans through screens for 
lineage-modifying  genes  that  alter  developmental  timing,  or  heterochrony  (lin-28; 
Ambros and Horvitz 1984). Two other prominent heterochronic genes, lin-4 and let-7, 
were the first microRNAs to be discovered, and both directly repress lin-28 to suppress 
heterochronic  reiterations  of  cell  lineages.  Heterochronic  “reiteration”  of  nematode 
progenitor cells, as C. elegans geneticists first observed, was strongly reminiscent of 
mammalian stem cell self-renewal (Chalfie et al. 1981; Ambros and Horvitz 1984).  
This  connection  was  reinforced  by  the  discovery  that  mouse  embryonic  stem  cells 
(ESCs) express high levels of mammalian Lin28, which decrease upon differentiation 
(Moss and Tang 2003). Successful reprogramming of human fibroblasts into induced 
pluripotent stem cells (iPSCs) using Lin28, along with Oct4, Sox2, and Nanog, further 
corroborated its role in pluripotent stem cells (Yu et al. 2007), but the mechanism of 
action for Lin28 remained unclear. A subsequent flurry of studies showing that Lin28 
directly inhibits let-7 maturation in ESCs rapidly validated Lin28’s function in ESC self-
renewal (Viswanathan et al. 2008; Rybak et al. 2008; Heo et al. 2008; Newman et al. 
2008). With the discovery that Lin28 is also important in cancer, the germ lineage, and 
cellular  metabolism  (Viswanathan  et  al.  2009;  West  et  al.  2009;  Zhu  et  al.  2011), 
understanding  the  role  of  Lin28  in  stem  cells  during  development  and  disease 
pathogenesis has emerged as a new field of research. In this Review, we will discuss 2 
 
the Lin28 pathway and its complex molecular mechanisms, outline its known roles in 
stem cells, tissue development, and pathogenesis, and examine its ramifications for re-
engineering mammalian physiology. 
Lin28/let-7: A Conserved Bistable Switch  
Current insights into Lin28 rest heavily on precedents in C. elegans genetics. Lin-28 
was first discovered through mutagenesis screens for heterochronic genes (Horvitz and 
Sulston 1980; Sulston and Horvitz 1981; Ambros and Horvitz 1984). Loss-of-function in 
lin-28 accelerates differentiation of the hypodermal and vulval progenitor cells (called 
seam cells and VPCs respectively in nematodes).  In contrast, gain-of-function in lin-28 
promotes  self-renewal  and  delays  differentiation  of  the  hypodermal  and  vulval 
progenitor cells, leading to proliferation of hypodermal progenitors and a cell-cycle delay 
in  vulval  progenitors  (Moss  et  al.  1997).  Lin-28  is  highly  expressed  during 
embryogenesis  and  during  early  larval  development  in  the  hypodermal,  neural  and 
muscle cells, but gradually diminishes and disappears by adulthood.  
Two heterochronic microRNAs (miRNAs) repress lin-28 post-transcriptionally via direct 
binding sites in its 3’ UTR: lin-4 and let-7 (Reinhart et al. 2000; Pasquinelli et al. 2000; 
Roush  et  al.  2008).  Although  the  canonical  let-7  is  only  expressed  late  in  larval 
development to drive the transition to adulthood, three let-7 homologs (mir-48, mir-84 
and  mir-241)  display  overlapping  expression  with  lin-28.  Indeed,  loss-of-function  in 
these let-7 homologs phenocopied lin-28 gain-of-function in the hypodermal progenitors, 
and lin-28 was epistatic to the three let-7 homologs (Abbott et al. 2005). Mutation of the 
let-7  binding  site in  the  lin-28  3’ UTR  also led  to  an increase in  lin-28 3’ UTR-lacZ 3 
 
reporter expression (Morita and Han 2006), suggesting that let-7 binding contributes to 
lin-28 repression, and underlies their opposing roles in regulating differentiation. 
The role of lin-28 in mammalian stem cells was less clear until quite recently. The first 
glimpse of a connection came from the discovery that the mammalian lin-28 ortholog is 
highly expressed in mouse ESCs and human embryonal carcinoma cells (Moss and 
Tang 2003). The connection was further validated when human Lin28 was used with 
Oct4, Sox2 and Nanog to reprogram human somatic fibroblasts into pluripotent stem 
cells (Yu et al. 2007). Around the same time, a post-transcriptional mechanism  was 
proposed to be responsible for the dramatic disparity between high levels of pri-let-7 
transcript and the deficiency of mature let-7 microRNA in early mouse embryos and 
ESCs (Thomson et al. 2006; Wulczyn et al. 2007). These two lines of inquiry rapidly 
converged  through  a  flurry  of  studies  that  showed  that  Lin28  (now  routinely  termed 
Lin28a) and its paralog Lin28b directly inhibit the post-transcriptional maturation of let-7 
in ESCs (Viswanathan et al. 2008; Rybak et al. 2008; Heo et al. 2008; Newman et al. 
2008). A generally similar mechanism was later verified to be conserved in C. elegans 
(Lehrbach  et  al.  2009;  Van  Wynsberghe  et  al.  2011).  Since  Lin28a/b  inhibit  the 
biogenesis of let-7 microRNAs, which in turn repress Lin28a/b expression, it became 
clear that this bistable switch represents a central mechanism that governs stem cell 
self-renewal from worms to mammals. 
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Molecular Mechanisms of Lin28 Function  
Following the discovery that Lin28a/b represses let-7 biogenesis, several groups  set 
about to determine the detailed biochemical mechanisms underlying let-7 repression as 
a  model  for  understanding  miRNA  biogenesis.  Similar  to  the  biogenesis  of  other 
miRNAs,  let-7  is  first  transcribed  as  part  of  long  pri-let-7  transcripts  in  the  nucleus 
(Roush  et  al.  2008).  Within  the  pri-let-7  transcripts  is  a  hairpin  structure  that  is  the 
precursor miRNA (pre-let-7). Drosha, in complex with its RNA-binding cofactor DGCR8, 
cleaves and releases the ~70 nt hairpin structure to produce pre-let-7. Like other pre-
miRNAs, pre-let-7 is then thought to be exported from the nucleus into the cytoplasm by 
exportin-5,  although  the  majority  of  pre-let-7  species  lack  the  3’  two-nucleotide 
overhang that exportin-5 presumably needs to export pre-miRNAs (Heo et al. 2012; Yi 
et  al.  2003),  suggesting  that  another  mechanism  might  serve  this  function.  In  the 
cytoplasm, pre-let-7 is further processed by Dicer to produce a 22-nt double-stranded 
RNA duplex. Mature single-stranded let-7 is then incorporated from the duplex into the 
RNA-induced silencing complex (RISC) to target mRNAs for translation inhibition and/or 
degradation in P-bodies (Figure 1.1). 
In  a  multi-pronged  fashion,  Lin28a/b  binds  to  both  pri-let-7  and  pre-let-7,  effectively 
sabotaging the post-transcriptional processing of let-7 (Viswanathan et al. 2008; Rybak 
et al. 2008; Heo et al. 2008; Newman et al. 2008). X-ray crystallography studies further 
revealed that Lin28a binds pre-let-7 at the terminal loop and at the bulge GGAG motif 
where  Dicer  cleaves  (Nam  et  al.  2011).  Lin28a  also  recruits  Tut4  (Zcchc11),  a 
cytoplasmic terminal uridylyl transferase, to oligo-uridylate pre-let-7 and prevent its  5 
 
 
Figure 1.1: Overview of Molecular Mechanisms Underlying Lin28 Function. 
Both  Lin28a  and  Lin28b  have  been  observed  to  shuttle  between  the  nucleus  and 
cytoplasm,  binding  both  mRNAs  and  pri-/pre-let-7.    In  the  nucleus,  Lin28a/b  could 
potentially work in tandem with the heterogeneous nuclear ribonucleoproteins (hnRNPs) 
to  regulate  splicing,  or  with  Musashi-1  (Msi1)  to  block  pri-let-7  processing.  In  the 
cytoplasm, Lin28a recruits Tut4/7 to oligo-uridylate pre-let-7, and block Dicer processing 
to  mature  let-7 miRNA  (right,  violet).  Lin28a  also  recruits  RNA  helicase  A  (RHA)  to 
regulate  mRNA  processing  in  messenger  ribonucleoprotein  (mRNP)  complexes,  in 
tandem with the Igf2bp’s, poly(A)-binding protein (PABP), and the eukaryotic translation 
initiation factors (eIFs). In response to unknown signals and stimuli, the mRNAs are 6 
 
Figure  1.1  (continued)  either  shuttled  into  poly-ribosomes  for  translation,  stress 
granules for temporary sequestering, or P-bodies for degradation, in part via miRNAs 
and the Ago2 endonuclease (left, orange).  
 
processing by Dicer (Heo et al. 2009; Hagan et al. 2009). Recent studies have further 
elaborated on this mechanism, suggesting that Tut7 (Zcchc6) is a redundant homolog of 
Tut4 that can also oligo-uridylate pre-let-7 in the presence of Lin28a (Thornton et al. 
2012; Heo et al. 2012). In contrast, when Lin28a is absent, Tut4/7 or Tut2 (Papd4/Gld2) 
mono-uridylates  pre-let-7’s  at  their  3’  one-nucleotide  overhang  to  generate  a  two-
nucleotide  overhang,  thereby  enabling  their  processing  by  Dicer  (Heo  et  al.  2012). 
Thus, one would expect oligo-uridylated pre-let-7 to accumulate when pri-let-7, Lin28a 
and Tut4/7 are present. But this is not observed, suggesting that an unknown nuclease 
must exist to degrade oligo-uridylated pre-let-7’s (Heo et al. 2008, 2009), and/or that 
Lin28 can sequester pri-let-7’s to prevent further processing (Viswanathan et al. 2008; 
Newman et al. 2008). Indeed, a study suggests that Lin28b is predominantly localized in 
the nucleolus where it can sequester pri-let-7 away from Drosha/DGCR8 processing, 
whereas Lin28a is predominantly localized in the cytoplasm where it can recruit Tut4 to 
oligo-uridylate  pre-let-7  and  prevent  Dicer  processing  (Piskounova  et  al.  2011). 
However, mammalian Lin28a/b and C. elegans lin-28 can all enter the nucleus as well 
as the cytoplasm (Moss et al. 1997; Guo et al. 2006; Balzer and Moss 2007; Heo et al. 
2008; Piskounova et al. 2011; Van Wynsberghe et al. 2011; Vogt et al. 2012; Hafner et 
al. 2013). Moreover, all three proteins possess a putative nucleolar localization signal, 
and  all  three  proteins  can  bind  to  both  pri-  and  pre-let-7  (Viswanathan  et  al.  2008; 7 
 
Rybak et al. 2008; Heo et al. 2008; Newman et al. 2008; Lehrbach et al. 2009; Van 
Wynsberghe et al. 2011). Thus, the mode of regulation of this division of labor between 
Lin28a and Lin28b remains unclear (Figure 1.1). 
Under  different  conditions  of  metabolic  stress  in  embryonal  carcinoma  cells  and 
myoblasts, Lin28a localizes specifically to cytoplasmic stress granules where mRNAs 
are sequestered and mRNA translation is temporarily stalled (Balzer and Moss 2007; 
Polesskaya  et  al.  2007).  Under  normal  growth  conditions,  cytoplasmic  Lin28a  can 
directly  or  indirectly  associate  with  translation  initiation  factors  eIF3B  and  eIF4E, 
elongation  factors  EF1ʱ  and  EF1ʱ2,  ribosomal  proteins,  poly(A)-binding  protein 
(PABP),  Igf2bp1/2/3,  Musashi1  (Msi1)  and  RNA  helicase  A  (RHA)  in  messenger 
ribonucleoprotein (mRNP) complexes to regulate mRNA translation (Balzer et al. 2007; 
Polesskaya et al. 2007; Jin et al. 2011). When point mutations are introduced into the 
RNA-binding motifs, Lin28a localizes to the nucleus (Balzer and Moss 2007). These 
findings suggest a model in which Lin28a regulates the post-transcriptional processing 
of its mRNA targets, perhaps by first binding them in the nucleus and subsequently 
shuttling  them  between  ribosomes,  P-bodies  or  stress  granules  for  translational 
regulation, depending on the environmental conditions. It would be interesting to know 
which factors sense the environmental conditions to regulate this shuttling of Lin28a, 
and whether these conditions alter the RNAs bound by Lin28a (Figure 1.1). One study, 
for example, suggests that retinoic acid-induced differentiation of ESCs triggers Msi1 
expression, which recruits Lin28a to the nucleus to sequester and inhibit pri-miR-98 but 
not  pri-let-7b (Kawahara  et  al. 2011). But  what  else  could  Lin28a/b  be  doing in  the 
nucleus? Nuclear Lin28 could also regulate the alternative splicing of pre-mRNAs, or 8 
 
processing of small nucleolar RNAs (snoRNAs) and long non-coding RNAs (lincRNAs) 
to generate greater RNA diversity. The likelihood for this additional role is supported by 
the RNA-dependent association between Lin28a protein and nuclear splicing factors like 
hnRNP F and hnRNP H1 (Polesskaya et al. 2007), and its direct regulation of splicing 
factors and snoRNAs (Wilbert et al. 2012; Hafner et al. 2013). How these various RNA-
processing mechanisms relate to stem cell self-renewal and plasticity in response to 
environmental changes remains an important avenue for future research.  
Regulatory Signals Upstream of Lin28 
Throughout  their  lifespan,  stem  cells  must  decide  whether  to  self-renew,  proliferate, 
differentiate or die. The regulation of stem cell homeostasis is a complex process that 
involves integrating intrinsic and extrinsic signals, so that stem cells can correctly adapt 
to the environment. The central role of the Lin28/let-7 bistable switch in governing stem 
cell  self-renewal  raises  the  provocative  question:  what  signaling  pathways  converge 
upstream to regulate the switch?  
In C. elegans, an important intrinsic signal upstream of lin-28 that regulates hypodermal 
progenitor self-renewal is the microRNA lin-4. In vertebrates, lin-4 is conserved as miR-
125a and miR-125b (Lagos-Quintana et al. 2002). Vertebrate miR-125/lin-4 has been 
shown  to  be  critical  for  regulating  processes  as  disparate  as  neurogenesis, 
somitogenesis,  hematopoiesis,  myogenesis  and  epidermal  stem  cell  self-renewal 
(Rybak et al. 2008; Le et al. 2009a; Le et al. 2009b; Klusmann et al. 2010; Bousquet et 
al. 2010; O’Connell et al. 2010; Ooi et al. 2010; Ge et al. 2011; Zhang et al. 2011; Guo  9 
 
 
Figure 1.2: Signals Upstream and Targets Downstream of Lin28. 
The  lin-4  homolog  miR-125a/b  represses  both  Lin28a  and  Lin28b  during  stem  cell 
differentiation. The core pluripotency transcription factors Oct4, Sox2, Nanog and Tcf3 
can activate Lin28a transcription in ESCs and iPSCs, whereas the growth regulator Myc 
and  the  inflammation-/stress-responsive  NF-κB  can  transactivate  Lin28b.  A  putative 
steroid hormone-activated nuclear receptor, conserved from C. elegans daf-12, might 
also regulate both Lin28a/b and let-7 expression. Downstream of Lin28a/b, the  let-7 
family  represses  a  network  of  proto-oncogenes,  including  the  insulin-PI3K-mTOR 
pathway, Ras, Myc, Hmga2, and the Igf2bp’s. At the same time, Lin28a can also directly 
bind to and regulate translation of mRNAs, including Igf2bp’s, Igf2, Hmga1, and mRNAs 10 
 
Figure  1.2  (continued)  encoding  metabolic  enzymes,  ribosomal  peptides,  and  cell-
cycle regulators. Together, this broad network of targets allows Lin28 to program both 
metabolism and growth to regulate self-renewal.  
 
Guo et al. 2010; Chaudhuri et al. 2012). During these developmental processes, miR-
125/lin-4 appears  to  regulate  stem  cell  self-renewal  and progenitor  differentiation  by 
repressing a variety of different targets, including Lin28a/b, as well as the p53 network 
(Le et al. 2011). In mammalian ESCs, the pluripotency factors Oct4, Sox2, Nanog and 
Tcf3 have also been shown to regulate the transcription of Lin28a (Marson et al. 2008). 
Amongst these pluripotency factors, Sox2 appears to be the most critical for regulating 
Lin28a  expression,  based  on  Bayesian  probabilistic  network  modeling  of  single-cell 
gene expression data during iPS reprogramming (Buganim et al. 2012). Interestingly, 
Sox2 directly binds to Lin28a in a nuclear protein-protein complex, suggesting a close 
relationship between Sox2 and Lin28a in pluripotency (Cox et al. 2010). Repression of 
the Dot1L H3K79 histone methyltransferase upregulates Lin28a during reprogramming, 
although the mechanism is indirect via mesenchymal regulators downstream of TGFβ 
signaling  (Onder  et  al.  2012).  Finally,  c-Myc  and  NF-κB  transactivate  Lin28b  in 
transformed cancer cells (Chang et al. 2009; Iliopoulos et al. 2009), suggesting that 
Lin28a and Lin28b possess distinct cis-regulatory elements to drive their transcription 
(Figure  1.2).  Beyond  these  studies,  relatively  little  is  known  about  the  transcription 
factors  that regulate  Lin28a  and  Lin28b expression  during  mammalian  development, 
and further investigation is warranted.  11 
 
The C. elegans nuclear receptor daf-12 feeds extrinsic signals from steroid hormones to 
lin-28 and let-7, to regulate diapause or dauer arrest (Antebi et al. 1998, 2000; Gerisch 
et al. 2007; Bethke et al. 2009; Hammell et al. 2009). Although this mechanism is well-
characterized  in  C.  elegans  development,  and  a  similar  ecdysone-let-7  mechanism 
operates  in  Drosophila  metamorphosis (Sokol  et  al.  2008;  Chawla et  al.  2012), it is 
unclear if a similar mechanism exists to hormonally regulate the Lin28/let-7 switch in 
mammals (Figure 1.2). Studies have shown that the homologous retinoic acid receptors 
and  estrogen  receptor  ʱ  regulate  let-7  expression  in  vitro  (Thomson  et  al.  2006; 
Wulczyn et al. 2007; Gehrke et al. 2010; Schulz et al. 2011; Bhat-Nakshatri et al. 2009), 
but both the directness and the physiological relevance of these mechanisms remain to 
be shown. It would also be interesting to test if any of the nuclear hormone receptors 
implicated in pluripotency and especially the naïve state (Feng et al. 2009; Heng et al. 
2010; Guo and Smith 2010; Wang et al. 2011; Martello et al. 2012), a state associated 
with rodent diapause (Nichols et al. 2001, 2009), also regulates the Lin28/let-7 switch 
(Figure 1.2).  
Coordinate Regulation of Metabolism and Cell Cycle by Targets of Lin28  
Given our wealth of understanding of the upstream regulators of lin-28 in worms, it is 
surprising that relatively little was discerned about the downstream RNA targets in the 
C. elegans literature. It was only after the discovery that lin-28 directly binds to and 
represses pre-let-7, that the more well-known let-7 targets could be placed downstream 
of lin-28. Only some of these let-7 targets are known to be conserved in mammals, 
including lin-41 (Trim71), let-60 (Ras), and Lin28 itself. The regulation of  NRAS and 
KRAS by let-7 in human cancer cells has led to the proposal that let-7 functions as a 12 
 
tumor suppressor in humans (Johnson et al. 2005). Indeed, a network of let-7 targets 
involving numerous other proto-oncogenes has been uncovered in mammalian cells, 
including Myc, Hmga2, Igf2bp’s, cyclins (Sampson et al. 2007; Mayr et al. 2007; Lee et 
al. 2007; Johnson et al. 2007; Yu et al. 2007; Boyerinas et al. 2008; Iliopoulos et al. 
2009; Legesse-Miller et al. 2009; Chang et al. 2012), and components of the insulin-
PI3K-mTOR pathway like Igf1r, Insr, Irs2, Akt2 and Rictor (Zhu et al. 2011; Frost and 
Olson 2011). These studies fit with the suggestion that Lin28a/b function as oncogenes 
in multiple cancers by repressing the let-7 network (Viswanathan et al. 2009). A majority 
of these studies, however, were conducted in vitro and many of these claims still await 
validation in vivo through Lin28a/b or let-7 mouse models.  
Adding a second layer of complexity downstream of Lin28, some studies have shown 
that  Lin28a  directly  binds  to  many  mRNAs,  including  Igf2  in  myoblasts  and  neural 
progenitors, and cyclin A/B in ESCs, to directly enhance their translation independently 
of let-7 (Polesskaya et al. 2007; Xu et al. 2009; Balzer et al. 2010). Genome-wide RNA-
immunoprecipitation studies further reveal thousands of mRNA targets bound directly by 
Lin28. In human ESCs and cancer cells, LIN28A directly binds and promotes the mRNA 
translation  of  numerous  metabolic  enzymes,  ribosomal  peptides,  cyclins  as  well  as 
splicing factors (Peng et al. 2011; Li et al. 2012; Wilbert et al. 2012; Hafner et al. 2013). 
Curiously, in mouse ESCs, Lin28a was also recently found to bind and subtly repress 
the ribosomal occupancy of numerous membrane protein mRNAs (Cho et al. 2012). 
Given the plethora of mRNA targets that are emerging for Lin28a, including nearly 50% 
of  the  human  transcriptome  in  one  study (Cho  et  al.  2012),  an important  task  lying 
ahead is to determine whether all these targets or only a subset contribute to the Lin28 13 
 
phenotypes  observed  in  vivo.  Such  an  undertaking  might  require  a  return  to  the 
powerful genetics of C. elegans to search for conserved mRNA targets of lin-28. This 
idea is supported by the finding that let-7-independent mechanisms must account for 
the lin-28 phenotype in C. elegans as well (Vadla et al. 2012). 
Several  key  insights  into  Lin28  function  are  emerging  from  the  small  set  of  well-
validated  targets,  most  notably  that  Lin28  coordinates  both  proliferative  growth  and 
metabolism. Lin28a/b can upregulate a large number of cell-cycle regulators through let-
7 repression, including Myc, Ras, cyclin D1/2, Cdk6, Cdc25a, Cdc34, Trim71 (which 
represses p21
Cip1), Hmga2 (which represses p16
Ink4a and p19
Arf) and PI3K/Akt signaling 
(Johnson et al. 2005; Sampson et al. 2007; Johnson et al. 2007; Chang et al. 2012; 
Mayr et al. 2007; Nishino et al. 2008; Zhu et al. 2011). A recent study even suggested 
that let-7 can directly bind to and silence Rb1/E2F target genes via heterochromatin 
during senescence (Benhamed et al. 2012). Lin28a also directly binds and promotes the 
translation  of  mRNAs  encoding  cyclin  A/B/D,  Cdk1/2/4,  Cdc2  and  Cdc20,  thereby 
coordinating the cell-cycle at multiple checkpoints (Xu et al. 2009; Li et al. 2012; Hafner 
et  al.  2013).  Besides  the  cell-cycle,  Lin28a/b  might  also  control  cellular  growth  by 
regulating  ribosomal  synthesis  of  proteins.  Lin28a  directly  binds  to  the  mRNAs  of 
numerous ribosomal peptides in human ESCs (Peng et al. 2011). In addition, Lin28a/b 
increases mTOR signaling via let-7 (Zhu et al. 2011; Frost and Olson 2011), which can 
activate  ribosomal  biogenesis  and  translation  in  many  contexts.  In  parallel  with  its 
extensive  control  of  cell-cycle  and  cell  growth  regulators,  Lin28a/b  appears  to  also 
coordinate  cellular  metabolism,  both  via  let-7  and  by  directly  stimulating  mRNA 
translation.  Through  let-7,  Lin28a/b  upregulates  the  insulin/PI3K,  Ras  and  Myc 14 
 
pathways – all of which are oncogenic regulators of metabolism (Vander Heiden et al. 
2009;  Dang  2011).  By  directly  binding  mRNAs  and  influencing  translation  of  the 
Igf2bp’s,  Igf2,  glycolysis  enzymes,  and  mitochondrial  enzymes,  Lin28a  can  directly 
potentiate  cellular  metabolism  (Zhu  et  al. 2011;  Peng  et al.  2011;  Polesskaya  et  al. 
2007; Janiszewska et al. 2012; Hafner et al. 2013). Hmga1, another mRNA target of 
Lin28a, can also upregulate insulin/PI3K signaling (Liau et al. 2006; Chiefari et al. 2011; 
Peng et al. 2011). Given how growth signaling pathways are intertwined with cellular 
metabolism, it is perhaps not surprising that Lin28 would have to program both arms of 
genes  to  regulate  self-renewal.  Thus  a  model  is  emerging,  albeit  an  inchoate  one, 
whereby  Lin28  programs  both  metabolism  and  proliferative  growth  to  regulate 
stem/progenitor cell self-renewal (Figure 1.2).  
Lin28 in Embryonic Stem Cell Metabolism  
The functional role of Lin28 in cellular metabolism is evidenced by recent studies in 
ESCs. Recent work has shown that aerobic glycolysis, akin to the Warburg effect in 
cancer, is critical to ESCs and iPSCs (Zhu et al. 2010b; Folmes et al. 2011). This is 
perhaps  not  surprising,  given  the  high  proliferative  capacity  of  ESCs,  and  the 
importance of glycolysis in providing carbon intermediates for anabolic growth (Vander 
Heiden  et  al.  2009).  What  is  surprising  is  that  some  studies  have  shown  that 
mitochondrial oxidative metabolism is also critical to ESCs (Wang et al. 2009; Alexander 
et  al.  2011;  Zhang  et  al.  2011b),  despite  the  immature  morphology  of  ESC 
mitochondria.  Interestingly,  Lin28a  binds  to  a  large  number  of  mRNAs  encoding 
mitochondrial enzymes in human ESCs (Peng et al. 2011). One possibility is that ESC 
mitochondrial oxidation could be operating to recycle mitochondrial NAD
+ and keep the 15 
 
Krebs cycle running in order to generate fatty acids and various amino acids for ESCs 
(Shyh-Chang  et  al.  2011).  Curiously,  mouse  ESCs uniquely  rely  upon  mitochondrial 
oxidation of threonine (Thr) into glycine (Gly), via threonine dehydrogenase (Tdh), to 
generate one carbon/folate intermediates to fuel rapid nucleotide synthesis (Wang et al. 
2009).  This  seminal  early  work  led  to  findings  that  the  5-methyl-THF  generated  by 
mitochondrial Thr oxidation also fuels the synthesis of S-adenosyl-methionine (SAM) to 
regulate histone H3K4 methylation and the pluripotency of ESCs (Shyh-Chang et al. 
2013a). Surprisingly, Lin28a overexpression in ESCs leads to a dramatic accumulation 
of  many  metabolites  in  the  Thr-Gly-SAM  pathway,  whereas  overexpression  of  let-7 
reduces the abundance of these metabolites, suggesting that the Thr-Gly-SAM pathway 
is at least indirectly regulated by the Lin28/let-7 switch to maintain ESC self-renewal. 
These findings might also have relevance to cancer, since lung cancer stem cells have 
been  found  to  express  and  depend  upon  high  levels  of  both  Lin28b  and  glycine 
decarboxylase  (Gldc)  in  the  Thr-Gly  pathway  to  initiate  tumorigenesis  (Zhang  et  al. 
2012).  In  fact  several  enzymes  in  Gly  metabolism  have  recently  been  implicated  in 
human tumorigenesis (Locasale et al. 2011; Possemato et al. 2011; Jain et al. 2012). 
Lin28 could thus potentially regulate glucose and amino acid metabolism in a variety of 
stem and progenitor cells, both normal and malignant (Shyh-Chang et al. 2013b).        
Lin28 in Early Embryogenesis, Pluripotent Stem Cells and Reprogramming  
The  earliest  phases  of  embryogenesis  feature  high  levels  of  Lin28a  due  to  protein 
inheritance through the maternal oocyte. From the mouse zygote to the pre-implantation 
blastocyst, Lin28a is exclusively localized in the nucleolus where it is thought to regulate 
nucleolar maturation (Vogt et al. 2012). Morpholino knockdown of Lin28a in the zygote 16 
 
produces defects in nucleolar morphology and developmental arrest at the 2-cell and 4-
cell stages, suggesting that Lin28a is required for proper nucleolar genesis and function 
and  early  embryogenesis.  Curiously,  Lin28a  is  localized  in  the  nucleolus  of  mouse 
ESCs as well, but not primate ESCs (Vogt et al. 2012). Given that Lin28a is an RNA-
binding protein, these observations suggest that maternal Lin28a might also be involved 
in ribosomal RNA processing in the nucleolus to regulate zygotic genome activation 
during the maternal-zygotic transition, although this remains speculative.  
After zygotic genome activation, mammalian blastocysts show high levels of Lin28a and 
Lin28b transcription in the pluripotent cells of the inner cell mass (ICM) and epiblast and 
their  in  vitro  correlates  –  the  indefinitely  self-renewing  ESCs.  Studies  suggest  that 
Lin28a/b acts as a repressor of let-7 microRNAs to prevent premature differentiation in 
the  pluripotent  ICM  and  epiblast  (Suh  et  al.  2010;  Melton  et  al.  2010).  When  the 
pluripotent ICM is cultured in vitro for ESC derivation, Lin28a is further upregulated, in 
parallel with acquisition of indefinite self-renewal capacity in vitro (Tang et al. 2010). 
Furthermore,  overexpression  of  Lin28a  with  a  cocktail  of  the  core  pluripotency-
associated transcription factors Oct4, Sox2 and Nanog, helps promote reprogramming 
of  human  somatic  fibroblasts  into  indefinitely  self-renewing  iPSCs  (Yu  et  al.  2007; 
Hanna et al. 2009). These data suggest that Lin28a is critical to pluripotent stem cell 
self-renewal.  
But is Lin28 also required for pluripotency? Lin28 knockout mouse models suggest the 
answer  is  no.  Lin28a  knockout  mice  progress  through  the  blastocyst  stage  without 
obvious developmental defects in utero, although they weigh 20% less at birth (Zhu et 17 
 
al. 2010). Lin28b knockout mice are viable and fertile. Thus Lin28a/b do not appear to 
be essential for pluripotency per se, in vivo. 
Do pluripotent stem cells then require Lin28a/b for indefinite self-renewal? The answer 
depends on the context, since overexpression of mature let-7 does not inhibit mouse 
ESC self-renewal unless DGCR8 is knocked out and miRNA biogenesis is prevented 
(Melton et al. 2010). Another class of miRNAs called the miR-290 family can respond to 
and compensate for the effects of let-7 overexpression. Although the breadth of genes 
targeted  by  the  miR-290  family,  and  the  connections  with  Lin28a/b  (if  any)  remain 
unclear, it is thought that let-7 promotes ESC differentiation in the absence of DGCR8 
by directly repressing Sall4, Nmyc, and Lin28a. Conversely, Lin28a or Lin28b knockout 
in  the  presence  of  DGCR8    should  not  lead  to  defects  in  self-renewal  via  let-7 
upregulation alone, even if we ignore the compensatory redundancy observed between 
Lin28a and Lin28b (Wilbert et al. 2012). RNAi against Lin28, however, does lead to 
proliferative defects in both mouse and human ESC (Xu et al. 2009; Peng et al. 2011), 
suggesting  that  Lin28a/b  might  synergistically  promote  ESC  self-renewal  through  a 
combination  of  let-7  repression  and  let-7-independent  mechanisms  such  as  direct 
binding of mRNAs involved in metabolism and growth. Thus it will also be interesting to 
see if Lin28a/b double knockout leads to defects in ESC self-renewal. On the other 
hand, let-7 knockdown in fibroblasts promotes iPS reprogramming (Melton et al. 2010), 
suggesting that Lin28a might promote self-renewal via repression of let-7 during iPS 
reprogramming,  without  compensatory  effects  from  ESC-specific  miR-290.  Indeed, 
studies  have  shown  that  Lin28a  can  accelerate  the  early  stochastic  phase  of  iPS 
reprogramming  by  accelerating  the  cell-cycle,  and  that  Lin28a  is  one  of  the  earliest 18 
 
markers  of  the  deterministic  phase  of  iPS  reprogramming  after  endogenous  Sox2 
expression is induced (Hanna et al. 2009; Buganim et al. 2012; Golipour et al. 2012). It 
remains to be verified, however, whether let-7 is the relevant target of Lin28a during 
reprogramming, and what downstream targets of  let-7 drive iPS reprogramming. It is 
also  unknown  whether  Lin28/let-7  is  implicated  in  the  much  more  rapid  and 
deterministic process of reprogramming by somatic cell nuclear transfer (SCNT). 
Lin28 in Normal and Transformed Tissue Progenitors 
Contrary to popular belief, Lin28a/b’s expression and influence on development is far 
from unique to pluripotent cells in the blastocyst ICM, but rather extends to a variety of 
tissues.  For  instance,  the  trophoblast  and  the  resultant  placental  tissues  show  high 
levels of Lin28a/b. Studies suggest that the high Lin28a levels in trophoblast stem cells 
decrease  to  permit  differentiation  into  trophoblast  giant  cells  (Fromme  et  al.  2009; 
Winger  et  al.  2010), and  Lin28a  levels increase  again  during  the invasive  phase  of 
placenta development to regulate cell migration (Seabrook et al., 2011). Moreover, the 
LIN28B  locus  shows  imprinting  and  paternal  monoallelic  expression  in  the  human 
placenta (Barbaux et al. 2012). However the placental function of Lin28 remains unclear 
in vivo.  
Germline  stem  cells  also  retain  high  levels  of  Lin28  expression  during  mammalian 
development.  Lin28a  promotes  primordial  germ  cell  (PGC)  specification  via  let-7 
regulation  of  the  master  regulator  Blimp1  (West  et  al.  2009),  and  remains  high 
specifically in the spermatogonial stem cells of adult male testes (Zheng et al. 2009). 
Both  Lin28a  knockout  and  let-7  overexpression  led  to  a  reduction  in  PGCs  during 19 
 
embryogenesis, and a reduction in proliferating spermatogonia and germ cells before 
adulthood (Shinoda et al., 2013). Interestingly, aberrant overexpression of Lin28a/b is 
associated with the malignancy of human germ cell tumors, such as  choriocarcinomas, 
embryonal  carcinomas,  seminomas,  yolk-sac  tumors,  and  mixed  germ  cell  tumors 
(West et al. 2009; Cao et al. 2011a; Cao et al. 2011b; Gillis et al. 2011; Xue et al. 2011). 
Overexpression  of  Lin28a  produces  higher  grade  teratomas  whereas  Lin28a 
knockdown leads to smaller teratomas, suggesting that Lin28a acts as an oncogene in 
germ cell tumors by enhancing the self-renewal of PGCs and spermatogonial stem cells 
(West et al. 2009).  
Although Lin28a/b declines rapidly upon implantation (Tang et al. 2010), high levels of 
Lin28 persist in the neural tube and neural crest (Yang and Moss 2003; Balzer et al. 
2010). miR-125 is thought to promote neural differentiation, in part by downregulating 
Lin28a  in  neural  stem  cells  (Wulczyn  et  al.  2007;  Rybak  et  al.  2008).  Lin28a/b 
overexpression, in turn, regulates the balance of neurogenesis and gliogenesis in vitro 
(Balzer et al. 2010), and leads to an abundance of primitive neural tissue in teratomas 
formed by ESCs (West et al. 2009). By increasing Nmyc, conditional overexpression of 
Lin28b in neural crest progenitors in mice could inhibit neuronal differentiation and lead 
to  neuroblastoma  (Molenaar  et  al.  2012).  Interestingly,  a  genome-wide  association 
study (GWAS) also found that a Lin28b variant with higher expression is associated with 
higher  neuroblastoma  risk  in  humans  (Diskin  et  al.  2012).  This  suggests  that 
dysregulation of Lin28b in neural crest progenitors, which normally show only limited 
self-renewal,  can  provoke  transformation  into  neuroblastoma.  Lin28a  is  also  highly 
expressed in aggressive primitive neuroectodermal brain tumors and medulloblastoma, 20 
 
although  its  oncogenic  role  in  these  tumors  remains  less  clear  (Picard  et  al.  2012; 
Rodini et al. 2012).  
Within  the  developing  mesodermal  tissues,  fetal  hematopoietic  stem  and  progenitor 
cells (HSPCs) express high levels of Lin28b, whereas adult HSPCs do not (Yuan et al. 
2012). Overexpression of Lin28a alone in adult Lin
- bone marrow cells can reprogram 
some  of  them  into  fetal-like lymphoid  progenitors  (Yuan  et  al. 2012),  which  may  be 
relevant to Lin28’s oncogenic role in T-cell lymphoma and leukemia (Beachy et al. 2012; 
Rao et al. 2012). In acute myeloid leukemia (AML) however, Lin28a appears to act as 
an oncogene in MLL-driven AML on one end of the spectrum, and a tumor suppressor 
in miR-125-driven AML on the other (Jiang et al. 2012; Chaudhuri et al. 2012). It is 
especially interesting that miR-125 overexpression alone can promote self-renewal of 
long-term adult HSCs, to cause a variety of myeloid and lymphoid malignancies in both 
mice and humans (Bousquet et al. 2008, 2010; Guo et al. 2010; O’Connell et al. 2010; 
Ooi  et  al.  2010;  Chaudhuri  et  al.  2012),  even  though  the  miR-125  homolog  lin-4 
promotes differentiation in nematode stem cells. The unresolved questions surrounding 
miR-125 and Lin28’s roles in hematopoiesis indicate that our understanding of how the 
miR-125-Lin28-let-7 pathway regulates hematopoiesis remains incomplete. 
In another mesoderm-derived tissue, muscle stem cells or satellite cells have not been 
observed to express Lin28a/b, but proliferative myoblasts do upregulate Lin28a during 
muscle  regeneration  (Polesskaya  et al.  2007).  Loss  of Lin28a  by  siRNA  knockdown 
inhibits myogenesis, whereas Lin28a overexpression promotes myogenesis, at least in 
vitro. This process depends on direct stimulation of Igf2 translation (Polesskaya et al. 
2007), and probably other Lin28a targets in cellular growth and metabolism (Zhu et al. 21 
 
2011).  Although  muscle  development  does  not  seem  overtly  affected  in  Lin28a 
transgenic or knockout mice (Zhu et al. 2010; Zhu et al. 2011), it remains to be tested 
whether Lin28a/b are functionally important in muscle regeneration upon injury, or in 
rhabdomyosarcoma growth in vivo.  
Despite tremendous progress in our knowledge of Lin28 function in tissues of germline, 
ectodermal and mesodermal origin, little is known about Lin28 function in endodermal 
tissues. Lin28 expression has been detected in the fetal liver, kidney, intestines and 
lung by immunohistochemistry (Yang and Moss 2003). A variety of cancers involving 
these  tissues  express  Lin28b,  including  hepatocellular  carcinoma,  Wilm’s  tumors, 
colorectal cancer and lung cancer – suggesting that Lin28a/b might play a role in both 
the  normal  development  and  malignancy  of  endodermal  tissues  (Guo  et  al.  2006; 
Viswanathan et al. 2009; King et al. 2011; Zhang et al. 2012). Given the limitations of 
immunohistochemistry in small cellular compartments, and the expectation that Lin28 
may only be active in stem or progenitor cells, careful analysis using tissue specific Cre- 
or Cre-ER-driven mouse models are needed to rigorously address the role of Lin28a/b 
in tissue development by lineage-tracing. 
Lin28 in the Re-engineering of Mammalian Physiology 
It has been proposed that Lin28 is an oncofetal gene with little physiological relevance 
in normal adult tissues (Boyerinas et al. 2008; Peter 2009). Since Lin28a/b are primarily 
expressed  during  embryogenesis  and  largely silent in  most  adult  tissues,  one  could 
argue that these proteins bear little relevance to normal adult human physiology except 
when  reactivated  in  the  setting  of  malignancy.  Evolutionarily,  this  could  be  due  to 22 
 
Lin28’s  potency  in  promoting  stem  cell  self-renewal,  and  hence  tumorigenesis,  if 
dysregulated. Another gene endowed with similar properties is the catalytic component 
of  telomerase,  Tert,  which  is  likewise  predominantly  expressed  during  early 
embryogenesis, in small compartments of adult stem cells, and in cancers (Kolquist et 
al. 1998; Schaetzlein et al. 2004). Despite its apparent irrelevance to adult physiology 
initially – telomerase knockout mice are healthy and viable for the first few generations 
(Blasco et al. 1997; Yuan et al. 1999) – Tert has gained preeminence as an agent for 
re-engineering mammalian adult cells, by immortalizing cells and extending lifespan in 
vivo, along with being a potential target in cancer therapy (Sahin et al. 2010). Could 
Lin28 show similar potential in re-engineering adult human cells (Figure 1.3)? 
The answer appears to be in the affirmative. Taken together, the demonstrations that 
Lin28a overexpression with Oct4, Sox2 and Nanog can help reprogram adult human 
fibroblasts  into  ESC-like  iPSCs  (Yu  et  al.  2007),  that  Lin28a  overexpression  can 
reprogram adult HSPCs into a fetal-like HSPCs (Yuan et al. 2012), and that Lin28b 
overexpression can expand neural crest progenitors (Molenaar et al. 2012), suggest 
that Lin28a/b overexpression might be useful for promoting stem cell or progenitor self-
renewal in  vitro.  This  is  conceptually  distinct  from  Tert-based immortalization  of  any 
somatic cell, since Lin28a/b appears to counteract cellular differentiation whereas Tert 
counteracts replicative senescence. If Lin28a/b can enhance self-renewal, what effects 
would it exert on adult tissue repair in vivo? Although Lin28’s effects on mammalian 
tissue repair remains unexplored, a study has shown that zebrafish Lin28 can promote 
retinal regeneration by repressing let-7 (Ramachandran et al. 2010). This finding hints 23 
 
at the possibility that Lin28 might also extend the limits of mammalian tissue repair upon 
injury – a hypothesis that awaits further testing (Figure 1.3).  
 
Figure  1.3:  Potential  of  Lin28  in  Re-Engineering  Adult  Mammalian  Physiology. 
Lin28a,  in  conjunction  with  the  pluripotency  factors  Oct4,  Sox2  and  Nanog,  can 
reprogram somatic cells into iPSCs. Alone, Lin28a/b can reprogram adult HSPCs into a 
fetal-like  state,  and  enhance  insulin  sensitivity  in  the  skeletal  muscles  to  improve 
glucose homeostasis, resist obesity and prevent diabetes. Emergent clues suggest that 
optimal  doses  of  Lin28a/b  might  have  the  potential  to  re-engineer  adult  mammalian 
tissue repair capacities and extend longevity, although Lin28a/b could also cooperate 
with oncogenes to initiate tumorigenesis. Future work might elucidate these mysteries.  24 
 
In the same vein, the Lin28/let-7 pathway could impact longevity, although it remains 
unclear whether Lin28 overexpression would promote or delay aging. Given that Lin28 
upregulates  and  let-7  downregulates  insulin-PI3K  signaling  in  mammals  (Zhu  et  al. 
2011), and insulin-PI3K signaling also regulates mammalian aging in an evolutionarily 
conserved  fashion,  one  might  expect  Lin28  to  promote  and  let-7  to  delay  aging  in 
mammals.  This  would  concur  with  several  studies  showing  that  several  long-lived 
mouse strains like the Ames, Snell, GHRKO and Igfr1
+/- mice are all dwarfed (Bartke 
2012), similar to mice overexpressing let-7 (Zhu et al. 2011; Frost and Olson 2011). Yet 
improved insulin sensitivity, a prominent phenotype of mice overexpressing Lin28a/b, is 
associated with longevity (Barbieri et al. 2003), indicative of how longevity is regulated 
by  a  multifaceted  network  of  factors.  Adding  to  this  complexity,  deficiency  in  tissue 
repair can accelerate aging as shown in telomerase-deficient and p53-overexpressing 
mice (Rudolph et al. 1999; Tyner et al. 2002), but hyperactive tissue regeneration can 
also lead to stem cell exhaustion and shorter lifespans, as shown in models of Pten
-/- 
myelodysplasias  and  muscular  dystrophy  (Yilmaz  et  al.  2006;  Sacco  et  al.  2010).  It 
could  well  be  that  only  the  precise  dosage  of  Lin28/let-7  that  strikes  an  optimal 
equilibrium  between  insulin  signaling  and  tissue  repair  would  enhance  mammalian 
longevity.   
As is the case with telomerase, a wide variety of cancers reactivate Lin28 to re-
engineer their cellular states (Viswanathan et al. 2009). Although the oncogenic role of 
Lin28a/b has only been demonstrated in vivo for a small subset of cancers including 
neuroblastoma,  T-cell  acute  lymphoblastic  leukemia  and  peripheral  T-cell  lymphoma 
(Molenaar et al. 2012; Beachy et al. 2012; Rao et al. 2012), the cancer stem cell model 25 
 
seems  to  apply  in  all  these  cases,  with  Lin28  as  a  stem  cell  factor  promoting  self-
renewal. The cancer stem cell model posits that cancers are maintained by a  small 
population of tumor-sustaining cancer stem cells with self-renewal capacity (Rosen et 
al. 2009). Although the cancer stem cell model has engendered debate and does not 
apply universally to all cancers, as shown most convincingly  in advanced melanoma 
and lymphoma (Quintana et al. 2008, 2010; Boiko et al. 2010), leukemias, germ cell 
tumors  and  some  other  solid  cancers  appear  to  follow  the  cancer  stem  cell  model 
(Ishizawa  et  al.  2010).  Irving  Weissman  and  colleagues  have  proposed  that  in  the 
earliest  stages  of  melanoma,  rare  cancer  stem  cells  differentiate  into  nonmalignant 
progeny to form the bulk of the tumor, whereas in the advanced stages cancer stem cell 
clones dominate and constitute the bulk of the tumor (Boiko et al. 2010). These ﬁndings 
suggest  that  targeting  cancer  cell  heterogeneity  may  be  a  relevant  approach  for 
eradicating tumors only during a cancer’s early stages. If Lin28’s role in promoting stem 
cell  and  progenitor  self-renewal  is  also  its  essential  mechanism  for  promoting 
tumorigenesis, then Lin28 would represent a promising universal factor for therapeutic 
targeting in a wide variety of cancer stem cells. This exciting prospect warrants attempts 
to drug the Lin28 pathway.  
Conclusion   
Seminal observations made nearly three decades ago by Victor Ambros and Robert 
Horvitz on the role of Lin28 in C. elegans heterochronic reiterations have spawned great 
leaps in  our  understanding of  how  post-transcriptional  RNA  processing  can  regulate 
stem cells. Recent advances are painting a detailed picture of how Lin28 regulates let-7 
microRNA  biogenesis  and  mRNA  translation,  to  coordinate  both  cellular  metabolism 26 
 
and proliferative growth pathways for the purpose of stem cell self-renewal. Although 
much effort has been expended to elucidate the let-7 microRNA regulatory mechanism, 
it is imperative that we also understand how Lin28a/b regulates mRNA processing and 
trafficking between the nucleus, ribosomes, P-bodies and stress granules – a mystery 
that remains unresolved. And what conditions or pathways regulate the mechanism of 
Lin28a  or Lin28b  within  the  nucleolus,  the cytoplasm,  and  P-bodies?  How  do  these 
mechanisms  affect  Lin28a/b  function in  tissue  stem  cells  and  progenitors,  especially 
those derived from the endoderm given its preponderance in colon, kidney, liver and 
lung cancers? And can we harness Lin28 to re-engineer and improve mammalian tissue 
repair and longevity? Or target it for cancer therapy? Hopefully we can answer these 
questions, and more, in the coming decade.  
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Chapter 2: The Lin28/let-7 axis regulates glucose metabolism in mammals 
Introduction 
One  rapidly  emerging  paradigm  in  cancer  biology  is  that  malignancy  and  metabolic 
disease  share  common  biological  mechanisms.  Reprogramming  towards  glycolytic 
metabolism can increase a cancer cell’s ability to generate biomass, a phenomenon 
termed the “Warburg Effect” (Denko, 2008; Engelman et al., 2006; Gao et al., 2009; 
Guertin and Sabatini, 2007; Laplante and Sabatini, 2009; Vander Heiden et al., 2009; 
Yun et al., 2009). Likewise, many genes identified in type 2 diabetes (T2D) genome 
wide association studies (GWAS) are proto-oncogenes or cell cycle regulators (Voight 
et  al.,  2010).  MicroRNAs  (miRNAs)  are  also  emerging  as  agents  of  metabolic  and 
malignant regulation in development and disease (Hyun et al., 2009; Peter, 2009). The 
let-7  miRNA  family  members  act  as  tumor  suppressors  by  negatively  regulating  the 
translation  of oncogenes  and  cell  cycle  regulators (Johnson  et  al., 2005;  Lee  et al., 
2007; Mayr et al., 2007; Kumar et al., 2008). Widespread expression and redundancy 
among  the  well-conserved  let-7  miRNAs  raise  the  question  of  how  cancer  and 
embryonic  cells  are  able  to  suppress  this  miRNA  family  to  accommodate  rapid  cell 
proliferation.  In  human  cancers,  loss  of  heterozygosity,  DNA  methylation,  and 
transcriptional  suppression  have  been  documented  as  mechanisms  to  reduce  let-7 
(Johnson et al., 2005; Lu et al., 2007). Another mechanism for  let-7 downregulation 
involves  the  RNA-binding  proteins  Lin28a  and  Lin28b  (collectively  referred  to  as 
Lin28a/b), which are highly expressed during normal embryogenesis and upregulated in 
some cancers to potently and selectively block the maturation of let-7 (Heo et al., 2008; 
Newman et al., 2008; Piskounova et al., 2008; Rybak et al., 2008; Viswanathan et al., 28 
 
2008). By repressing the biogenesis of let-7 miRNAs and in some cases through direct 
mRNA binding and enhanced translation (Polesskaya et al., 2007; Xu and Huang, 2009; 
Xu et al., 2009; Peng et al., 2011), Lin28a/b regulate an array of targets involved in cell 
proliferation and differentiation in the context of embryonic cells, stem cells, and cancer.  
 
Little is known about the in vivo function of the Lin28/let-7 axis. The pathway was first 
revealed  in  a  screen  for  heterochronic  mutants  in  C.  elegans,  where  loss  of  lin-28 
resulted in precocious vulval differentiation and premature developmental progression 
(Ambros and Horvitz, 1984; Moss et al., 1997; Nimmo and Slack, 2009), whereas loss 
of let-7 led to reiteration of larval stages and delayed differentiation (Abbott et al., 2005; 
Reinhart  et  al., 2000). We  previously  showed  that  Lin28a  gain of  function  promotes 
mouse growth and delays sexual maturation, recapitulating the heterochronic effects of 
lin-28 and let-7 in C. elegans, as well as the height and puberty phenotypes linked to 
human genetic variation at the Lin28b locus identified in GWAS (Zhu et al., 2010). The 
conservation  of  Lin28  and  let-7’s  biochemical and physiological functions  throughout 
evolution suggests an ancient mechanism for Lin28 and let-7’s effects on growth and 
developmental timing. 
 
In this report we found that both Lin28a and LIN28B transgenic mice were resistant to 
obesity and exhibited enhanced glucose tolerance. In contrast, muscle-specific Lin28a 
knockout and inducible let-7 transgenic mice displayed glucose intolerance, suggesting 
that the Lin28/let-7 pathway plays a specific and tightly regulated role in modulating 
glucose metabolism in mammals. In vitro experiments revealed that Lin28a enhances 29 
 
glucose  uptake  via  an  increase  in  insulin-PI3K-mTOR  signaling  due  in  part  to  the 
derepression  of  multiple  direct  let-7  targets  in  the  pathway,  including  IGF1R,  INSR, 
IRS2,  PIK3IP1,  AKT2,  TSC1  and  RICTOR.  Experiments  with  the  mTOR-specific 
inhibitor rapamycin demonstrate that Lin28a regulates growth, glucose tolerance, and 
insulin sensitivity in an mTOR-dependent manner in vivo. In addition, analysis of T2D 
and fasting glucose whole genome associations suggests a genetic connection between 
multiple genes regulated by let-7 and glucose metabolism in humans. These metabolic 
functions for Lin28a/b and let-7 in vivo provide a mechanistic explanation for how this 
pathway might influence embryonic growth, metabolic disease and cancer.  
 
Experimental Procedures 
Mice. All animal procedures were based on animal care guidelines approved by the 
Institutional  Animal  Care  and  Use  Committee.  Mouse  lines  used  in  this  study  are 
described in Figure S2.5. 
Indirect Calorimetry. The apparatus used was a set of 16 OxyMax® Metabolic Activity 
Monitoring  chambers  (Columbus  Instruments;  Columbus,  OH,  USA).  Each  chamber 
consisted of a self-contained unit capable of providing continuous measurements of an 
individual mouse’s total activity and feeding behavior. Monitoring occurred over a 3-day 
period. Each subject was placed into an individual chamber on day 1, with free access 
to food and water during the course of the experiment. Subjects were maintained under 
a  normal  12:12  h  light:dark  cycle.  All  measurements  were  sampled  periodically  (at 
approximately 12-min intervals) and automatically recorded via the OXYMAX Windows 
V3.22 software. Activity measures over the final 24-h period were parceled into 2-h bins 30 
 
and these were used to express diurnal activity levels. 
Quantitative RT-PCR. Performed with standard methods. 
Histology. Tissue samples were fixed in 10% buffered formalin or Bouin’s solution and 
embedded in paraffin.  
Glucose and insulin tolerance tests. Overnight-fasted mice were given i.p. glucose 
(2 mg/g body weight). For insulin tolerance test, 5 hour fasted mice were given 0.75 U 
insulin/kg body weight by i.p. injection (Humulin). Blood glucose was determined with a 
Lifescan One Touch glucometer. Insulin, GH, and Igf1 levels were measured by ELISA 
(Crystal Chem). 
Cloning. Murine Lin28a and human LIN28B cDNA was subcloned into pBabe.Puro and 
pMSCV.Neo retroviral vectors. LIN28B and Control shRNA in lentiviral plasmids were 
purchased from Sigma-Aldrich and previously reported in Viswanathan et al., 2009.  
Cell culture, viral production, and transfection. Performed using standard methods. 
Glucose uptake assay. In vitro glucose uptake assays were performed as described in 
Berti and Gammeltoft, 1999. 
Drug treatments. Rapamycin was injected i.p. 3 times a week for mouse experiments. 
For cell culture, C2C12 myotubes differentiated for 3 days were incubated with inhibitors 
for 1 day prior to glucose uptake assays. See Extended Experimental Procedures for 
further details. 
Western blot assay. Performed using standard methods. 
Luciferase reporter assay.  10 ng of each construct was co-transfected with 10 nM 
miRNA  duplexes  or  into  HEK-293T  cells  in  a  96-well  plate  using  lipofectamin-2000 31 
 
(Invitrogen). After 48 hours, the cell extract was obtained; firefly and Renilla luciferase 
activities were measured with the Promega Dual-Luciferase
® reporter system.  
MAGENTA analysis. See Table 2.1 Legend.  
Statistical analysis. Data is presented as mean ﾱ SEM, and Student’s t-test (two-tailed 
distribution, two-sample unequal variance) was used to calculate p values. Statistical 
significance is displayed as p < 0.05 (one asterisk) or p < 0.01 (two asterisks). The tests 
were performed using Microsoft Excel where the test type is always set to two-sample 
equal variance. 
 
Results 
Lin28a Tg mice are resistant to obesity and diabetes 
We previously described a tetracycline-inducible Lin28a transgenic mouse that showed 
leaky  constitutive  Lin28a  expression  in  the  absence  of  induction  (See  Experimental 
Procedures, “Lin28a Tg” mice: Zhu et al., 2010). In that study, we showed that these 
mice cleared glucose more efficiently during glucose and insulin tolerance testing (GTT 
and ITT), classic metabolic tests used for the characterization of whole animal glucose 
handling. Given that young Lin28a Tg mice exhibited enhanced glucose metabolism, we 
tested if old Lin28a Tg mice were also resistant to age-induced obesity. Compared to 
Lin28a Tg mice, wild-type mice fed a normal diet gained significantly more fat mass with 
age  (Figure  2.1A).  Dual  Energy  X-ray  Absorptiometry  scans  showed  increased 
percentage lean mass and reduced percentage body fat in the Lin28a Tg mice (Figure 
2.1B,C).  To  rule  out behavioral  alterations, we  measured  activity  over  three  days  in 32 
 
isolation cages and found no differences in horizontal activity, O2/CO2 exchange, and 
food/water  intake  between  wild-type  and  Tg  mice  (Figure  S2.1A,B  in  Appendix).  To 
determine  if  these  mice  were  resistant  to  HFD-induced  obesity,  we  fed  mice  a  diet 
containing 45% kcals from fat, and observed resistance to obesity in the Lin28a Tg mice 
(Figure  2.1D).  Lin28a  Tg  mice  consumed  as  much  high-fat  food  as  their  wild-type 
littermates, ruling out anorexia (data not shown). Furthermore, we inquired if Lin28a Tg 
mice  were  resistant  to  HFD-induced  diabetes  and  found  that  they  had  markedly 
improved  glucose  tolerance  and  insulin  sensitivity  under  HFD  conditions  (Figure 
2.1E,F).  Lin28a  Tg  mice  also  showed  resistance  to  HFD-induced  hepatosteatosis 
(Figure  2.1G).  Taken  together,  leaky  Lin28a  expression  in  the  muscle,  skin  and 
connective  tissues  (Zhu  et  al.,  2010)  protected  against  obesity  and  diabetes  in  the 
context of aging and HFD.   
iLIN28B Tg mice are likewise resistant to diabetes  
Although Lin28a and Lin28b both block let-7 miRNAs, they are differentially regulated, 
resulting  in  distinct  expression  patterns  during  normal  development  and  malignant 
transformation  (Guo  et  al.,  2006;  Viswanathan  et  al.,  2009).  Given  that  LIN28B  is 
overexpressed more frequently than LIN28A in human cancer, we sought to determine 
if LIN28B exerts a similar effect on glucose metabolism. Thus, we generated a mouse 
strain with human LIN28B driven by a tetracycline transactivator rtTA placed under the 
control of the Rosa26 locus (iLIN28B mouse) (See Experimental Procedures). After 14 
days  of  treatment  with  the  tetracycline  analogue  doxycycline  (dox),  high  levels  of 
LIN28B  were  induced  and  mature  let-7’s  were  repressed  in  metabolically  important 
organs (Figure 2.1H,I), resulting in hypoglycemia with an average fasting glucose of <50  33 
 
Figure 2.1: Lin28a Tg and iLIN28B Tg mice are resistant to obesity and diabetes 
and Lin28a is physiologically required for normal glucose homeostasis. (A) Aged 
wild-type (left) and Lin28a Tg mice (right) fed a normal diet, at 20 weeks of age. (B) 
Percentage body fat and (C) lean mass as measured by DEXA. (D) Weight curve of 
mice fed a HFD containing 45% kcals from fat. (E) Glucose tolerance test (GTT) and (F) 
Insulin tolerance test (ITT) of mice on HFD. (G) Liver histology of mice fed HFD. (H) 
Human LIN28B mRNA expression in a mouse strain with dox inducible transgene 
expression (named iLIN28B). (I) Mature let-7 expression in gut, spleen, liver, muscle 
and fat. (J) Kinetics of fed state glucose change after induction. (K) GTT and (L) ITT 
under normal diets. (M) iLIN28B growth curve under HFD. (N) GTT after 14 days of 
HFD and induction. (O) GTT and (P) ITT of Myf5-Cre; Lin28a
fl/fl mouse. Controls for 
Lin28a Tg mice are WT. Controls for iLIN28B Tg mice carry only the LIN28B transgene. 
Controls for muscle knockout mice are Lin28a
fl/fl mice. The numbers of experimental 
animals are listed within the charts. 
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Figure 2.1 (continued)
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mg/dL  in  induced  mice  compared  to  >150  mg/dL  in  control  mice  (p  <  0.01).  To 
determine the kinetics of this effect, we measured fed state glucose daily and noted 
falling glucose levels after 5 days (Figure 2.1J). Glucose and insulin tolerance tests on 
dox-induced animals on normal diets showed considerable improvements in glucose 
tolerance and insulin sensitivity (Figure 2.1K,L). In checking for islet β cell hyperactivity, 
we found that iLIN28B mice produced no more insulin than control littermates during 
glucose challenge (data not shown).  Under HFD, we found that induced iLIN28B mice 
were surprisingly resistant to weight gain (Figure 2.1M) despite a slight increase in food 
intake (9.9 vs. 4.8 g/mouse/day; p = 0.075). These mice continued to exhibit superior 
glucose  tolerance  after  14  days  of  dox  induction  under  HFD  (Figure  2.1N),  when 
average weights were 33.5 ± 1.05 grams for controls and 27.1 ± 0.99 grams for iLIN28B 
mice,  demonstrating  that  HFD  had  a  strong  obesogenic  and  diabetogenic  effect  on 
control but not on LIN28B induced animals. Unlike the Lin28a Tg mice, expression was 
not leaky in the iLIN28B mice (Figure 2.1H) and uninduced mice exhibited no growth or 
glucose phenotypes (Figure S2.1C,D), making this a better model for inducible Lin28 
hyperactivation. These data show that both Lin28 homologues have similar effects on 
glucose metabolism and obesity, suggesting that these effects are mediated through 
common mRNA or miRNA targets of the Lin28 family. 
 
Lin28a is physiologically required for normal glucose homeostasis 
We then asked if Lin28a is physiologically required for normal glucose metabolism in 
one  specific  adult  tissue  compartment,  skeletal  muscle,  since  previous  studies  have 
found  low  but  significant  levels  of  Lin28a  expression  in  the  muscle  tissues  of  mice 36 
 
(Yang  and  Moss,  2003;  Zhu  et  al,  2010).  We  generated  a  skeletal  muscle-specific 
knockout of Lin28a by crossing the mouse myogenic factor 5 Cre recombinase strain 
(Myf5-Cre)  to  the  Lin28a
fl/fl  conditional  loss  of  function  mouse  (See  Experimental 
Procedures). These muscle-specific knockout mice showed impaired glucose tolerance 
(Figure  2.1O)  and  insulin  resistance  (Figure  2.1P)  relative  to  wild-type  littermates, 
demonstrating that Lin28a activity in skeletal muscles is required for normal glucose 
homeostasis. We analyzed miRNA expression in muscle tissue by qRT-PCR and found 
no  significant  difference  in  let-7  levels  during  adult  (data  not  shown)  or  embryonic 
stages  (Figure  S2.1E),  suggesting  that  Lin28a  loss  of  function  affects  glucose 
homeostasis either through let-7-independent mRNA binding or through changes in the 
spatiotemporal  distribution  of  let-7  miRNA.  Together,  these  data  show  that  Lin28 
isoforms are important and essential regulators of glucose homeostasis. 
 
iLet-7 mice are glucose intolerant 
In addition to their ability to suppress let-7 biogenesis, Lin28a and Lin28b also regulate 
mRNA  targets  such  as  Igf2,  HMGA1,  OCT4,  histones  and  cyclins  through  non-let-7 
dependent mechanisms of mRNA binding and enhanced translation (Polesskaya et al., 
2007; Xu and Huang, 2009; Xu et al., 2009; Peng et al., 2011). To test if altered let-7 
expression  might  produce  the opposite  phenotypes  of  Lin28a/b  gain of  function,  we 
generated a mouse strain in which let-7g can be induced with dox under the control of 
the  Rosa26  locus  (iLet-7  mouse,  See  Experimental  Procedures).  To  ensure  that 
endogenous Lin28 would not block pri- or pre-let-7g biogenesis, we used a chimeric let-  37 
 
 
Figure  2.2:  iLet-7  mice  are  glucose  intolerant.  (A)  let-7g  and  let-7a  qRT-PCR  in 
tissues of dox induced iLet-7 mice (n = 3) and controls (n = 3). (B) Reduced size of 
induced animals. (C) iLet-7 growth curve for males and females. (D) Fed state glucose 
in iLet-7 mice induced for 5 days. GTTs performed on mice fed with either (E) normal 
diet  or  (F)  HFD.  (G)  ITT  on  normal  diet.  (H)  Insulin  production  during  a  glucose 
challenge. (I) GTT of LIN28B/Let-7 compound heterozygote mice before (blue) and after 
(red) induction with dox. (J) Area under the curve (AUC) analysis for this GTT. Controls 
for iLet-7 Tg mice carry either the Let-7 or Rosa26-M2rtTa transgene only. The numbers 
of experimental animals are listed within the charts. 38 
 
7g species called let-7S21L (let-7g Stem, mir-21 Loop), in which the loop region of the 
precursor miRNA derives from mir-21 and cannot be bound by Lin28, thus allowing for 
let-7 processing despite Lin28 expression (Piskounova et al., 2008). Global transgene 
induction from three weeks of age onwards increases mature let-7g levels in liver (>50-
fold), skin (>20-fold), fat (~4-fold) and muscle (~4-fold) (Figure 2.2A). This level of let-7 
overexpression led to reduced body size and growth rates in induced animals (Figure 
2.2B,C). Growth retardation was proportional and not manifested as preferential size 
reduction in any particular organs (Figure S2.2A). Similar to the iLIN28B mice, leaky 
expression was not detected and uninduced male mice exhibited no growth or glucose 
phenotypes (Figure S2.2B-D). 
  
After  5  days  of  let-7 induction, these  iLet-7  mice  produced  an increase in  fed  state 
glucose (Figure 2.2D). GTT revealed glucose intolerance in mice fed normal (Figure 
2.2E)  or  HFD  (Figure  2.2F).  Surprisingly,  ITT  failed  to  detect  a  difference  in  insulin 
sensitivity (Figure 2.2G). The decreased glucose tolerance in the setting of comparable 
insulin  sensitivity  suggested  either  decreased  insulin  production  from  islet  β  cells  in 
response to glucose, or higher insulin secretion to compensate for peripheral insulin 
resistance.  Thus,  we  measured  insulin  production  following  glucose  challenge,  and 
found that iLet-7 mice produced slightly more insulin than controls (Figure 2.2H). These 
results demonstrated that broad overexpression of  let-7 results in peripheral glucose 
intolerance and compensatory overproduction of insulin from islet β cells.  
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To  test  if  let-7  induction  could  abrogate  the  glucose  uptake  phenotype  of  LIN28B 
overexpression, we crossed the iLIN28B to the iLet-7 inducible mice. After 10 days of 
induction, simultaneous induction of LIN28B and let-7g did not result in any differences 
in  glucose  tolerance  (Figure  2.2I,J), in  contrast  to  LIN28B  or  let-7g induction  alone. 
Taken  together,  the  opposing  effects  of  Lin28  and  let-7  expression  on  glucose 
regulation show that Lin28 overexpression influences metabolism in part by suppressing 
let-7, and that let-7 alone is sufficient to regulate glucose metabolism in vivo. 
 
Insulin-PI3K-mTOR signaling is activated by Lin28a/b and suppressed by let-7 
To  dissect  the  molecular  mechanism  of  the  effects  of  Lin28  and  let-7  on  glucose 
regulation, we turned to the C2C12 cell culture system. Overexpression of Lin28a in 
C2C12 myoblasts resulted in protein levels of Lin28a similar to that observed in mouse 
embryonic stem cells (ESCs) (Figure 2.3A), and led to robust let-7 suppression (Figure 
2.3B).  In  C2C12  myotubes  differentiated  for  3  days,  Lin28a  promoted  Ser473 
phosphorylation  of  Akt  and  Ser235/236  phosphorylation  of  S6  ribosomal  protein, 
suggesting activation of the PI3K-mTOR pathway (Figure S2.3A). In this setting, Lin28a 
increased myotube glucose uptake by 50% (Figure 2.3C). Lin28a-dependent glucose 
uptake was abrogated by 24hr treatment with the PI3K/mTOR inhibitor LY294002 or the 
mTOR  inhibitor  rapamycin  (Figure  2.3C),  but  not  the  MAPK/ERK  inhibitor  PD98059 
(Figure  S2.3B),  demonstrating  that  Lin28a-dependent  glucose  uptake  requires  the 
PI3K-mTOR pathway.  
To  exclude  myotube  differentiation-dependent  phenomena,  we  tested  the  effects  of 
Lin28a on PI3K-mTOR signaling in undifferentiated myoblasts under serum-fed, serum- 40 
 
 
Figure 2.3: Insulin-PI3K-mTOR signaling is activated by Lin28a/b and suppressed 
by let-7. (A) Western blot analysis of Lin28a protein expression in C2C12 myoblasts 
infected with control pBabe or Lin28a overexpression vector, and mouse ESCs, with 
tubulin  as  the  loading  control.  (B)  Quantitative  PCR  for  let-7  isoforms  in  C2C12 
myoblasts,  normalized  to  sno142,  after  Lin28a  overexpression.  (C)  2-deoxy-D-[
3H] 
glucose uptake assay on 3-day-differentiated C2C12 myotubes with and without Lin28a 
overexpression,  treated  with  DMSO,  the  PI3K  inhibitor  LY294002,  and  the  mTOR 
inhibitor rapamycin for 24 hrs. (D) Western blot analysis of the effects of Lin28a 41 
 
Figure 2.3 (continued) overexpression on PI3K-mTOR signaling in C2C12 myoblasts, 
under serum-fed (fed), 18 hr serum starved (SS) or insulin-stimulated (Ins) conditions. 
Insulin stimulation was performed in serum-starved myoblasts with 10 µg/mL insulin for 
5  min.  Prior to insulin  stimulation,  serum-starved  myoblasts  were  treated  with either 
DMSO or 20 ng/mL rapamycin for 1 hr. (E) Western blot analysis of the effects of let-7f 
or control miRNA on PI3K-mTOR signaling in C2C12 myoblasts under serum-fed (fed), 
18  hr  serum  starved  (SS)  or  insulin-stimulated  (Ins)  conditions.  (F)  Western  blot 
analysis  of  the  effects  of  LIN28B  induction  by  dox  on  PI3K-mTOR  signaling  in 
quadriceps muscles in vivo (n = 3 iLIN28B Tg mice and 3 LIN28B Tg only mice). (G) 
Insr and p-4EBP1 protein levels in wild-type and Lin28a muscle-specific KO adults. 
 
starved,  and  insulin-stimulated  conditions  (Figure  2.3D).  In  the  serum-fed  state,  we 
found  that  Lin28a  promoted  the  activation  of  PI3K/Akt  signaling  by  increasing  Akt 
phosphorylation at both Ser473 and Thr308, compared to the pBabe control.  
 
Furthermore, we found that Lin28a robustly increased the phosphorylation of mTORC1 
signaling targets S6 and 4EBP1 in the serum-fed state. Serum-starvation for 18 hours 
abrogated the phosphorylation of Akt, S6 and 4EBP1, indicating that Lin28a-induction of 
PI3K-mTOR  signaling  requires  exogenous  growth  factor  stimulation.  Upon  insulin 
stimulation,  Akt  phosphorylation  increased  dramatically  and,  both  phospho-S6  and 
phospho-4EBP1  levels  were  increased  even  further  by  Lin28a  overexpression, 
suggesting  that  Lin28a  increases  the  insulin-sensitivity  of  C2C12  myoblasts. 
Importantly,  we  found  that  rapamycin  abrogated  the  Lin28a-induction of  phospho-S6 42 
 
and  phospho-4EBP1  upon  insulin  stimulation,  but  did  not  affect  let-7  levels  (Figure 
S2.3C) or Lin28a itself (Figure 2.3D), indicating that the mTOR dependence is occurring 
downstream of Lin28a.  
 
To test if the effects of Lin28a on insulin-PI3K-mTOR signaling are let-7-dependent, we 
transfected either mature let-7f duplex or a negative control miRNA into both Lin28a-
overexpressing and pBabe control myoblasts (Figure S2.3D and Figure 2.3E). Because 
mature let-7 duplexes cannot be bound and inhibited by Lin28a protein, this experiment 
tests if PI3K-mTOR activation is occurring downstream of let-7. Transfection with control 
miRNA did not affect Lin28a-induction of the phosphorylation of Akt, S6, or 4EBP1 in 
serum-starved  myoblasts  upon  insulin  stimulation.  Transfection  with  let-7f,  however, 
attenuated the Lin28a-induction of phospho-Akt (Ser473), and abrogated the increase in 
S6  and  4EBP1  phosphorylation  upon  insulin  stimulation  in  Lin28a-overexpressing 
myoblasts (Figure 2.3E). In pBabe control myoblasts, let-7 duplex still suppressed S6 
and  4EBP1  phosphorylation  in  the  serum-fed  state,  serum-starved,  and  insulin-
stimulated conditions, relative to total S6 and 4EBP1 protein. The suppression of mTOR 
signaling by let-7 even in the absence of Lin28a implies that let-7 can act independently 
downstream  of  Lin28a.  Together  with  data  indicating  that  let-7  abrogates  Lin28a-
specific  induction  of  p-Akt,  p-S6  and  p-4EBP1  upon  insulin  stimulation,  this 
demonstrates that the effects of Lin28a on PI3K-mTOR signaling are at least in part due 
to let-7 and that Lin28 and let-7 exert opposing effects on PI3K-mTOR signaling. 
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To test if these effects of Lin28 on insulin-PI3K-mTOR signaling are also relevant in 
vivo,  we  examined  the  quadriceps  muscles  of  iLIN28B  mice  and  found  that  dox-
induction led to increases in the phosphorylation of Akt (S473), S6 and 4EBP1, the 
targets  of  PI3K-mTOR  signaling  (Figure  2.3F).  Furthermore,  the  Insulin-like  growth 
factor 1 receptor (Igf1r) and the Insulin receptor (Insr) proteins were also upregulated in 
the muscles upon LIN28B induction, reinforcing the fact that  Lin28a/b drives insulin-
PI3K-mTOR  signaling  in  C2C12  myoblasts  and  within  mouse  tissues.  On  the  other 
hand, similar analysis of the Lin28a muscle-specific knockout mice revealed reduced 
Insr  and  p-4EBP1  expression  (Figure  2.3G),  demonstrating  that  Lin28a  is  both 
necessary  and  sufficient  to  influence  glucose  metabolism  through  the  regulation  of 
insulin-PI3K-mTOR signaling in vivo.  
 
Lin28a/b and let-7 regulate genes in the insulin-PI3K-mTOR pathway 
On the RNA level, Lin28a overexpression in C2C12 myoblasts leads to an increase in 
mRNA  levels  of  multiple  genes in  the insulin-PI3K-mTOR  signaling  pathway  (Figure 
S2.4A). Although both Lin28a suppression of let-7 and direct Lin28a binding to mRNAs 
could increase mRNA stability and thus increase mRNA levels, it is possible that these 
increases  do  not  reflect  direct  interactions.  To  find  direct  targets,  we  performed  a 
bioinformatic screen using the TargetScan 4.1 algorithm (Grimson et al., 2007), and 
found  that  16  genes  in  the  insulin-PI3K-mTOR  pathway  contained  evolutionarily 
conserved  let-7  binding  sites  in  their  respective  3’UTRs  (Figure  2.4A,B).  Next,  we 
performed 3’ UTR luciferase reporter assays to determine if these genes were bona fide 
and direct targets of  let-7. To do this, we generated luciferase reporters with twelve 44 
 
 
Figure 2.4: Lin28a/b and let-7 regulate genes in the insulin-PI3K-mTOR pathway. 
(A) Shown are the numbers of conserved let-7 binding sites within 3’UTRs found using 
the TargetScan algorithm. (B) Putative let-7 binding sites in 16 genes of the insulin-
PI3K-mTOR pathway and in Lin28a/b. (C) 3’UTR luciferase reporter assays performed 
to determine functional let-7 binding sites. Bar graphs show relative luciferase reporter 
expression  in  human  HEK293T  cells  after  transfection  of  mature  let-7f  duplex 
normalized to negative control miRNA. Shown also are mutations in the seed sequence 
of  the  let-7  binding  sites  for  INSR,  IGF1R  and  IRS2.  (D)  Western  blot  analysis  of 
Lin28a, Irs2, and tubulin in C2C12 myoblasts with and without Lin28a overexpression.  
(E) Western blot analysis of LIN28B, total IRS2, INSR and TUBULIN in HEK293T cells 
with either let-7f transfection or shRNA knockdown of LIN28B. 
 
human  3’UTR  fragments  containing  conserved  let-7  sites.  Luciferase  reporter 
expression in human HEK293T cells after transfection of either mature let-7f duplex or a 
negative control miRNA demonstrated that the 3’ UTRs of INSR, IGF1R, IRS2, PIK3IP1, 45 
 
AKT2, TSC1 and RICTOR were targeted by let-7 for suppression in varying degrees 
(Figure 2.4C). Three-base mismatch mutations in the seed region of the let-7 binding 
sites  abrogated  let-7’s  suppression  of  INSR,  IGF1R  and  IRS2.  To  confirm  that  the 
luciferase reporters predicted actual changes in protein expression mediated by let-7, 
we  assayed  the  endogenous  expression  of  some  of  these  proteins  upon  Lin28a/b 
overexpression. We found that an increase in Lin28a upregulated Irs2 (Figure 2.4D) in 
vitro,  and  that  an  increase  in  LIN28B  upregulated  Igf1r  and  Insr  protein  in  skeletal 
muscles in vivo (Figure 2.3F). Conversely, INSR and IRS2 are reduced upon both let-7f 
transfection  and  LIN28B  shRNA  knockdown  in  HEK293T,  demonstrating  that  these 
regulatory mechanisms hold in both mouse and human cells, and in the setting of both 
LIN28B gain and loss of function (Figure 2.4E). This establishes a direct mechanism for 
let-7’s repression and Lin28’s derepression of multiple components in the insulin-PI3K-
mTOR signaling cascade. 
 
Previously, Lin28a has been shown to enhance Igf2 translation independently of let-7 
(Polesskaya  et  al.,  2007),  offering  an  alternative  mechanism  by  which  Lin28a  might 
activate the insulin-PI3K-mTOR pathway. To determine the relative contribution of this 
mechanism, we performed in vitro and in vivo loss of function experiments. Following 
siRNA  knockdown  of  Igf2  in  C2C12  (the  efficacy  of  knockdown  is  shown  in  Figure 
S2.4B),  we  found  only  minimal  changes  in  S6  and  4EBP1  phosphorylation  (Figure 
S2.4C). In these C2C12 myotubes, glucose uptake was unaffected by Igf2 knockdown, 
but significantly decreased by let-7a (Figure S2.4D). In addition, we crossed the Lin28a 
Tg mice with Igf2 knockout mice and found that the absence of Igf2 did not abrogate 46 
 
enhanced  glucose  uptake,  insulin  sensitivity,  or  the  anti-obesity  effect  mediated  by 
Lin28a  (Figure  S2.4E-H).  Taken  together,  these  data  indicate  that  the  metabolic 
phenotypes we have observed are not solely due to the ability of Lin28a/b to promote 
translation of Igf2 mRNA, but do not rule out the possibility that Lin28a/b might modulate 
other mRNAs in the insulin-PI3K-mTOR signaling pathway.  
 
mTOR mediates Lin28a’s enhancement of growth and glucose metabolism in vivo 
Given that Lin28a activates the insulin-PI3K-mTOR pathway both in vitro and in vivo, we 
asked  whether  the  metabolic  effects  of  Lin28a  in  vivo  could  be  abrogated  by 
pharmacological inhibition of the mTOR pathway. To do this, we injected Lin28a Tg and 
wild-type littermates with rapamycin 3 times per week beginning when mice were 18 
days old. Rapamycin abrogated the growth enhancement in Lin28a Tg mice at doses 
that  had  minimal  growth  suppressive  effects  on  wild-type  mice  (Figure  2.5A,B), 
suggesting  that  Lin28a  promotes  growth  in  an  mTOR-dependent  manner.  Selective 
suppression of Lin28a-driven growth was observed using several parameters: weight 
(Figure 2.5B,C), crown-rump length (Figure 2.5D), and tail width (Figure 2.5E). We also 
tested if the enhanced glucose uptake phenotype  in vivo was likewise dependent on 
mTOR. Indeed, glucose tolerance testing showed that short-term rapamycin reversed 
the enhanced glucose uptake effect of Lin28a (Figure 2.5F,G) and reduced the insulin-
sensitivity of Lin28a Tg mice to wild-type levels (Figure 2.5H,I). These data indicate that 
the  glucose  uptake,  insulin  sensitivity  and  animal  growth  phenotypes  of  Lin28a 
overexpression in vivo are dependent on mTOR signaling. 
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Figure  2.5:  mTOR  is  required  for  Lin28a’s  effects  on  growth  and  glucose 
metabolism in vivo. (A) Rapamycin (left 2 mice) and vehicle (right 2 mice) treated wild-
type and Lin28a Tg mice shows relative size differences. (B) Curves showing relative 
growth (normalized to weight on first day of treatment) for mice treated from 3 weeks to 
5.5 weeks of age. Blue and red represent wild-type and Lin28a Tg mice, respectively. 
Solid  and  dotted  lines  represent  vehicle  and  rapamycin  treated  mice,  respectively. 
Growth was measured by several other parameters: (C) weight, (D) crown-rump length 
or  height,  and  (E)  tail  width.  (F)  GTT  performed  after  2  doses  of  vehicle  or  (G) 
rapamycin. (H) ITT performed after 1 dose of vehicle or (I) rapamycin. Controls for Tg 
mice are WT. The numbers of experimental animals are listed within the charts. 48 
 
Let-7 target genes are associated with type 2 diabetes in human GWAS 
Finally, we sought to assess the relevance of the Lin28/let-7 pathway to human disease 
and  metabolism,  using  human  genetic  studies  of  T2D  and  fasting  glucose  levels. 
Because the Lin28/let-7 pathway has not been previously implicated in T2D, we first 
asked whether any of the genes that lie in T2D association regions identified in T2D 
GWAS and meta-analyses (Voight et al., 2010) are known or predicted let-7 targets. We 
used TargetScan 4.1 to computationally predict let-7 targets (Grimson et al., 2007), and 
found that 14 predicted let-7 target genes lie in linkage disequilibrium to 39 validated 
common  variant  associations  with  T2D,  including  IGF2BP2,  HMGA2,  KCNJ11  and 
DUSP9  (strength  of  T2D  association  signals  p  <  4x10
-9)  (Table  2.1).  Of  the 
computationally predicted let-7 targets associated with T2D, IGF2BP1/2/3 and Hmga2 
have been verified as let-7 targets in several studies (Boyerinas et al., 2008; Mayr et al., 
2007).  To  validate  the  connection  between  Lin28  and  GWAS  candidate  genes,  we 
analyzed the expression of Igf2bp and Hmga family members in C2C12 cells with and 
without Lin28a overexpression, and observed increases in Igf2bp1, Igf2bp2, and Hmga2 
mRNA following Lin28a overexpression (Figure 2.6A). To ensure that this was not a 
C2C12- or muscle-specific phenomenon, we confirmed the upregulation of these genes 
in 3T3 cells following human LIN28A or LIN28B overexpression on the mRNA (Figure 
2.6B)  and  the  protein  level  for  the  Igf2bp  family  (Figure  2.6C).  We  also  observed 
increased  expression  of  Igf2bp2  and  Igf2bp3  (Figure  2.6D)  in  Lin28a  Tg  muscle, 
confirming this link in vivo.  
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Figure 2.6: Let-7 target genes are associated with Type 2 diabetes mellitus and a 
model  of  the  Lin28/let-7  pathway  in  glucose  metabolism.  mRNA  expression  of 
Igf2bp and Hmga family members in (A) C2C12 with and without Lin28a overexpression 
and in (B) 3T3 cells with and without LIN28A or LIN28B overexpression. (C) Western 
blot  of  NIH  3T3  cells  with  Lin28a  overexpression  showing  Lin28a  and  Igf2bp1/2/3 
protein levels (n = 3 biological replicates). (D) Igf2bp2 and Igf2bp3 mRNA in Lin28a Tg 
muscle. (E) Model of Lin28/let-7 pathway in glucose metabolism.  
 
We  next  asked  whether  there  is  a  more  widespread  connection  between  T2D 
susceptibility and let-7 targets, in addition to the targets in validated T2D association 
regions  (p  <  5x10
-8).  To  address  this,  we  applied  a  computational  method  called 
MAGENTA (Meta-Analysis Gene-set Enrichment of variaNT Associations) (Segre et al., 
2010) to GWAS meta-analyses of T2D and fasting glucose blood levels, and tested 
whether the distributions of disease or trait associations in predefined let-7 target gene   50 
 
Table  2.1:  MAGENTA  analysis  of  T2D  and  fasting  glucose  associations  in 
different let-7 target gene sets. The statistical enrichment for genes associated with 
T2D  and  fasting  glucose  among  let-7  targets  using  the  MAGENTA  algorithm.  The 
TargetScan  algorithm  was  used  to  define  the  “All  human  let-7  targets”  and  the 
“Conserved  let-7  targets”  gene  sets  (http://www.targetscan.org/).  mRNAs 
downregulation following  let-7 overexpression (OE) was measured in primary human 
fibroblasts (Legesse-Miller et al., 2009), and protein downregulation following let-7 OE 
was measured in HeLa cells (Selbach et al., 2008). The enrichment cutoff used is the 
75
th percentile of all gene association scores in the genome. The enrichment fold is the 
ratio  between  the  observed  and  expected  number  of  genes  above  the  enrichment 
cutoff.  Genes linked  to  validated  GWAS  SNPs  (39  SNPs  for  T2D and  14  SNPs  for 
fasting glucose) were ordered according to the number of target gene sets they appear 
in and then alphabetically. 
† The following genes were removed from the analysis: (i) 
genes absent from the full human gene list used in the analysis, (ii) genes that had no 
SNPs within 110 kb upstream or 40 kb downstream to their most extreme transcript 
boundaries,  or  (iii)  to  correct  for  potential  inflation  of  enrichment  due  to  physical 
proximity of let-7 target genes along the genome, subsets of proximal genes assigned 
the same best local SNP were collapsed to one gene and assigned the score of the 
most significant gene p-value in that subset. *gene sets that pass a Bonferroni corrected 
cutoff (p < 0.004). 
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Table 2.1 (continued) 
  
sets are skewed towards highly ranked associations (including ones not yet reaching a 
level of genome-wide significance) compared to matched gene sets randomly sampled 
from  the  genome  (Table  2.1).  We  tested  three  types  of  let-7  target  definitions  with 
increasing  levels  of  target  validation,  from  in  silico  predicted  let-7  targets  using 
TargetScan 4.1 (Grimson et al., 2007) to experimentally defined targets. For the latter, 
we used (i) a set of genes with at least one let-7 site in their 3’ UTR and whose mRNA 
was downregulated by let-7b overexpression in primary  human fibroblasts (Legesse-52 
 
Miller et al., 2009), and (ii) a set of genes whose protein levels were  most strongly 
downregulated by let-7b overexpression in HeLa cells (Selbach et al., 2008). We first 
tested the let-7 target sets against the latest T2D meta-analysis of eight GWAS (called 
DIAGRAM+) (Voight et al., 2010), and found significant enrichment (Table  2.1). The 
enrichment rose from 1.05-fold for the broadest definition of let-7 targets predicted using 
TargetScan (~1800 genes; p = 0.036) to 1.92-fold for the experimentally validated target 
set based on protein level changes in response to let-7 overexpression (~100 genes; p 
= 1x10
-6). In the latter case, an excess of about 20 genes regulated by let-7 at the 
protein  level  are  predicted  to  contain  novel  SNP  associations  with  T2D.  Notably 
IGF2BP2, which is a canonical let-7 target that lies in a validated T2D association locus, 
was found in all types of let-7 target definitions in Table 2.1. Furthermore, the genes 
driving  the  T2D  enrichment  signals  for  the  different  let-7  target  sets  include  both 
functionally  redundant  homologues  of  T2D-associated  genes,  such  as  IGF2BP1 
(IGF2BP2),  HMGA1  (HMGA2),  DUSP12  and  DUSP16  (DUSP9),  and  genes  in  the 
insulin-PI3K-mTOR pathway, including IRS2, INSR, AKT2 and TSC1 (best local SNP 
association p = 10
-4 to 4*10
-3). 
 
We next tested for enrichment of  let-7 target gene associations with fasting glucose 
levels, using data from the MAGIC (Meta-Analysis of Glucose and Insulin-related traits 
Consortium) study of fasting glucose levels (Dupuis et al., 2010). We observed an over-
representation of multiple genes modestly associated with fasting glucose at different 
levels of significance for the different let-7 target gene sets (Table 2.1). The strongest 
enrichment  was  found  in  the  genes  downregulated  at  the  mRNA  level  by  let-7,  an 53 
 
enrichment  of  1.20  fold  over  expectation  (p  =  1*10
-4).  Taken  together,  our  human 
genetic results support the hypothesis that genes regulated by let-7 influence human 
metabolic disease and glucose metabolism.  
 
Recently it has also become clear that Lin28a/b has important let-7-independent roles in 
mRNA translation, as evidenced by numerous direct mRNA targets whose translation is 
enhanced by LIN28A (Peng et al., 2011). Using GSEA, we found that this list of direct 
mRNA  targets  is  also  significantly  enriched  for  glucose,  insulin  and  diabetes-related 
genes (Table  S2.1). Thus,  Lin28a/b  may  regulate  metabolism  through  direct  mRNA-
binding as well as let-7 targets. 
 
Discussion 
Lin28 and let-7 are mutually antagonistic regulators of growth and metabolism 
Our work defines a new mechanism of RNA-mediated metabolic regulation. In mice, 
Lin28a  and  LIN28B  overexpression  results  in  insulin  sensitivity,  enhanced  glucose 
tolerance, and resistance to diabetes. Our analysis of iLet-7 Tg mice shows that let-7 
upregulation is also sufficient to inhibit normal glucose metabolism, supporting the idea 
that gain of Lin28a/b exerts effects on whole animal glucose metabolism at least in part 
through  let-7  suppression.  Previously,  we  showed  that  transgenic  overexpression  of 
Lin28a  causes  enhanced  growth  and  delayed  puberty,  phenotypes  that  mimicked 
human traits linked to genetic variation in the Lin28/let-7 pathway in GWAS (Zhu et al., 
2010). Given that Lin28a/b is downregulated in most tissues after embryogenesis, while 
let-7 increases in adult tissues, lingering questions from our earlier report were first, 54 
 
whether let-7 was sufficient to influence organismal growth, and second, what function 
does let-7 have in adult physiology? Our observation that the iLin28a, iLIN28B, and iLet-
7 Tg  gain  of  function  mice,  as  well  as  muscle-specific  Lin28a  loss  of  function  mice 
manifest complementary phenotypes supports the notion that Lin28a/b and let-7 are 
both  regulators  of  growth  and  developmental  maturation.  We  propose  that  different 
developmental time-points demand distinct metabolic needs, and that global regulators 
such as Lin28 temporally coordinate growth with metabolism. The dynamic relationship 
between Lin28, let-7 and metabolic states during major growth milestones in mammals 
is reminiscent of the heterochronic mutant phenotypes originally defined in C. elegans 
(Ambros and Horvitz, 1984; Moss et al., 1997; Boehm and Slack, 2005), and suggests 
that metabolism, like differentiation, is temporally controlled.  
 
Lin28a/b and let-7 influence glucose metabolism through the insulin-PI3K-mTOR 
pathway  
We have shown that Lin28a/b and let-7 regulates insulin-PI3K-mTOR signaling, a highly 
conserved pathway that regulates growth and glucose metabolism throughout evolution. 
PI3K/Akt  signaling  is  known  to  promote  Glut4  translocation  to  upregulate  glucose 
uptake, while mTOR signaling can promote glucose uptake and glycolysis by changing 
gene expression independently of Glut4 translocation (Brugarolas et al., 2003; Buller et 
al.,  2008;  Duvel  et  al.,  2010).  Previous  studies  have  shown  that  Lin28a  directly 
promotes Igf2 (Polesskaya et al., 2007) and HMGA1 translation (Peng et al., 2011), and 
that let-7 suppresses IGF1R translation in hepatocellular carcinoma cells (Wang et al., 
2010). Consistent with these findings, our results define a model whereby Lin28a/b and 55 
 
let-7 coordinately regulate the insulin-PI3K-mTOR pathway at  multiple points (Figure 
2.6E), a concept that is consistent with the hypotheses that miRNAs and RNA binding 
proteins  regulate  signaling  pathways  by  tuning  the  production  of  a  broad  array  of 
proteins rather than switching single components on or off (Kennell et al., 2008; Hatley 
et  al.,  2010;  Small  and  Olson,  2011).  Coordinated  regulation  is  important  because 
negative feedback loops exist within the insulin-PI3K-mTOR pathway. Loss-of-function 
and  pharmacological  inhibition  studies  have  shown  that  the  mTOR  target  S6K1,  for 
instance,  inhibits  and  desensitizes  insulin-PI3K  signaling  by  phosphorylating  IRS1 
protein and suppressing IRS1 gene transcription (Harrington et al., 2004; Shah et al., 
2004; Tremblay et al., 2007; Um et al., 2004). Conversely, TSC1-2 promotes insulin-
PI3K signaling by suppressing mTOR signaling (Harrington et al., 2004; Shah et al., 
2004). Although the effects of let-7 and Lin28a/b on the expression of individual genes 
are  modest,  simultaneous  regulation  of  multiple  components  such  as  IGF2,  IGF1R, 
INSR,  IRS2,  PIK3IP1,  AKT2,  TSC1,  RICTOR  in  the  insulin-PI3K-mTOR  signaling 
pathway could explain how this RNA processing pathway coordinately regulates insulin 
sensitivity and glucose metabolism by effectively bypassing these negative feedback 
loops.  
 
Whereas our work has implicated let-7 as a regulator of insulin-PI3K-mTOR signaling, 
we  do  not  exclude  a  parallel  role  for  direct  mRNA  targets  of  Lin28a/b  in  glucose 
metabolism, a hypothesis supported by the recent findings that HMGA1 is translationally 
regulated by LIN28A and mutated in 5-10% of T2D patients (Peng et al., 2011; Chiefari 
et  al.,  2011).  Such  non-let-7  functions  are  also  suggested  by  the  fact  that  muscle-56 
 
specific loss of Lin28a results in glucose derangement without significant let-7 changes. 
Nevertheless,  it  remains  likely  that  during  other  developmental  stages  or  in  other 
tissues,  let-7  suppression  by  Lin28a  or  Lin28b  is  required  for  normal  glucose 
homeostasis.  The  effects  of  the  Lin28/let-7  pathway  on  glucose  metabolism  in  our 
murine  models,  together  with  our  observation  that  genes  regulated  by  let-7  are 
associated  with  T2D  risk  in  humans,  indicates  important  functional  roles  for  both 
Lin28a/b and let-7 in human metabolism.  
 
Let-7 targets are relevant to disparate human diseases: cancer and T2D  
Metabolic  reprogramming  in  malignancy  is  thought  to  promote  a  tumor’s  ability  to 
produce biomass and tolerate stress in the face of uncertain nutrient supplies (Vander 
Heiden et al., 2009). During their rapid growth phase early in development, embryos 
may utilize similar programs to  maintain a growth-permissive metabolism. Dissecting 
the  genetic  underpinnings  of  embryonic  metabolism  would  likely  provide  important 
insights into the nutrient uptake programs that are co-opted in cancer. While loss of 
function studies in the early embryo would help define the metabolic roles of oncofetal 
genes  in  their  physiologic  context,  classical  in  vivo  metabolic  assays  are  difficult  to 
perform in embryos. Lin28a and Lin28b are oncofetal genes, and thus highly expressed 
in  early  embryogenesis  and  then  silenced  in  most  adult  tissues,  but  reactivated  in 
cancer (Yang and Moss, 2003; Viswanathan et al., 2009). Cancer cells may utilize the 
embryonic  function  of  Lin28a/b  to  drive a metabolic  shift  towards increased  glucose 
uptake  and  glycolysis  –  a  phenomenon  termed  the  “Warburg  effect.”  Previously,  we 
showed that Lin28a expression promotes glycolytic metabolism in muscle in vivo and in 57 
 
C2C12 myoblasts in vitro (Zhu et al., 2010). Though we cannot yet readily determine 
the metabolic effects of shutting off Lin28a/b within the embryo, we have dissected the 
potent  effects  of  reactivating  and  inactivating  this  oncofetal  program  in  adults. 
Conversely, in normal adult tissues that do not express high levels of Lin28a or Lin28b, 
one might ask if a role for the highly abundant let-7 is to lock cells into the metabolism of 
terminally differentiated cells to prevent aberrant reactivation of embryonic metabolic 
programs.  Further  studies  are  required  to  understand  how  this  pathway  may  link 
mechanisms of tumorigenesis and diabetogenesis.  
 
Our report implicates Lin28a/b and let-7 as important modulators of glucose metabolism 
through interactions with the insulin-PI3K-mTOR pathway and T2D-associated genes 
identified in GWAS. Although it is likely that additional mechanisms and feedback loops 
exist,  our  data  suggests  a  model whereby  Lin28a/b  and  let-7  coordinate  the  GWAS 
identified genes and the insulin-PI3K-mTOR pathway to regulate glucose metabolism 
(Figure 2.6E). It also suggests that enhancing Lin28 function or abrogating let-7 may be 
therapeutically promising for diseases like obesity and diabetes. Likewise, results from 
this  work  might  shed  light  on  the  physiology  of  aging  and,  specifically,  how  the 
accumulation of let-7 in aging tissues may contribute to the systemic insulin resistance 
that accompanies aging.  
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Chapter 3: Lin28 enhances adult tissue regeneration by reprogramming cellular 
metabolism 
 
Introduction 
Our  prior  studies  linking  Lin28  to  juvenile  programs  of  growth,  development  and 
metabolism led us to ask if reprogramming the developmental age of tissues with Lin28 
could  influence  their  post-natal  regenerative  capacities.  Across  the  evolutionary 
spectrum  of  organisms,  the  juvenile  state  is  associated  with  superior  tissue  repair 
(defined as the partial or complete restoration of cellular content and tissue integrity 
after injury). Drosophila and Tribolium larvae repair robustly, but the adult insects do not 
(Smith-Bolton et al., 2009; Shah et al., 2011). Tadpoles, but not adult frogs, can repair 
multiple tissues (Sánchez Alvarado and Tsonis, 2006), and in Ambystoma salamanders, 
regenerative capacity declines with age  (Young et al., 1983). Young fish repair their 
caudal  fins  better  than  older  ones  (Anchelin  et  al.,  2011),  and  it  is  well-known  that 
during gestation, fetal mammals repair their tissues more robustly than older mammals 
(Deuchar,  1976;  Conboy  et  al.,  2005;  Nishino  et  al.,  2008;  Porrello  et al.,  2011).  In 
contrast, insects like the Apterygota, which do not undergo complete metamorphosis, 
retain  remarkable  larval  capacities  for  appendage  repair  throughout  life  (Pearson, 
1984),  and  some  hyper-regenerative  urodeles  such  as  the  neotenic  Axolotl  fail  to 
undergo  metamorphosis  and  exhibit  larval  regenerative  potential  throughout  their 
lifespan. These exceptions notwithstanding, the correlation between juvenility and tissue 
repair has long been discussed by Charles Darwin and others (Darwin, 1887; Pearson, 
1984; Poss, 2010), but the causal mechanisms remain obscure.  60 
 
 
Here we report that engineering the re-expression of Lin28 can enhance tissue repair in 
a variety of contexts. Surprisingly, let-7 repression is necessary but alone insufficient to 
account for Lin28a’s enhancement of tissue repair. Lin28a also binds and promotes the 
translation of the mRNAs for several metabolic enzymes, including Pfkp, Pdha1, Idh3b, 
Sdha,  Ndufb3  and  Ndufb8,  which  as  established  through  metabolomic  profiling, 
enhance  oxidative  metabolism  and  promote  an  embryonic  bioenergetic  state. 
Pharmacologic studies with specific inhibitors shows that Lin28a-mediated tissue repair 
is significantly more sensitive to OxPhos inhibition by antimycin-A, than normal tissue 
repair. These data suggest that Lin28a promotes repair capacities in post-natal tissues 
by enhancing mitochondrial oxidative metabolism and promoting a bioenergetic state 
characteristic of embryonic cells. 
 
Experimental Procedures. 
Mice. All animal procedures were based on animal care guidelines approved by the 
Institutional Animal Care and Use Committee. 
Digit amputation. A dissection microscope was used for all digit amputations. Neonatal 
mice were cryoanesthetized before the forelimb and hindlimb central digits 2, 3, and 4 
were amputated at the distal interphalangeal joint using a no. 11 scalpel. In all animals, 
right limb digits were left un-amputated as controls. Digit regrowth was measured as % 
of the uninjured digit length. In adults, mice were anesthetized with ketamine/xylazine 
before 400μm of hindlimb digits 2 and 4 were amputated using a no. 11 scalpel. Digit 3 
was left unamputated as a control. One dose of 0.05 mg/kg buprenorphine was given as 61 
 
postsurgical analgesia.  
Ear hole punch assay. A 2-mm-diameter through-and-through hole was punched in 
the  centre  of  each  outer  ear  (pinna)  by  using  a  clinical  biopsy  punch  (Roboz, 
Gaithersburg, MD). After wounding, the animals were killed at different time points to 
establish  a  time  course.  For  profiling  experiments,  the  entire  pinna  was  punched 
throughout  with  1-mm-diameter  holes  to  maximize  the  amount  of  pinnal  tissue 
undergoing tissue repair, then harvested 3 days after injury and frozen in liquid nitrogen 
before further processing. 
Quantitative RT-PCR, Western blot and Immunohistochemistry. All assessments of 
mRNA levels were performed by qRT-PCR, and all assessments of protein levels were 
performed by Western Immunoblotting, as previously described (Zhu et al. 2011). For 
immunohistochemistry, sections were incubated with anti-Lin28a (Cell Signaling), anti-
Lin28b (Cell Signaling), anti-Ki-67 (Dako) or anti-BrdU (Cell Signaling), and visualized 
using the VECTASTAIN Elite ABC System (Vector Labs).  
RNA  immunoprecipitation.  Cells  and  tissues  were  lysed  in  M2  buffer  with  RNAse 
inhibitor, then incubated with anti-FLAG M2 affinity gel beads (Sigma Aldrich) according 
to the manufacturer’s instructions, to pull-down FLAG-tagged Lin28a. After 4 washes 
with  M2  buffer,  RNA  bound  to  the  M2  affinity  gel  beads  was  isolated  using  Trizol 
(Invitrogen).   
Metabolomics,  and  Seahorse  Analyzer.  Metabolomics  analysis  was  performed  as 
previously described (Shyh-Chang et al., 2013). Seahorse data analysis was performed 
as previously described (Wu et al., 2007).  62 
 
Drug  treatments.  For  the  pinnal  repair  experiments,  drug  inhibitors  were  applied 
topically  using  25uL  of  5mM  2-deoxy-D-glucose,  100uM  3-bromopyruvate,  500nM 
antimycin-A,  or  10mM  N-acetyl-cysteine,  per  ear  3  times  a  week,  with  1  g/L  dox 
dissolved  in  DMSO  as  the  vehicle  control.  Let-7  antimiR  (Exiqon,  Denmark)  was 
injected subcutaneously once weekly as previously described (Frost and Olson, 2011), 
or  applied  topically  with  25ug  LNA  per  ear  using  jetPEI  according  to  manufacturer 
instructions (Polyplus, France).  
Histology. Tissue samples were fixed in 10% buffered formalin or Bouin’s solution and 
embedded in paraffin.   
Statistical analysis. Data is presented as mean ﾱ SEM, and Student’s t-test (two-tailed 
distribution, two-sample unequal variance) was used to calculate p values. Statistical 
significance is displayed as p < 0.05 (one asterisk) or p < 0.01 (two asterisks) unless 
specified otherwise. The tests were performed using Microsoft Excel where the test type 
is always set to two-sample equal variance. 
 
Results 
Lin28a promotes epidermal hair regrowth 
Lin28a  is  expressed  in  the  embryonic  epidermis,  but  disappears  by  birth  (Yang  and 
Moss, 2003). We previously described a doxycycline (dox)-inducible Lin28a transgenic 
mouse (“iLin28a Tg”) with constitutively low levels of leaky  Lin28a expression in the 
absence of induction (Zhu et al., 2010). Relative to non-transgenic wild type littermates 
(WT), iLin28a Tg mice displayed thicker hair coats and increased skin thickness (Figure 
4.1A and Figure S3.1A), correlating with Lin28a overexpression and let-7 repression in 63 
 
the epidermis (Figure 3.1B-D). The hair appearance was not explained by greater hair 
follicle density or follicle bulb diameter (Figure S3.1B,C). Given these observations, we 
analyzed the response to shaving to determine if Lin28a overexpression might influence 
hair regrowth.  
 
In  mice, the hair follicle cycle is normally synchronized for the ﬁrst 10 weeks of life 
(Muller-Rover  et  al.  2001).  The  ﬁrst  post-natal  growth  phase  (anagen)  ends  at 
approximately post-natal day 16 (p16), followed by the ﬁrst resting phase (telogen). The 
second anagen begins at p28 and is followed by a second protracted telogen phase 
between p42 and p70 (Muller-Rover et al. 2001). We shaved the hair of mice expected 
to be in the first and second telogen phases (p21 and p70), and found that iLin28a Tg 
mice  displayed  enhanced  dorsal  hair  regrowth  at  both  of  these  time  points  (Figure 
3.1E). To explore the mechanism of this growth difference, we performed a full 10-week 
hair cycle survey and found that while WT mice conform to the expected timing of the 
anagen-telogen  phases,  iLin28a  Tg  mice  have  extended  periods  of  anagen  and 
shortened telogen periods (Figure 3.1F). Specifically, WT mice were in telogen at p20, 
24, 42, 47, 49, 56 and 69, while iLin28a Tg mice manifested only a brief resting phase 
at p42 and p47. We then asked if hair regrowth occurs differently in WT and iLin28a Tg 
mice  when  both  are  in  anagen. We  synchronized  hair  cycling  using  wax  depilation, 
which removes the entire hair follicle and thus induces anagen in both genotypes, and 
found  no  differential  in  hair  regrowth  during  anagen  (Figure  S3.1D),  which  was 
corroborated  by  equivalent  cell  proliferation  in  anagen  hair  follicles  (Figure  S3.1E).  
Additionally, we inquired if Lin28a induction could induce anagen during a telogen  64 
 
Figure 3.1: Lin28a reactivation promotes hair regrowth. (A) Uninduced iLin28a Tg 
mice possess a thicker fur coat than WT mice. (B) Lin28a expression in the skin of WT 
or iLin28a Tg mice as determined by immunohistochemistry. (C) Lin28a mRNA levels 
as determined by qRT-PCR. (D) Mature let-7 expression as determined by qRT-PCR in 
tail epidermis of WT and uninduced iLin28a Tg mice. (E) Hair regrowth in mice shaved 
at p21 was observed 1 week post-shaving in 0/6 WT vs. 6/6 Lin28a Tg littermates (Left 
image). Hair regrowth in mice shaved at p70 was observed 3 weeks post-shaving in 0/6 
WT vs. 5/5 iLin28a Tg littermates (Right image). (F) Histologic hair cycle analysis over 
10 weeks. All sections are 10x and H+E stained. (G) Hair regrowth on dorsal skin in 
topical dox-treated p47 WT and iLin28a Tg littermates, 1 and 2 weeks after shaving. 
Ectopic hair regrowth was observed in 0/4 WT dox treated vs. 0/3 DMSO treated Tg vs. 
3/4 dox induced Tg mice. 
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phase. We induced Lin28a by topical application of dox at p47, when both WT and 
iLin28a Tg mice were in telogen. Dox treated WT or DMSO treated iLin28a Tg mice 
showed no hair regrowth, whereas iLin28a Tg mice with topical dox showed patchy hair 
regrowth after 7 and 14 days, indicating that Lin28a overexpression during telogen is 
sufficient to induce anagen in hair follicles (Figure 3.1G). Thus, Lin28a overexpression 
promotes  hair  regrowth  by  promoting  anagen.  Findings  from  this  tissue  context 
suggested  that  ectopic  reactivation  of  Lin28a  might  be  capable  of  promoting 
regeneration in other post-natal tissues as well.  
 
Lin28a promotes digit regeneration 
Lin28a mRNA is expressed in the embryonic limb buds of E9.5 – E11.5 embryos, but 
declines sharply by birth (Yokoyama et al. 2008). Limb digits consist of multiple tissue 
types and show limited regenerative capacity after amputation in neonatal mammals. To 
assess regeneration, mouse digits were amputated at the distal interphalangeal joint on 
day 2 after birth, and digit length was measured at 3 weeks of age. Relative to WT 
neonates, iLin28a Tg neonates displayed significantly enhanced soft tissue and bone 
regrowth in amputated digit tips (Figure 3.2A-C). Even after normalizing for the greater 
body growth in iLin28a Tg mice, Lin28a accelerated the regrowth of injured digits over 
time (Figure 3.2D). Whereas Lin28a showed no significant increase in expression in WT 
digits following amputation, Lin28a expression was elevated in iLin28a Tg digits before 
and after amputation (Figure 3.2E-F). Consistent with this pattern, only let-7b dropped 
after digit amputation in WT mice, whereas several let-7 species were repressed both 
before and after injury in iLin28a Tg mice (Figure 3.2G).  67 
 
 
Figure 3.2: Lin28a reactivation promotes digit regrowth after amputation. For all 
digit measurements, % regrowth is quantified by dividing the length of the regrowing 
digit in the injured limb with the length of the normal digit on the opposite uninjured limb. 68 
 
Figure 3.2 (continued) (A) Left image shows p1 digits and the amputation site (blue 
hash mark). Right images show digits 21 days after neonatal digit amputation. Red bar 
depicts  the  soft  tissue  dimension  measured  between  the  digit  tip  and  the  proximal 
interphalangeal joint. (B) Quantification of soft tissue regrowth 21 days after neonatal 
digit  amputation.  (C)  Quantification  of  bone  regrowth  21  days  after  neonatal  digit 
amputation. X-ray film with red bar showing that bone length was measured from the 
proximal interphalangeal joint. (D) Post-injury growth kinetics (as % of uninjured digit 
length) over 21 days. (E) Lin28a mRNA expression in WT, injured WT, iLin28a Tg, and 
injured  iLin28a  Tg  digits,  as  determined  by  qRT-PCR.    (F)  Immunohistochemistry 
indicating Lin28a protein expression in Tg and WT bone from the neonatal skeleton. (G) 
Mature let-7 expression in WT, injured WT, iLin28a Tg, and injured iLin28a Tg digits, as 
determined by qRT-PCR. (H) Digit tip regrowth in iLin28a Tg mice backcrossed onto the 
hyper-regenerative  MRL  strain  background. Control  mice  are WT  MRL  littermates.  * 
P<0.05, ** P< 0.01. 
  
We next asked if Lin28a overexpression could further improve tissue regeneration in 
MRL mice, a well-known hyper-regenerative strain (Clark et al. 1998; Chadwick et al. 
2007; Gourevitch et al. 2009). After backcrossing iLin28a Tg mice onto the MRL strain 
for 5 generations, Lin28a overexpression further enhanced digit tip regeneration relative 
to WT MRL controls, suggesting non-overlapping, additive mechanisms of enhanced 
repair. This supports the idea that even the enhanced regeneration of the MRL strain 
could be augmented by genetic reactivation of Lin28a (Figure 3.2H).  
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Because  Lin28a  improved  neonatal  digit  regeneration,  we  hypothesized  that  Lin28a 
overexpression might also improve adult digit tip regeneration. In 5-week old mice, we 
amputated hindlimb digit tips, but found that reactivation of Lin28a expression conferred 
no significant enhancement of regeneration (Figure S3.2), suggesting that Lin28a alone 
is insufficient to enhance adult repair in this context.  
 
Lin28a promotes pinnal tissue repair  
We assayed repair in the adult pinnal tissues of the outer ear, another complex tissue 
that fails to regenerate completely upon injury (Goss et al. 1975; McBrearty et al. 1998; 
Liu  et  al.  2011).  Low-level  leaky  Lin28a  overexpression  in  the  iLin28a  Tg  mice 
enhanced  wound  healing  after  2mm  full-thickness  punch  biopsy  (Figure  3.3A),  as 
indicated by smaller wound sizes detected at 5, 8, and 11 days (Figure 3.3B). In WT 
mice, 28% of the wounds could not be evaluated quantitatively because of poor healing 
and  severe  tearing  of  the  wounds,  whereas  only 2%  of  wounds  in  iLin28a Tg  mice 
displayed  such  severe  damage  (Figure  3.3C).  Similar  to  the  digits,  we  observed  a 
transient drop in let-7b following injury (Figure 3.4A), but did not observe an increase in 
Lin28a during WT tissue repair (Figure  3.3D, E). To determine if direct activation of 
Lin28a at the site of injury would promote pinnal repair, we applied dox topically onto 
wounds after punch biopsy. 
 
We detected local induction of Lin28a protein (Figure 3.3D) and mRNA (Figure 3.3E), 
and measured 50% greater wound closure after 11 days relative to uninduced iLin28a 
Tg ears (Figure 3.3F). Hmga2, a prominent let-7 target, was also induced in iLin28a Tg  70 
 
Figure 3.3: Lin28a reactivation promotes pinnal tissue repair. (A) WT and iLin28a 
Tg wound healing 8 days after 2mm-diameter ear hole punches. (B) Wound area size at 
day 5, 8, and 11, during the course of wound healing. (C) Proportion of WT and iLin28a 
Tg ear holes torn by mice after ear hole punching. (D) Western blot indicating Lin28a 
protein levels in topical dox-treated iLin28a Tg ears, before (n=2) and 3 days after (n=2) 
injury, compared to WT ears. (E) mRNA levels of Lin28a and the let-7 target Hmga2 in 
topical dox-treated iLin28a Tg ears, as determined by qRT-PCR. (F) Wound area size 
after 10 days of local topical treatment with dox. (G) H+E, trichrome, Lin28a, and Ki-67 
staining in WT, iLin28a Tg and induced iLin28a Tg mice.  
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but not in WT ears (Figure 3.3E). Histologically, there was an increase in mesenchymal 
connective tissue after local Lin28a induction, and an increase in proliferation according 
to Ki67 staining (Figure 3.3G), indicating that Lin28a induction promotes mesenchymal 
cell proliferation and tissue repair in pinnae. Interestingly, local dox induction of LIN28B 
in iLIN28B Tg mice (Zhu et al. 2011) was not sufficient to promote ear wound healing, 
suggesting a Lin28a-specific mechanism for this process (Figure S3.3). 
 
Repression of let-7 is necessary but insufficient for promoting tissue repair 
A major downstream effect of Lin28 is the repression of let-7 microRNAs. Because a 
subset of let-7 miRNAs decreased after digit and pinnal injury in WT animals (Figure 
3.2G,  3.4A),  we  hypothesized  that  suppression  of  let-7  might  be  essential  to  tissue 
repair,  and  that  enforced  expression  of  let-7  would  antagonize  wound  healing.  We 
therefore assessed tissue repair in a transgenic mouse that expresses a dox-inducible 
form of the let-7 miRNA (“iLet-7 mice”; Zhu et al. 2011). Indeed, induction of let-7 after 
ear punch biopsy inhibited wound closure and pinnal repair relative to uninduced mice 
(Figure 3.4B). To test if let-7 repression would be sufficient to phenocopy the enhanced 
tissue repair observed with overexpression of Lin28a, we used a locked nucleic acid 
(LNA)-modified  antimiR  to  antagonize  let-7  function.  Previously,  let-7  antimiRs 
successfully reduced mature  let-7 levels and promoted an anti-diabetic phenotype in 
mice,  thus  phenocopying  Lin28a  overexpression  (Frost  and  Olson  2011;  Zhu  et  al. 
2011).  
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Figure  3.4:  Let-7  repression  is  necessary  but  insufficient  for  tissue  repair.  (A) 
Expression of mature let-7g and let-7b in WT and iLet-7 ears, before and after injury, as 
determined  by  qRT-PCR.  (B)  Ear  hole  wound  area  size  after  whole  animal  let-7g 
induction in iLet-7 mice. (C) Mature let-7 miRNA expression in MEFs after let-7 antimiR 
treatment, as determined by qRT-PCR. (D) Mature let-7 miRNA expression in vivo after 
2 subcutaneous injections of let-7 antimiR. (E) Northern blot indicating let-7a levels in 
the liver and skin of control and let-7 antimiR-treated WT mice. (F) Ear hole wound size 
after subcutaneous let-7 antimiR treatment of WT mice. (G) Ear hole wound size after 
local topical let-7 antimiR treatment of WT mice. (H) Hair regrowth after let-7 antimiR 
treatment of WT mice. 
   74 
 
Figure 3.4 (continued) 
 75 
 
In our experiments, the let-7 antimiR repressed a wide range of mature let-7’s in MEFs 
and  in  vivo  (Figure  3.4C-E),  to  a  greater  extent  than  achieved  by  Lin28a 
overexpression. However, despite an efficient knockdown of let-7, neither systemic nor 
topical delivery of let-7 antimiR enhanced pinnal tissue repair (Figure 3.4F,G) nor hair 
regrowth (Figure 3.4H). These data indicate that let-7 antagonizes normal tissue repair, 
but also suggest that let-7 repression is necessary but not alone sufficient to explain the 
mechanism of enhanced tissue repair by Lin28a. 
 
Lin28a alters the bioenergetic state during tissue repair 
Although  Lin28a  is  most  well-known  as  a  repressor  of  let-7  microRNA  biogenesis, 
Lin28a also regulates mRNA translation independently of let-7 (Polesskaya et al., 2007; 
Peng et al., 2011; Wilbert et al., 2012; Cho et al., 2012). Transcripts encoding metabolic 
enzymes in mitochondrial oxidative phosphorylation (OxPhos) and glycolysis are among 
the top mRNAs bound specifically by Lin28a (Peng et al., 2011; Zhu et al., 2011). To 
test if these findings are consistent with the embryonic metabolic state influenced by 
Lin28a, we profiled metabolism in whole Lin28a
-/- Lin28b
-/- embryos vs. Lin28a
+/+ Lin28b
-
/-  embryos  at  E10.5,  using  Liquid  Chromatography/Tandem  Mass  Spectrometry 
metabolomics (Shyh-Chang et al., 2013). Lin28a deficiency led to lower levels of some 
glycolytic intermediates  (Figure  S3.4A), lower  ATP/AMP  and  NADH/NAD  ratios,  and 
higher levels  of reduced  glutathione (higher  GSH/GSSG  ratio,  which indicates lower 
levels of reactive oxygen species - ROS; Figure S3.4B). These data demonstrate that 
Lin28a  is  physiologically  required  for  normal  embryonic  bioenergetics,  and  are 
consistent with our previous study which compared Lin28a
+/- to Lin28a
-/- embryos and  
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Figure 3.5: Lin28a alters the bioenergetic state during tissue repair. (A) LC-MS/MS 
selected reaction monitoring (SRM) analysis of abundance in glycolysis intermediates in 
WT and iLin28a Tg pinnal tissue after injury (inj), relative to WT uninjured pinnae. G3P, 
D-glyceraldehyde-3-phosphate.  DHAP,  dihydroxyacetone-phosphate.  BPG,  1,3-
bisphosphoglycerate. 3PG, 3-phosphoglycerate. PEP, phosphoenolpyruvate. (B) SRM 
analysis of several metabolic indicators in WT and iLin28a Tg pinnal tissue after injury 
(inj), relative to WT uninjured pinnae. ATP, adenosine-5’-triphosphate. AMP, adenosine-
5’-monophosphate.  GTP,  guanosine-5’-triphosphate.  GMP,  guanosine-5’-
monophosphate. GSH/GSSG, glutathione/glutathione disulfide. (C) Fraction of glycolytic 
intermediates labeled by 
13C, derived from [U-
13C]glucose in MEFs over 30 minutes, as 
measured by SRM analysis (n=3). (D) Fraction of Krebs cycle intermediates labeled at 2 
carbons by 
13C, derived from [U-
13C]glucose in MEFs over 8 hours, as measured by 
SRM analysis (n=3). (E) SRM analysis of the ATP/AMP and GSH/GSSG ratios in WT 
and iLin28a Tg MEFs (n=3). (F) Mitochondrial biogenesis, glycolytic enzyme, and let-7 
target mRNAs, analyzed by qRT-PCR. Lin28a, and the let-7 targets Imp1 and Imp2 
served as positive controls. Relative expression levels were normalized to WT MEFs. 
(G) Oxygen consumption rate (OCR) of WT and iLin28a Tg MEFs, as measured by the 
Seahorse Analyzer (n=4 each). Oligomycin treatment inhibits ATP synthase-dependent 
OCR,  the  proton  gradient  uncoupler  FCCP  then  induces  maximal  OCR,  and 
antimycin/rotenone  finally  inhibits  all  OxPhos-dependent  OCR.  (H)  Extracellular 
acidification rate (ECAR) of WT and iLin28a Tg MEFs, as measured by the Seahorse 
Analyzer  (n=4  each).  Addition  of  glucose  induces  glycolysis-dependent  lactic  acid 
production  and  ECAR,  oligomycin  then  induces  maximal  ECAR,  and  3BP  partially 77 
 
Figure 3.5 (continued) inhibits glycolysis-dependent ECAR. (I) Mature let-7 expression 
in WT and iLin28a Tg MEFs, after transfection with a scrambled (scr) control, let-7 LNA 
antimiR,  or  let-7a  duplex,  as  determined  by  qRT-PCR.  (J)  Expression  of  the  let-7 
targets  Hmga2  and  Imp2  in  WT  and  iLin28a  Tg  MEFs,  after  transfection  with  a 
scrambled (scr) control, let-7 LNA antimiR, or let-7a duplex, as determined by qRT-
PCR.  (K)  Fraction  of  the  glycolytic  intermediate  3-phosphoglycerate  (3PG)  and  the 
glycolytic  side-product  serine,  labeled  by 
13C  derived  from  [U-
13C]glucose  over  30 
minutes, in MEFs after transfection with a scrambled (scr) control, let-7 LNA antimiR, or 
let-7a duplex (n=3). (L) Fraction of the Krebs cycle intermediates citrate, malate and 
oxaloacetate-derived  aspartate,  labeled  at  2  carbons  by 
13C  derived  from  [U-
13C]glucose over 8 hours, in MEFs after transfection with a scrambled (scr) control, let-7 
LNA antimiR, or let-7a duplex (n=3). (M) SRM analysis of several metabolic indicators in 
WT and iLin28a Tg MEFs after transfection with a scrambled (scr) control, let-7 LNA 
antimiR, or let-7a duplex (n=3). 
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Figure 3.5 (continued)  
  
 
likewise concluded that Lin28a is essential for normal embryonic metabolism (Shinoda 
et al., 2013). 80 
 
These precedents prompted us to profile the metabolomic effects of Lin28a reactivation 
during  tissue  repair.  We  found  that  Lin28a  induction  led  to  an  increase  in  several 
glycolytic  intermediates  in  pinnal  tissues  after  injury  (e.g.,  glucose-6-phosphate, 
fructose-6-phosphate  as  well  as  lactate),  suggesting  a  general  increase  in  glucose 
oxidation, whereas WT ears exhibited few changes (Figure 3.5A). Lin28a induction also 
enhanced  the  bioenergetic  state  during  tissue  repair  in  vivo,  as  indicated  by  the 
increase  in  acetyl-CoA  biosynthesis,  and  the  increased  ATP/AMP  and  GTP/GMP 
bioenergetic ratios (Figure 3.5B). 
 
Using 
13C-glucose, we measured the flux of glucose through glycolysis and the Krebs 
cycle  in  MEFs,  and  found  that  Lin28a  increased 
13C-glucose  flux  into  glycolytic 
intermediates  (Figure  3.5C),  as  well  as  Krebs  cycle  intermediates  (Figure  3.5D), 
consistent with our observations in vivo. Furthermore, we found that the ATP/AMP ratio 
increased by 40% whereas the GSH/GSSG ratio decreased significantly with Lin28a 
overexpression (Figure 3.5E), consistent with our observations that Lin28a  enhances 
glucose oxidation to produce more ATP and ROS during tissue repair.  
 
To  determine  if  Lin28a  was  promoting  the  bioenergetic  state  by  simply  increasing 
mitochondrial  biogenesis,  we  measured  mitochondrial  markers.  We  failed  to  detect 
increases  in  the  mRNA  levels  of  mitochondrial  biogenesis  markers  and  enzymes 
(Figure 3.5F); there was no change in mitochondrial DNA (Figure S3.4C); and CMXRos 
staining revealed no significant changes in the mitochondrial density and distribution 
(Figure  S3.4D).  These  data  indicate  that  Lin28a  enhances  mitochondrial  OxPhos 81 
 
activity rather than mass. We confirmed this using the Seahorse analyzer to measure 
the O2 consumption rates of primary MEFs from iLin28a Tg mice. Relative to WT control 
MEFs, Lin28a increased both the basal and maximal OxPhos capacity, as indicated by 
the  increases  in  O2  consumption  (Figure  3.5G).  Lin28a  also  increased  the  basal 
glycolytic  capacity  (Figure  3.5H),  consistent  with  findings  from 
13C-glucose  flux 
metabolomics.   
 
To assess if Lin28a was causing metabolic changes in a let-7-dependent manner, we 
transfected a let-7 mimic and/or the let-7 antimiR into WT and iLin28a Tg MEFs. As 
expected,  the  let-7  LNA  antimiR  led  to  let-7  repression  (Figure  3.5I)  and  increased 
expression of the canonical let-7 targets Hmga2 and Imp2 (Figure 3.5J), whereas the 
let-7 mimic led to the converse (Figure 3.5I-J). 
13C-glucose flux metabolomic profiling of 
these  transfected  MEFs  then  revealed  that  let-7  repression  phenocopied  Lin28a’s 
enhancement  of  glycolytic  flux  (into  3-phosphoglycerate  and  serine  biosynthesis), 
whereas  let-7  overexpression  suppressed  WT  glycolysis  and  partially  abrogated 
Lin28a’s  enhancement  of  glycolysis  (Figure  3.5K).  These  data  are  consistent  with 
previous  studies  showing  that  let-7  regulates  insulin-PI3K-mTOR  signaling,  which 
promotes  glycolysis  (Zhu  et  al.,  2011;  Frost  and  Olson,  2011).  However,  let-7 
repression failed to fully phenocopy Lin28a’s enhancement of Krebs cycle flux, and let-7 
overexpression failed to reduce WT Krebs cycle flux, although it did partially abrogate 
Lin28a’s  enhancement  of  Krebs  cycle  flux  (Figure  3.5L).  Most  importantly,  let-7 
repression  failed  to  phenocopy  Lin28a’s  enhancement  of  OxPhos,  and  let-7 
overexpression failed to block Lin28a’s enhancement of OxPhos (Figure 3.5M). These 82 
 
results show that Lin28a acts on OxPhos in ways that do not involve let-7, and support 
our conclusion that let-7 regulation is necessary but insufficient to phenocopy Lin28a’s 
effects on tissue repair.  
 
Lin28a promotes the expression of mitochondrial oxidation enzymes 
We  used  RNA  immunoprecipitation  (RIP)  to  determine  which  of  the  mRNAs  for 
metabolic enzymes previously shown to be bound by Lin28a in human ESCs (Peng et 
al., 2011) are likewise bound and regulated by Lin28a in primary MEFs and tissues in 
vivo. FLAG-tagged Lin28a bound to mRNAs for Pfkp, Pdha1, Idh3b, Sdha, Ndufb3 and 
Ndufb8, both in MEFs (Figure 3.6A) and pinnal tissues (Figure 3.6B). Western blots 
further  revealed  that  Lin28a  overexpression  correlated  with  increased  expression  of 
Pfkp, Pdha1, Idh3b, Sdha, Ndufb3 and Ndufb8 proteins in primary MEFs and pinnal 
tissues in vivo (Figure 3.6C), consistent with previous studies showing that Lin28a can 
directly  enhance  mRNA  translation  (Polesskaya  et  al.,  2007).  Interestingly, 
phosphofructokinase (Pfkp) and pyruvate dehydrogenase (Pdha1) are the rate-limiting 
enzymes that fuel glycolysis and the Krebs cycle respectively (Figure S3.5A). Isocitrate 
dehydrogenase (Idh3b) is the  mitochondrial enzyme that catalyzes the first oxidative 
decarboxylation step in the Krebs cycle to produce ʱ-ketoglutarate, NADH and CO2, 
whereas succinate dehydrogenase (Sdha) oxidizes succinate to produce fumarate and 
FADH2,  and  also  serves  as  Complex  II  in  the  electron  transport  chain.  NADH 
dehydrogenases  (Ndufb3/8)  constitute  the  rate-limiting  Complex  I  in  the  electron 
transport chain that oxidizes NADH for ATP synthesis during OxPhos. Hence, Lin28a  
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Figure  3.6:  Lin28  promotes  wound  healing  by  enhancing  bioenergetic 
metabolism.  (A)  RNA  immunoprecipitation  (RIP)  using  FLAG-tagged  Lin28a  and 
subsequent RT-PCR shows the metabolic enzyme mRNAs bound by Lin28a in MEFs in 84 
 
Figure 3.6 (continued) vitro. (B) RNA immunoprecipitation (RIP) using FLAG-tagged 
Lin28a and subsequent RT-PCR shows the metabolic enzyme mRNAs bound by Lin28a 
in pinnal tissues in vivo. (C) Western blots for Lin28a mRNA targets in primary MEFs 
and pinnal tissues in vivo. (D) Distance traveled by WT and iLin28a Tg MEFs, 18 hours 
after a defined scratch was made on equal-numbered monolayers (n=18). MEFs were 
treated with 50nM Anti-A, 100uM 3BP, or DMSO vehicle control immediately after the 
scratch. (E) Distance traveled by WT and iLin28a Tg MEFs treated with a scrambled 
(scr)  control,  let-7  LNA  antimiR,  or  let-7a  duplex.  (F)  Distance  traveled  by WT  and 
iLin28a Tg MEFs treated with siRNAs against metabolic enzymes. (G) Cell proliferation 
of WT and iLin28a Tg MEFs treated with a scrambled (scr) control, let-7 LNA antimiR, 
or let-7a duplex. (H) Cell proliferation of WT and iLin28a Tg MEFs treated with siRNAs 
against metabolic enzymes. 
 
directly binds and promotes translation of multiple rate-limiting enzyme components in 
both glycolysis and OxPhos (Figure 3.6A-C). 
To determine if Lin28a-mediated metabolic enhancements might influence cell migration 
or proliferation, two processes that are critical for tissue repair (Guo and DiPietro, 2010), 
we subjected MEFs to in vitro migration and proliferation assays. Indeed, iLin28a Tg 
MEFs migrated more than WT MEFs (Figure 3.6D). We then tested if pharmacological 
inhibition  of  glycolysis  or  OxPhos  could influence  MEF  migration  (see  Figure  S3.5A 
forsummary of inhibitor targets). OxPhos inhibition by antimycin-A, a specific electron 
transport chain Complex III inhibitor, reduced iLin28a Tg MEF migration more than WT 
MEFs  (Figure  3.6D).  The  glycolysis  inhibitor  3-bromopyruvate  (3BP)  also  reduced 85 
 
iLin28a Tg MEF migration more than WT MEFs (Figure 3.6D), together suggesting that 
Lin28a promotes cell migration by enhancing glycolysis and OxPhos.  
 
To determine if Lin28a was influencing cell migration in a let-7-dependent manner, we 
transfected the let-7 LNA antimiR and let-7 mimic into Tg and WT MEFs. Neither let-7 
repression nor overexpression had significant effects on WT MEF migration, whereas 
let-7  overexpression  significantly  inhibited  iLin28a  Tg  MEF  migration  (Figure  3.6E). 
These data are consistent with our observations that let-7 repression is necessary but 
insufficient to recapitulate Lin28a’s effects, suggesting that the mRNA targets of Lin28a 
play critical roles. Indeed, siRNA knockdown of Pfkp, Pdha1, Idh3b, Sdha, Ndufb3 or 
Ndufb8 (Figure S3.5A-E) all impaired cell migration for WT and Tg MEFs (Figure 3.6F), 
indicating that these metabolic enzymes contribute to cell migration.  
 
Cell proliferation is critical for tissue repair as well, but the necessity for OxPhos in this 
process is unclear. In vitro, OxPhos inhibition by antimycin-A impaired the proliferation 
of  both  WT  and  iLin28a  Tg  MEFs  (Figure  S3.5F),  with  no  changes  in  apoptosis, 
suggesting that normal OxPhos is essential for cell proliferation. Overexpression of let-7 
inhibited cell proliferation in both WT and iLin28a Tg MEFs, whereas let-7 repression 
did not significantly affect proliferation in either MEFs (Figure 3.6G). These data are, 
again,  consistent  with  our  observations  that  let-7  repression  alone  is  necessary  but 
insufficient to recapitulate Lin28a’s effects, suggesting that the mRNA targets of Lin28a 
are also important. Depletion of Pfkp, Pdha1, Idh3b, Sdha, Ndufb3 or Ndufb8 (Figure 
S3.5A-E), led to a defect in cell proliferation for both WT and iLin28a Tg MEFs (Figure 86 
 
3.6H),  showing  that  these  metabolic  enzymes  are  also  involved  in  cell  proliferation. 
Over  the  course  of  passaging,  Lin28a  suppressed  MEF  proliferation  in  vitro  (Figure 
S3.5F) while in vivo, Lin28a promoted cell proliferation in hair follicles (Figure 3.1) and 
pinnal tissues (Figure 3.3G). Lin28a is therefore likely to be inducing senescence in vitro 
after  long-term  passage,  via  pyruvate  dehydrogenase-dependent  oxidative  stress 
(Kaplon  et  al.,  2013).  This  counter-intuitive  effect  is  also  observed  when  other 
oncogenes like Kras, Braf and PI3K are over-expressed in cells cultured in vitro, even 
when these oncogenes are known to promote cell proliferation in vivo.  
 
To assess the importance of Lin28a-mediated metabolic changes in vivo, we applied 
specific  pharmacologic  inhibitors  of  glycolysis  and  OxPhos  in  the  setting  of  hair 
regrowth  (Figure  3.7A).  As  shown  in  Figure  3.1,  topical  induction  of  Lin28a  in  the 
epidermis  improves  hair  regrowth  during  telogen.  OxPhos  inhibition  with  topical 
antimycin-A (+dox) suppressed hair regrowth specifically in iLin28a Tg mice, with no 
effect  on  WT  mice  (Figure  3.7A).  Glycolysis  inhibition  with  topical  3BP  (+dox)  also 
suppressed hair growth specifically in iLin28a Tg mice, without influencing WT mice. 
When the drugs were discontinued for 10 days, WT mice showed partial hair regrowth 
whereas iLin28a Tg mice showed complete regrowth, indicating that hair follicle cycling 
was only transiently, and not irreversibly inhibited by this dosing regimen (Figure 3.7A). 
These results imply that Lin28a promotes hair regrowth by enhancing both glycolysis 
and OxPhos. 
   87 
 
Figure  3.7:  Lin28  promotes  tissue  repair  in  vivo  by  enhancing  bioenergetic 
metabolism.  (A)  Hair  regrowth  of  dorsal  skin  in  p42  iLin28a  Tg  mice  and  WT 
littermates, at the time of shaving, and 3 weeks after local topical treatment with 3BP, or 
Anti-A, dissolved in 1g/L dox in DMSO (Ctrl). Mice were then taken off all treatment for 1 
week.  (B)  Pinnal  wound  size  after  10  days  of  local  topical  treatment  with  Anti-A, 
dissolved in 1g/L dox in DMSO (Ctrl), on both iLin28a Tg and WT littermate ear holes. 
(C) Pinnal wound size after 10 days of local topical treatment with the antioxidant N-
acetyl-cysteine (NAC) dissolved in 1g/L dox in DMSO (Ctrl), on both iLin28a Tg and WT 
littermate ear holes. (D) Pinnal wound size after 10 days of local topical treatment with 
the  glycolysis  inhibitors  3BP  or  2-deoxy-D-glucose  (2DG)  dissolved  in  1g/L  dox  in 
DMSO (Ctrl), on both iLin28a Tg and WT littermate ear holes. (E) Metabolomic profiling 
on WT ears 1 and 7 days after daily 3BP treatment. Shown are glycolytic intermediates 
and the bioenergetics ratios NADH/NAD, ATP/AMP, ATP/ADP, and GTP/GMP (n=4). 
(F) Fraction of the Krebs cycle intermediates isocitrate, succinate, and malate, labeled 
at  2  carbons  by 
13C  derived  from  [U-
13C]glucose  over  8  hours,  in  WT  MEFs    after 
continuous incubation in 3BP for 3 days (n=3). (G) Maximal O2 consumption rate in WT 
MEFs after continuous incubation in 3BP for 3 days (n=6). 
 88 
 
Figure 3.7 (continued)   
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We sought to confirm this mechanism in another tissue context. Hence, we blocked 
OxPhos  by  topically  applying  antimycin-A  daily  on  ears  following  pinnal  injury. 
Consistent with the results in hair regrowth, antimycin-A specifically abrogated Lin28a’s 
enhancement of pinnal repair, with no significant effects on WT pinnae (Figure 3.7B). 
This implies that iLin28a Tg tissue repair is more sensitive to OxPhos inhibition than WT 
tissue repair. In contrast, the antioxidant N-acetyl-cysteine had only a small effect on 
pinnal repair in both WT and iLin28a Tg mice (Figure 3.7C), thus excluding a role for 
ROS or ROS-induced macrophage recruitment in the Lin28a mechanism.  
 
Surprisingly, daily topical application of glycolysis inhibitors (3BP or 2-deoxy-D-glucose 
(2DG)),  induced  a  substantial  enhancement  in WT  tissue  repair,  comparable  to  the 
Lin28a-mediated  enhancement  (Figure  3.7D).  Interestingly,  3BP  also  enhanced 
migration in WT MEFs (Figure 3.6D). One possible result of glycolysis inhibition is a 
compensatory  increase  in  OxPhos  activity,  a  phenomenon  frequently  observed  in 
cancer cells (Wu et al. 2007). To test if a compensatory increase in OxPhos explains 
how  glycolysis  inhibition  in  WT  ears  enhances  tissue  repair  similarly  to  Lin28a 
overexpression (Figure 3.7D), we performed metabolomic profiling on WT ears 1 and 7 
days  after  daily  3BP  treatment.  1  day  after  topical  treatment,  we  found  that  3BP 
drastically reduced glycolytic intermediates and significantly decreased the NADH/NAD, 
ATP/AMP, ATP/ADP, and GTP/GMP bioenergetic ratios (Figure 3.7E), as expected with 
glycolysis  inhibition.  After  7  days  of  daily  3BP  treatment,  however,  the  levels  of 
glycolytic intermediates and the NADH/NAD ratio returned to normal, and there was a 
significant increase in  the  ATP/AMP  and  ATP/ADP  ratios  (Figure  3.7E), indicating  a 90 
 
compensatory increase in OxPhos activity in vivo. In WT MEFs, continuous incubation 
in 3BP for 3 days also led to an increase in 
13C-glucose flux through the Krebs cycle 
(Figure  3.7F),  and  an  increase  in  the  maximal  O2  consumption  rate  (Figure  3.7G), 
further  confirming  that  chronic  glycolysis  inhibition  by  3BP  induces  a  compensatory 
increase in  OxPhos  to  enhance  tissue repair. Together  with our results  on Lin28a’s 
enhancement of OxPhos (Figure 3.5A-M), and the necessity for increased OxPhos in 
Lin28a’s  enhancement  of  tissue  repair  in  vivo  (Figure  3.7A-G),  these  results 
demonstrate that the enhancement of oxidative metabolism by Lin28a can confer the 
higher  bioenergetic  capacities  needed  to  activate  adult  cells  out  of  quiescence  to 
enhance tissue repair.  
 
Discussion 
Our  work  demonstrates  that  the  highly  conserved  heterochronic  gene  and  juvenility 
regulator Lin28a, first described in a genetic screen for C. elegans mutants with altered 
developmental timing (Ambros and Horvitz, 1984), promotes mammalian tissue repair 
by altering cellular metabolism. Lin28a is normally highly expressed in the early embryo, 
downregulated during mid-gestation, and silenced in most tissues after birth. We have 
shown that engineering its reactivation in post-natal tissues reactivates an embryonic 
metabolic state that confers on post-natal tissues the enhanced regenerative potential 
of embryonic tissues. In another model organism, the zebrafish, lin-28 reactivation has 
also been found to promote retinal regeneration (Ramachandran et al., 2010).  
 
Collectively,  our  results  demonstrate  that  Lin28a  can  promote  tissue  repair  through 91 
 
mechanisms  independent  of  let-7,  a  result  that  was  unexpected.  Although 
overexpression  of  let-7  could  inhibit  tissue  repair,  let-7  repression  alone  failed  to 
promote it. One possibility is that let-7-dependent and independent functions of Lin28 
synergize  to  regulate  tissue  homeostasis  in  a  context-dependent  manner;  thus  let-7 
repression  is  necessary  but  alone  insufficient  to  promote  tissue  repair.  There  is 
accumulating  evidence  that  Lin28a,  like  other  RNA-binding  proteins,  enhances  the 
translation of thousands of mRNAs and thus operates at the systems level (Peng et al., 
2011; Wilbert  et  al.,  2012;  Cho  et  al.,  2012).  Our  findings  that  specific  inhibition  of 
OxPhos can reversibly abrogate the effects of Lin28a on tissue repair, without detriment 
to WT tissue repair, provides strong evidence that Lin28a is promoting tissue repair by 
enhancing  oxidative  metabolism  and  bioenergetics,  with  pleiotrophic  effects.  For 
example, enhanced ATP and GTP levels could supply the higher energetic needs of 
anabolic biosynthesis, mitosis, and migration during tissue repair, or promote growth 
signaling  pathways  like  mTOR,  all  of  which  are  enhanced  by  Lin28a.  Our  results 
suggest that Lin28a-mediated enhancement of mitochondrial oxidation, independently 
of let-7, is one important mechanism by which Lin28a executes its functions.  
 
We have shown here that altering oxidative metabolism can modulate repair capacities 
in several different post-natal somatic tissues. It is still possible that the effects of Lin28a 
on metabolism and tissue repair might differ in other contexts. For example, adult digits 
and the adult heart do not show improved tissue repair after injury in iLin28a Tg mice 
(Figure S3.2 and S3.6), indicating that even general metabolic pathways have injury- or 
tissue-specific activities. It is interesting to note that prior studies have linked PPARs 92 
 
(peroxisome  proliferator-activated  receptors),  master  regulators  of  mitochondrial 
biogenesis  and  oxidative  metabolism,  to  tissue  repair  in  the  mammalian  skin,  liver, 
muscles, and cornea (Michalik et al., 2001; Anderson et al., 2002; Angione et al., 2011; 
Nakamura et al., 2012). ATP-powered ion gradients and ROS have also been found to 
be  critical  in  other  regenerative  animal  models,  such  as  Xenopus  tail  and  planarian 
regeneration (Adams et al., 2007; Beane et al., 2011; Love et al., 2013). Clinically, the 
utility of topical oxygen for chronic wound therapy (Schreml et al., 2010), might also be 
partially related to the metabolic mechanisms that we have uncovered for Lin28a. Our 
findings support a novel use for Lin28a and the enhancement of oxidative metabolism 
for treating injuries and diseases related to tissue degeneration. 
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Chapter 4: Lin28 promotes threonine metabolism to regulate S-adenosyl-
methionine levels and histone methylation in pluripotent stem cells 
Introduction  
Recent advances had improved our understanding of cellular mechanisms that underlie 
mESC pluripotency (Ng and Surani, 2011), yet the connections between the particular 
metabolic  states  of  ESCs  and  pluripotency  were  only  beginning  to  come  into  focus 
(Tahiliani  et  al.,  2009).  Metabolically,  mESCs  show  a  high  glycolytic  flux  and  high 
sensitivity  to  glucose  restriction  in  the  culture  media  (Facucho-Oliveira  et  al.,  2007; 
Kondoh et al., 2007). It was also recently shown that mESCs possess a distinct mode of 
amino acid catabolism. Thr abundance is particularly low in mESCs and increases upon 
mESC  differentiation  (Wang  et  al.,  2009).  Threonine  dehydrogenase  (Tdh),  which 
catalyzes  the  first  step  of  threonine  (Thr)  metabolism,  is  expressed  at  over  200-fold 
greater levels in mESCs and induced pluripotent stem cells (iPSCs) relative to mouse 
embryonic fibroblasts (MEFs) (Wang et al., 2009; Mikkelsen et al., 2008). Furthermore, 
Thr restriction in the culture media or pharmacological inhibition of Tdh abolishes growth 
of mESCs (Wang et al., 2009; Alexander et al., 2011). Although Thr catabolism appears 
to  be  critical  for  mESCs,  the  functions  of  the  downstream  metabolites  and  the 
mechanisms connecting amino acid metabolism to the pluripotent state had remained 
unclear. 
 
My  interest  in  the  central  principles  of  stem  cell  metabolism  led  us  to  map  the 
metabolomic  changes  associated  with  Lin28/let-7  perturbation  in  ESCs  and  induced 
pluripotent stem cell (iPS) reprogramming. Instead of glycolysis and OxPhos, we found 95 
 
that Thr and S-adenosylmethionine (SAM) metabolism consistently showed the most 
dramatic changes during both Lin28/let-7 perturbation and iPS reprogramming.  
 
We demonstrate that Thr and methionine (Met) metabolism are coupled in pluripotent 
stem  cells,  resulting  in  regulation  of  SAM  levels  and  histone  methylation.  Isotope 
labeling of mESCs revealed that Thr provides a significant fraction of both the cellular 
glycine (Gly) and the acetyl-CoA needed to regulate SAM synthesis. Depleting Thr from 
the  culture  medium  or  knocking  down  expression  of  Tdh  in  mESCs  resulted  in 
decreased SAM levels, reduced tri-methylation of lysine 4 of histone H3 (H3K4me3), 
slowed  growth,  and  increased  differentiation.  Ectopic  expression  of  Tdh  in  human 
fibroblasts, which lack a functional Tdh gene, increased SAM and H3K4me3 levels and 
enhanced  reprogramming  to  the  pluripotent  state.  These  findings  demonstrate  that 
metabolic regulation of cellular SAM levels play a critical role in determining the extent 
of  H3K4  methylation,  and  illustrate  a  novel  mechanism  by  which  modulation  of  a 
metabolic pathway influences cell fate.  
 
Experimental Procedures 
Cell  Culture.  iOSKM-MEFs  were  obtained  and  cultured  according  to  previously 
published  methods  (12,15).  For  consistency,  iOSKM-MEFs  (no  dox,  dox  4D,  or  dox 
18D) and mESCs were cultured in feeder-free conditions and fed fresh mESC media 2 
hours  prior  to  harvesting  for  metabolomics.  E14Tg2a,  Ainv-15,  iLin28a  and  iLet-
7mESCs were maintained on gelatinized plates and irradiated MEFs in mESC media 
(MEF  media  plus  LIF:  DMEM  (Gibco)  plus 10%  FBS  (Hyclone),  100  uM  MEM  non-96 
 
essential  amino  acids  (Gibco),  2  mM  glutamine,  200  ug/ml  penicillin,  100  ug/ml 
streptomycin  (Gibco),  50  uM  2-mercaptoethanol  and  1000  U/ml  LIF  (Chemicon)). 
iLin28a and iLet-7 mESCs were generated according to the methods of H. Zhu et al., 
(Cell,  147,  81,  2011).  Irradiated  MEFs  were  omitted  during  feeder-free  culture  for 
metabolomics,  qRT-PCR,  immunoblotting,  and  metabolite-rescue  experiments. 
Pluripotent colonies were visualized with alkaline phosphatase staining (Sigma). Amino 
acid restriction media were prepared by omitting the indicated amino acids from amino 
acid-free  DMEM  powder,  and  reconstituting  the  media  in  ultra-pure  embryo-tested 
water.  The  pH  of  the  mESC  media  was  adjusted  using  NaHCO3.  All  component 
chemicals  were  obtained  from  Sigma.  Embryoid  body  (EB)  differentiation  was 
performed according to the methods of M. Kyba et al., (Cell, 109, 29, 2002). Briefly, 
mESCs were trypsinized, collected in EBD media (IMDM plus 15% FBS, 200 μg/mL 
iron-saturated  transferrin  (Sigma),  3.5  mM  monothiolglycerol  (Sigma),  50  μg/mL 
ascorbic acid (Sigma), and 2 mm glutamine), and plated for 45 min to allow MEFs to 
adhere. Nonadherent cells were collected and plated in hanging drops at 100 cells per 
10 μl drop in an inverted bacterial petri dish. EBs were collected from the hanging drops 
at day 2 and transferred into 10 ml EBD media in slowly rotating 10 cm petri dishes.  
14C-Thr labeling, amino acid derivatization and reverse-phase HPLC analysis. At 
~50%  confluence, feeder-free  mESCs  were  grown  in  complete  media  supplemented 
with 2.5 uCi/ml of [U-
14C]Thr [Moravek]. After 24 hours, mESCs were quickly washed 
with  ice-cold  PBS  twice,  and  then  snap-frozen  in  liquid  nitrogen.  Polar  metabolites 
including amino acids were extracted using 80% methanol, as described above. Primary 
amino acids readily react with ortho-phthalaldehyde (OPA) and the resulting derivatives 97 
 
can  be  analyzed  by  reversed  phase  HPLC  with  UV  detection.  Dried  80%  methanol 
extract from one well of a 6-well plate was dissolved in 100 ul of distilled water. A 20-ul 
aliquot was mixed with 60 ul of OPA reagent [Sigma] at room temperature for 1 min, 
and then immediately injected onto HPLC, according to the methods of R. Schuster (J. 
Chromatogr., 431, 271, 1988). Derivatized amino acids were analyzed on an Agilent 
1200  quaternary  HPLC  system  equipped  with  a  multiple  wavelength  UV  detector, 
connected  on-line  to  a  Flo-One  A510  radioactive  detector.  Reversed  phase  HPLC 
analysis was performed using an Agilent ZORBAX Eclipse Plus C18 column (0.46 cm × 
15 cm), a linear gradient program from 98% mobile phase A, 2% mobile phase B to 
50%  mobile phase A, 50%  mobile phase B in 60 min, and a flow rate of 1 ml/min. 
Mobile phase A was 10  mM Na2HPO4 : 10 mM Na2B4O7 pH 8.2 : 5 mM NaN3 and 
mobile phase B was acetonitrile/methanol/water (45:45:10 v/v/v). UV detection was set 
at 338 nm. Peaks were assigned by measuring the retention times of pure standards 
(Sigma).  NADH/NAD  and  NADPH/NADP  ratios  were  measured  using  colorimetric 
enzyme-based assay kits, according to the manufacturer’s instructions (Biovision).  
Targeted  liquid-chromatography  mass  spectrometry  (LC/MS/MS).  LC/MS/MS-
based  metabolomics  analysis  was  performed  according  to  the  methods  of  J.W. 
Locasale et al., (Nat. Genet., 43, 869, 2011). 10
6 cells were harvested in 80% (v/v) 
methanol at -78
oC. Insoluble material in lysates was centrifuged at 2,000g for 15 min, 
and the resulting supernatant was evaporated using a refrigerated speed vac. Samples 
were resuspended using 20 µL LC/MS grade water. 7 µL was injected and analyzed 
using a 5500 QTRAP triple quadrupole mass spectrometer (AB/SCIEX) coupled to a 
Prominence HPLC system (Shimadzu) using selected reaction monitoring (SRM) of a 98 
 
total  of  252  endogenous  water  soluble  metabolites  for  analyses  of  samples.  Some 
metabolites were targeted in both the positive and negative ion mode for a total of 292 
SRM transitions. ESI voltage was +4,900 V in the positive ion mode and −4,500 V in the 
negative ion mode using positive/negative switching. The dwell time was 4ms per SRM 
transition,  and  the  total  cycle  time  was  1.82  sec  producing  9-12  data  points  per 
metabolite  peak.  Samples  were  delivered  to  the  MS  using  hydrophilic  interaction 
chromatography(HILIC)  using  a  3.6  mm  internal  diameter  ×  10  cm  Amide  XBridge 
column  (Waters)  at  300  µL/min.  Mobile  phase  gradients  were  run  startingfrom  85% 
buffer B (LC/MS grade acetonitrile) to 35% buffer B from 0–3 min; 35% buffer B to 0% 
buffer B from 3–12 min; 0% buffer B held from 12–17 min; 0% buffer B to 85% buffer B 
from 17–18 min; and 85% B held for 7 min tore-equilibrate the column. Buffer A was 
comprised  of  20  mM  ammonium  hydroxide  and  20  mM  ammonium  acetate  in 
95:5water:acetonitrile  (pH=9.0).  Peak  areas  from  the  total  ion  current  for  each 
metabolite SRM transition were integrated using MultiQuant v2.0 software (AB/SCIEX). 
For 
13C-Thr, -Ser, -Gln, and -glucose flux metabolomics, complete mESC media was 
deprived of the relevant nutrients and supplemented with the equivalent concentration 
of [U-
13C]Thr, [U-
13C]Ser, [U-
13C]Gln, or [U-
13C]glucose (Cambridge Isotopes), and cells 
were quickly harvested at the given time points using the above mentioned protocol. 
Samples were prepared as described above, and run with 153 total SRM transitions for 
expected 
13C incorporation (93 transitions in positive ion mode and 60 in negative ion 
mode). All data was normalized to total biomass, and analyzed using MATLAB. 
Antibodies.  Immunoblot  analysis  for  H3K4me3  (Millipore),  H3K4me2  (Millipore), 
H3K4me1 (Millipore), H3K27me3 (Millipore), H3K9me3 (Millipore), H3K36me3 (Abcam), 99 
 
H3K79me3  (Abcam),  pan-methyl-lysine  (Abcam),  acetyl-histone  H3  (Millipore),  total 
histone  H3  (Abcam),  Tdh  (Millipore),  Gldc  (Abcam),  Mat2a  (Abcam),  tubulin  (Santa-
Cruz), actin (Santa Cruz), was performed according to the methods of H. Zhu et al., 
(Cell, 147, 81, 2011).  
Gene  knockdown  by  shRNA.  The  Tdh-targeting  short  hairpin  RNA  (shRNA) 
sequences used were   ACTGGCCCATGATTCTAGATGATAGTGAAGCCACAGAT 
GTATCATCTAGAATCATGGGCCAGC (shTdh-1) and    ACACCAGAGTTGCCCA 
AGTGAATAGTGAAGCCACAGATGTATTCACTTGGGCAACTCTGGTGC  (shTdh-2). 
The  Gldc-targeting  short  hairpin  RNA  (shRNA)  sequences  used  were 
TGCTGTTGACAGTGAGCGATAGGGTCTTCATTCAAGAGAATAGTGAAGCCACAGAT
GTATTCTCTTGAATGAAGACCCTAGTGCCTACTGCCTCGGA  (shGldc-1)  and 
TGCTGTTGACAGTGAGCGACCACAGAAATCGCCATTCTAATAGTGAAGCCACAGAT
GTATTAGAATGGCGATTTCTGTGGCTGCCTACTGCCTCGGA  (shGldc-2).  The 
Mat2a-targeting  short  hairpin  RNA  (shRNA)  sequences  used  were 
TGCTGTTGACAGTGAGCGATAGGTGTTTTGTTCACCATTATAGTGAAGCCACAGAT
GTATAATGGTGAACAAAACACCTAGTGCCTACTGCCTCGGA  (shMat2a-1)  and 
TGCTGTTGACAGTGAGCGACCAGATAAGATTTGTGACCAATAGTGAAGCCACAGAT
GTATTGGTCACAAATCTTATCTGGGTGCCTACTGCCTCGGA  (shMat2a-2).  An 
shRNA  in  the  pTRIPZ  vector  that  targeted  firefly  luciferase  (shLuc)  was  used  as  a 
control.  The  shRNA  constructs  were  cut  from  the  pGIPZ  vector  (Open  Biosystems) 
using  the  restriction  enzymes  MluI  and  XhoI  and  ligated  into  the  precut  (MluI/XhoI) 
doxycycline-inducible  pTRIPZ  vector  (Open  Biosystems)  and  sequence-verified.  To 
generate shRNA virus, HEK293T cells were transfected during log-growth with 2 µg of 100 
 
the pTRIPZ-shRNA vector, 2 µg of the Δ8.9 lenti-viral packaging construct and 0.2 µg 
the VSV-g envelope vector using PEI (3-to-1 ratio: PEI-to-DNA in 800 µL Opti-MEM). 12 
hours post-transfection, HEK293T supernatant containing the transfection mixture was 
replaced  with  fresh  growth  media  (DMEM  plus  10%  FBS).  Viral  supernatant  was 
collected  and  passed  through  a  0.22  µm  filter  36  and  60  hours  after  transfection. 
mESCs at 40% confluence growing on a MEF-feeder layer were transduced with viral 
supernatant  from  HEK293T  cells  1-to-1  with  growth  media.  Polybrene  hexabromide 
(Sigma)  was  added  to  a  final  concentration  of  6  ug/mL.  mESCs  were  transduced  2 
times, 24 hours apart. 12 hours after the second transduction, virus-depleted media was 
replaced  with  growth  media.  Virus-transduced  mouse  mESCs  were  subjected  to 
selection with 1 µg/mL puromycin 48 hours later. Inducible shRNA mESC lines were 
maintained in  1  µg/mL  puromycin.  For  experiments,  the  shRNA  was  induced  with 1 
µg/mL of doxycycline. The kinetics of shRNA expression was readily observed by RFP 
expression  upstream  of  the  shRNA  and  downstream  of  the  doxycycline-inducible 
promoter. 
Gene  overexpression  and  human  iPSC  reprogramming.  Mouse  Tdh  was  cloned 
from  mESC  cDNA  libraries  using  the  forward  primer 
CGTAGGAATTCGCCGCCACCATGCTATTCCTTGGGATGCTAAAACAGG  and  the 
reverse  primer  CCGGCCGGATCCGTTCACTTGGGCAACTCTGG,  and  inserted  into 
the  pCDH-MCS-T2A-copGFP-MSCV  vector  (System  Biosciences).  Tdh  and  empty 
vector lentivirus was generated and transduced into H1-derived differentiated human 
fibroblasts,  according  to  the above-mentioned  protocol  for lenviral  shRNA.  Tdh-T2A-
copGFP and empty-T2A-GFP human fibroblasts were sorted by FACS, and expanded 101 
 
in  DMEM  plus 10%  FBS  and  100uM  MEM  non-essential  amino  acids.  Mouse  Gldc, 
Ahcy, Wdr5, Rbbp5, Ash2l, Dpy30, Setd1a, Setd1b, and GFP cDNA constructs in the 
pCMV-SPORT6 vector were obtained from Open Biosystems. 1 µg of each construct 
was  transfected  into  feeder-free  mESCs  with  Fugene  6.0  (Roche),  according  to  the 
manufacturer’s instructions. Fresh medium was replaced after 24 hours. 2 days later, 
the mESCs were assayed for gene expression by qRT-PCR and duplicate wells were 
subjected  to  Thr  restriction.  Human  iPSC  reprogramming  with  OSKM  lentivirus  was 
performed  according  to  the  methods  of  I.H.  Park  et  al.,  (Nature,  451,  141,  2008). 
Proviral silencing was used to identify properly reprogrammed human iPSC colonies 
and Tra-160 immunohistochemistry (eBioscience) was used to evaluate human iPSC 
reprogramming  efficiency,  according  to  E.M.  Chan  et  al.,  (Nat.  Biotech.,  27,  1033, 
2009). 
 
Results 
To investigate how metabolism is altered upon reprogramming to pluripotency, we used 
the  liquid  chromatography-based  tandem  mass  spectrometry  (LC-MS/MS)  platform 
based on selected reaction monitoring (Locasale et al., 2011) to profile metabolomic 
changes during murine iPSC reprogramming. We utilized MEFs expressing inducible 
Oct4,  Sox2,  Klf4,  and  Myc  (OSKM;  Mikkelsen  et  al.,  2008)  and  profiled  metabolism 
without doxycycline (dox)-induction (no dox), 4 days after dox (dox 4D), and 18 days 
after dox (dox 18D), whereupon iPSC clones were isolated and compared to mESCs. 
Hierarchical clustering revealed that iPSCs are similar to mESCs, while MEFs form a  
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Figure 4.1: Pluripotency factors upregulate Threonine-Methionine metabolism. (A) 
Hierarchical  clustering  of  metabolomic  profiles  of  mouse  embryonic  fibroblasts  with 
doxycycline-inducible  Oct4,  Sox2,  Klf4,  and  Myc  (iOSKM-MEFs)  in  the  absence  of 
doxycycline (no dox) and 4 days after dox (dox 4D), compared to iPSC clones isolated 
18  days  after  dox  (dox  18D)  and  mESCs,  profiled  in  triplicate  (n=3)  using  selected 
reaction  monitoring  (SRM)  and  a  liquid-chromatography  based  mass  spectrometry 
platform.  (B)  Scatter  plot  of  mESC  (x-axis)  metabolites  vs.  iPSC  (y-axis)  of  raw 
metabolite intensities obtained from the integrated total ion current from a single SRM 
transition. Correlation coefficient r = 0.99. (C) Relative levels (Fold Change) of glycolytic 
intermediates in iOSKM-MEFs in the absence of doxycycline (no dox) and 4 days after 
dox  (dox  4D),  compared  to  iPSC  clones  isolated  18  days  after  dox  (dox  18D)  and 
mESCs  (n=3).**P<  0.01,  *  P<  0.05.  (D)  Relative levels  (Fold  Change)  of  threonine-
glycine  and  cysteine-methionine  metabolites  in  iOSKM-MEFs  in  the  absence  of 
doxycycline (no dox) and 4 days after dox (dox 4D), compared to iPSC clones isolated 
18  days  after  dox  (dox  18D)  and  mESCs  (n=3).  **  P<  0.01.  (E)  Most  significant 
metabolite  changes in  dox-inducible  let-7  (iLet-7)  and  dox-inducible  Lin28a  (iLin28a) 
mESCs, after dox treatment (P < 0.05). Overlap shows metabolites that are reciprocally 
downregulated by let-7 plus upregulated by Lin28a, and vice versa. (F) Relative levels 
(Fold Change) of threonine-glycine and cysteine-methionine metabolites in iLet-7 and 
iLin28a  mESCs  after  dox  (n=3).  All  error  bars  represent  the  s.e.m.  from  three 
independent measurements. 
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distinct  cluster.  The  dox  4D  cells  form  a  cluster  intermediate  to  the  MEFs  and  the 
iPSC/mESC  clusters  (Figure  4.1A).  A  scatter  plot  indicated  that  mESCs  are  largely 
indistinguishable from iPSCs based on their overall metabolic profiles (r = 0.99, Figure 
4.1B). Inspection of the top metabolites regulated by OSKM induction revealed a large 
number of glycolytic intermediates (Figure S4.1A). Glycolytic intermediates like fructose-
6-phosphate,  fructose-1,6-bisphosphate,  glyceraldehyde-3-phosphate, 
dihydroxyacetone  phosphate,  and  3-phosphoglycerate,  were  already  significantly 
upregulated within 4 days of reprogramming (P < 0.05). This coincides with the time 
frame  in  which  MEF  proliferation  is  accelerating,  but  well  before  the  cells  become 
pluripotent  (Mikkelsen  et  al.,  2008),  and  suggests  that  the  upregulation  of  glycolytic 
intermediates in reprogramming occurs prior to the acquisition of the pluripotent state 
(Figure 4.1C).  
 
Most of the remaining prominent metabolites regulated by OSKM induction are involved 
in  Thr  and  Met  metabolism.  In  contrast  to  glycolytic  intermediates,  cystathionine, 
glutathione, S-adenosyl-methionine (SAM), S-adenosyl-homocysteine (SAH), S-methyl-
5-thioadenosine  (SMTA),  folate,  3-phosphoserine,  cysteine  and  threonine  are  only 
significantly altered after 18 days of dox treatment (P < 0.01), suggesting that enhanced 
Thr/Met metabolism occurs later in the process of reprogramming (Figure 4.1D). Some 
of the largest changes were in threonine (down 5-fold), cysteine (down 33-fold), SAM 
(up  11-fold),  SMTA  (up  7-fold)  and  cystathionine  (up  85-fold).  These  observations 
suggest  that  reprogramming  to  the  pluripotent  state  is  correlated  with  significant 105 
 
changes in Thr/Met metabolism, consistent with observations of high SAM and SMTA 
levels in human iPSCs (Panapoulos et al., 2012). 
 
To study metabolic changes associated with the switch between mESC pluripotency 
and differentiation, we profiled the metabolites of mESCs after dox induction of a let-7 or 
Lin28a transgene (iLet-7 or iLin28a; Figure 4.1E). In the context of mESCs, the let-7 
microRNA promotes differentiation by targeting the pluripotency network, while Lin28a 
helps promote pluripotency by repressing the maturation of endogenous let-7 (Yu et al., 
2007; Viswanathan et al., 2008; Melton et al., 2009). We profiled metabolic changes in 
iLet-7 and iLin28a mESCs upon acute dox-induction, while the cell-cycle was relatively 
unperturbed (Figure S4.1B). Lin28a and let-7 regulated 38 metabolites in a reciprocal 
fashion  (Figure  4.1E),  amongst  which  were  a  large  number  of  Thr/Met  metabolites 
(Figure 4.1E-F). These data further support the idea that Thr/Met metabolism is tightly 
regulated by the pluripotent state.  
 
We then integrated our metabolomics data on mESCs with cDNA microarray data on 
mESCs (Mikkelsen et al., 2008), within the KEGG database of metabolic networks. This 
analysis showed that many of the metabolic enzymes that channel Thr metabolism into 
Met  metabolism  are  highly  expressed  in  mESCs  relative  to  MEFs  (Figure  4.2A). 
Consistent with the enzyme expression patterns, several Thr/Met pathway inputs like 
Thr, Cys, and folate are lower in mESCs than in MEFs, while downstream outputs like 
SAM, SAH, SMTA and cystathionine are higher in mESCs than MEFs (Figure 4.1D). 
Collectively, these findings suggest that Thr fuels Met metabolism in mESCs. 106 
 
Figure 4.2: Threonine is catabolized to maintain the SAM/SAH ratio in mESCs. (A) 
Schematic  of  glycolysis,  threonine-glycine  and  cysteine-methionine  metabolism,  with 
levels of metabolites and metabolic enzymes in mESCs/iPSCs vs. MEFs indicated (red: 
up >3-fold; pale red: up 1.5 – 3-fold; black: no significant change; pale green: down 1.5 
– 3-fold; green: down >3-fold). Tdh, threonine dehydrogenase. Sdhl, serine/threonine 
dehydratase. Gcat, glycine C-acetyltransferase. Gldc, glycine decarboxylase or glycine 
cleavage  system  protein  P.  TCA,  tricarboxylic  acid.  Shmt1,  serine 
hydroxymethyltransferase  1.  Folr1,  folate  receptor  1.  Dhfr,  dihydrofolate  reductase. 
THF, tetrahydrofolate. Mthfr, methylene tetrahydrofolate reductase. Cth, cystathionase. 
Cbs,  cystathionine-beta-synthase.  Mtr,  5-methyltetrahydrofolate-homocysteine 
methyltransferase. Mat2a/b, methionine adenosyltransferase II, alpha and beta. SAM, 
S-adenosyl-methionine.  SMTA,  S-methyl-5-thioadenosine.  SAH,  S-adenosyl-
homocysteine. AHCY, adenosyl-homocysteinase or SAH hydrolase. (B) HPLC analysis 
of radioactive 
14C-labeled amino acids derived from [U-
14C]Thr in mESCs, after 24h. 
Thr, threonine. Gly, glycine. Ser, serine. Glu, glutamate. GSH, glutathione. Scintillation 
counts  per  minute  (CPM)  are  plotted  against  retention  time  in  minutes  (time/min).  
Peaks were identified from the retention time of internal standards of the corresponding 
compounds.  (C) Isotopic tracing of 
13C-labeled metabolites derived from [U-
13C]Thr in 
mESCs.    Media  was  replaced  with  [U-
13C]Thr  and  monitored  over  a  5h  time-course 
(n=3).  The fraction of 
13C incorporation (
13C / total C ratio) is plotted against time in 
minutes  (Time/min).  (D)  Isotopic  tracing  of 
13C-labeled  metabolites  derived  from  [U-
13C]Thr in mESCs.  The fraction of 
13C incorporation (
13C / total C ratio) is plotted after 
24h of incubation (n=3). (E) SRM analysis of metabolites in mESCs during 6h of Thr 107 
 
Figure 4.2 (continued) restriction (n=3).  Metabolite levels (Fold change) relative to the 
zero time point are plotted over time across a 6h time course. (F) Levels (Fold change) 
relative to the zero time point are plotted for several metabolic ratios over time across a 
6h time course. (G) Threonine restriction and re-feeding in mESCs. Feeder-free mESCs 
were deprived of threonine in the media for 12h, then supplemented for 36h with the 
indicated  metabolites  at  the  given  concentrations.  Alkaline  phosphatase-positive 
colonies were quantified and normalized to mESC colony numbers in normal mESC 
media (% colonies recovered) and plotted across all conditions.  X denotes a relative 
concentration  with  respect  to  the  concentration  in  the  standard  mESC  media.  Thr, 
threonine. Gly, glycine. Ser, serine. Met, methionine. Cys, cysteine. Glu, glutamate. Gln, 
glutamine. NAC, N-acetyl-cysteine. Py, pyruvate. DMG, dimethylglycine. Bet, betaine. 
Hypo,  hypoxanthine. Thy,  thymidine.  HT,  hypoxanthine  and  thymidine.  All  error bars 
represent the s.e.m. from three independent measurements. 
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To test this pathway, we traced the metabolic fate of 
14C-Thr in mESCs with HPLC. 
14C-
isotope was incorporated into Gly and Glu, indicating that Thr was used to synthesize 
these  amino  acids  (Figure  4.2B).  In  contrast,  MEFs  incubated  with 
14C-Thr  did  not 
exhibit Thr catabolism (Figure S4.2A). We also traced the fate of 
13C-Thr in mESCs with 
LC-MS/MS  metabolomics  (Figure  S2B-F, Table  S1).  mESCs used  Thr  to  synthesize 
acetyl-CoA-derived TCA cycle intermediates (Figure 4.2C-D). At steady-state, 
13C-Thr 
contributed ~20% of the citrate via acetyl-CoA, whereas 
13C-glucose contributed ~35% 
via  acetyl-CoA  (+2  isotopomer).  Thus  Thr  contributes  significantly  to  the  acetyl-CoA 
pool in mESCs (Figure 4.2D). Extracellular 
13C-Thr-derived 
13C-Gly also donated its 
13C-
methyl group to ultimately generate 5-methyl-tetrahydrofolate (5mTHF) and SAM (+1 
isotopomer),  whereas  extracellular 
13C-Ser-derived 
13C-Gly  contributed  little  to  the 
synthesis of these metabolites (Figure 4.2C-D). Although only ~25% of intracellular Gly 
and 5mTHF, and ~10% of SAM were labeled by 
13C-Thr at steady state, these numbers 
underestimate the contribution of Thr to the synthesis of these intermediates due to 
rapid 1-for-1 antiport of intracellular 
13C-Gly and 
13C-Met for extracellular 
12C-Gly and 
12C-Met. Evidence for rapid antiport-mediated 
13C-isotope dilution was provided by the 
appearance of large quantities of 
13C-Gly and 
13C-Met in the media - 6% of extracellular 
Gly and 13% of extracellular Met was 
13C-labeled within 1 hour of 
13C-Thr addition to 
the media - with no significant consumption of Gly or Met from the media. These data 
suggest that the rapid conversion of Thr to Gly by Tdh provides a major fraction of 
5mTHF needed for recycling SAH to SAM.   
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Although we observed flux of Thr into the activated Met cycle, it was unclear whether 
Thr was necessary to regulate Met metabolism, as other metabolites can also be used 
to  support  the activated  Met  cycle and  the fraction  of  SAM  labeled  by 
13C-Thr  was 
small. Thus  we  profiled  metabolic  changes upon  Thr  restriction  in  mESCs.  We  first 
observed that Thr restriction kills mESCs even when protein synthesis is inhibited by 
cycloheximide,  indicating  that  Thr  restriction  affects  cell  viability  independently  of 
protein  synthesis  (Figure  S4.2G-H).  Concordant  with  the  rapid  drop  in  cellular  Thr 
following Thr restriction, Gly also steadily decreased over 6 hours after Thr restriction 
(Figure 4.2E), suggesting an imbalance in Gly synthesis and consumption. In addition, 
the SAM/SAH ratio dropped rapidly and steadily over 6 hours (Figure 4.2F). In contrast, 
the ATP/AMP ratio increased, as did glucose-6-phosphate and fructose-6-phosphate 
(Figure  4.2E),  consistent  with  a  compensatory  increase  in  ATP  synthesis  due  to 
increased glycolysis, whereas the total NADH/NAD ratio decreased over time (Figure 
S4.2K-L). This suggests that Thr is also necessary to provide the acetyl-CoA needed to 
regulate the pool of reducing equivalents and SAM synthesis (Figure 4.2A). It is difficult 
to measure NADPH and NADH levels in the mitochondrial matrix, but the drop in total 
NADH might be due to a drop in mitochondrial acetyl-CoA, which fuels the production of 
reducing equivalents. Thus, the drop in SAM/SAH after Thr restriction is consistent with 
the  metabolites  of  Thr  contributing  not  only  to  the  methyl  group  of  SAM  (from  Thr-
derived Gly), but also to the supply of acetyl-CoA needed to regulate SAM synthesis.  
 
To  test  this  model,  we  subjected  mESCs  to  12  hours  of  Thr  restriction,  and  then 
supplemented  the  culture  media  with  metabolites  identified  from  our  metabolomics 111 
 
analysis. Titration with varying concentrations of Gly and pyruvate (to supply acetyl-
CoA)  showed  that  only  a  combination  of  3X  Gly  and  10X  pyruvate  can  rescue  Thr 
restriction in mESCs to levels comparable to re-feeding of 1X Thr (Figure 4.2G). Given 
that Thr contributes a significant portion of the mitochondrial acetyl-CoA at steady-state 
(Figure  S4.2I),  our  working  model  is  that  glucose-derived  pyruvate  is  limiting  in 
producing the higher levels of mitochondrial acetyl-CoA needed by mESCs, and that 
supplying  extracellular  pyruvate  can  meet  the  demand  that  is  normally  met  by  Thr. 
Glucose, acetate, Ser, Met, Cys, Glu, Gln, N-acetyl-Cys, or combinations with pyruvate, 
all failed to rescue Thr restriction. However a combination of pyruvate with the methyl 
donors  dimethylglycine  and  betaine  also  rescued  Thr  restriction  in  mESCs  (Figure 
4.2G),  suggesting  that  Thr-derived  5-methyl-THF  and its  main  product  SAM  (Figure 
4.2C-D) are essential for viability of mESCs. SAM was not used to rescue the mESCs 
because  it  is  not  transported  efficiently  across  the  mammalian  plasma  membrane 
(McMillan et al., 2005). Conversely the addition of an inhibitor of SAH, hydrolase 3-
deaza-adenosine  (DZA,  Backlund  et  al.,  1986),  which  raises  the  SAH  levels  and 
decreases  the  SAM/SAH  ratio,  led  to  mESC  death,  thereby  phenocopying  Thr 
restriction  (Figure  S4.2M).  In  contrast,  the  two  main  products  of  formyl-THF  and 
methylene-THF,  hypoxanthine  and  thymidine  respectively,  failed  to  rescue  Thr 
restriction, although they can enter mESCs (Valancius et al., 1991). A side-product of 
SAM and SMTA catabolism, the polyamine spermidine (Zhang et al., 2012), also failed 
to  rescue  Thr restriction.  An  alternative  hypothesis is  that Thr is  also  necessary  for 
suppressing reactive oxygen species and maintaining redox balance in ESCs, but two 
different  antioxidants  ascorbate  and  N-acetyl-Cys  failed  to  rescue  Thr  restriction. 112 
 
Altogether,  these  experiments  demonstrate  that  Thr  is  necessary  to  generate  an 
optimal balance of Gly and acetyl-CoA, at least in part to maintain the SAM/SAH ratio in 
mESCs. 
 
SAM is the universal substrate for all protein  methylation reactions in the cell. After 
transferring  the  methyl  group  in  SAM,  protein  methyltransferases  are  competitively 
inhibited by the downstream product SAH (Luka et al., 2009); thus the SAM/SAH ratio is 
important for regulating methylation of proteins, including the abundant histones (Figure 
4.3A). To test if Thr restriction affects histone methylation, we used a pan-methyl-lysine 
antibody to probe which proteins show differential lysine methylation upon restriction of 
Thr,  Gly,  and  Ser,  relative  to  complete  growth  media.  Amongst  the  most  abundant 
methylated proteins (Iwabata et al., 2005), the 17 kDa histone H3 showed a significant 
drop in methylation upon Thr restriction, whereas the 71 kDa heat shock protein 8, the 
50 kDa elongation factor-1a and the 41 kDa actins showed no changes (Figure 4.3B). 
Because  ESCs  possess  an  open  euchromatin  conformation  crucial  for  epigenetic 
plasticity,  and  given  the  importance  of  histone  H3  lysine  4  methylation  and  H3 
acetylation in maintaining open euchromatin (Azuara et al., 2006; Gaspar-Maia et al., 
2011),  we  tested  if  Thr  catabolism  is  required  to  regulate  H3K4  tri-methylation 
(H3K4me3)  and  H3  acetylation  (H3ac)  in  mESCs.  We  checked  H3  modifications  in 
mESCs  under  conditions  of  Thr  restriction  (0.3X)  that  do  not  lead  to  mESC  death 
(Figure S4.3A). H3K4me3, the prevalent H3 methylation mark in ESCs (Azuara et al., 
2006; Pan et al., 2007; Zhao et al., 2007; Gaspar-Maia et al., 2011), was dramatically 
reduced in mESCs after 48 hours of 0.3X Thr restriction, whereas H3ac was relatively  113 
 
Figure 4.3: Threonine-methionine metabolism controls H3K4 methylation levels. 
(A)  Schematic  of  relevant  methyl-transferase  reactions.  Histone  lysine  methylation 
requires S-adenosyl-methionine (SAM) as a methyl donor, and is competitively-inhibited 
by  S-adenosyl-homocysteine  (SAH).  (B)  Immunoblot  analysis  of  mESCs  using  an 
antibody against methyl-lysine, after restriction (0X) of Thr, Gly, or Ser for 24h. Total 
tubulin is used as a loading control. (C) Immunoblot analysis of mESCs and MEFs for 
histone  H3  lysine  4  tri-methylation  (H3K4me3),  and  H3  acetylation  (H3ac),  when 
exposed to 3X and 0.3X relative threonine concentrations in the media for 48h. Total 
tubulin is used as a loading control. (D) Immunoblot analysis of mESCs for H3K4me3 
levels, total histone H3, and tubulin after Thr restriction (0X) for 6 hours, then re-fed for 
6 hours with 0X Thr, 1X Thr, 10X Py + 3X Gly, 3X Gly or 10X Py + 3X Gly + 20µM DZA. 
DZA, 3-deaza-adenosine. (E) Relative levels of the SAM/SAH ratio after Thr restriction 
(0X) for 6h, then re-fed for 6h with 0X Thr, 1X Thr, 3X Gly, 10X Py + 3X Gly, or 10X Py 
+ 3X Gly + 20µM DZA. (F) Rescue of threonine restriction with pyruvate and glycine. 
Feeder-free  mESCs  were  deprived  of  threonine  in  the  media  for  12h,  then 
supplemented for 36h with 10X Py + 3X Gly, with or without 20µM DZA. Pluripotent 
mESC  colonies  were  stained  for  alkaline  phosphatase.  (G)  Immunoblot  analysis  of 
mESCs for the levels of H3K4me3, K4me2, K4me1, K27me3, K9me3, K36me3, and 
K79me3, after restriction (0X) of threonine (Thr), glycine (Gly), serine (Ser), methionine 
(Met) or leucine (Leu) for 24h. (H) Model of how threonine catabolism regulates the 
SAM/SAH ratio and H3K4 methylation.  
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unaltered (Figure 4.3C), although both epigenetic modifications mark open euchromatin 
and activated gene expression (Azuara et al., 2006; Gaspar-Maia et al., 2011). These 
results  indicate  that  Thr  metabolism  regulates  the  SAM/SAH  ratio  and  H3K4me3  in 
mESCs, without affecting H3ac. In comparison, MEFs did not show significant changes 
in  H3ac  nor  H3K4me3  upon  0.3X  Thr  restriction  (Figure  4.3C),  consistent  with  our 
observations that MEFs do not utilize Thr for Gly or Met synthesis (Figure S4.2A) and 
with our finding that Thr/Met metabolism changes correlate with pluripotency (Figure 
4.1). 
 
To test the sensitivity and reversibility of H3K4me3, we supplemented Thr-restricted 
mESCs with increasing doses of Thr. While mESCs had lost most of the H3K4me3 
mark after just 6 hours of Thr restriction, re-feeding with increasing concentrations of 
Thr for 6 hours reversed the drop in H3K4me3 levels (Figure S4.3B). Furthermore, we 
were also able to rescue the drop in H3K4me3 levels by adding high levels of Gly and 
pyruvate to the medium (Figure 4.3D). Addition of both pyruvate and Gly was necessary 
to restore the SAM/SAH ratio to normal levels, consistent with the idea that Thr-derived 
acetyl-CoA and Gly are regulating H3K4me3 by modulating the SAM/SAH ratio (Figure 
4.3E). Conversely DZA, which decreases the SAM/SAH ratio by raising SAH levels led 
to a rapid extinction of H3K4me3 (Figure 4.3D), and over-rode the rescue by pyruvate 
and Gly (Figure 4.3F), suggesting that the SAM/SAH ratio lies downstream of acetyl-
CoA and Gly. We then tested H3 methylation on lysines 4, 9, 27, 36, and 79 in mESCs 
after restriction of a variety of individual amino acids. H3K4me3 and H3K4me2 were 
dramatically decreased by Thr restriction, while H3K27me3 decreased slightly following 116 
 
Thr restriction (Figure 4.3G). H3K9me3  was increased by restriction of every amino 
acid tested, suggesting that changes in H3K9me3 are regulated independently of Thr 
restriction.  H3K4me1,  H3K36me3  and  H3K79me3  did  not  change  significantly  with 
restriction of any amino acid. These results suggest that the SAM/SAH ratio maintained 
by Thr catabolism is not required to regulate all protein lysine methylation in mESCs, 
but  rather  certain  specific  lysines  such  as  H3K4me3  and  H3K4me2  (Figure  4.3H). 
Assays of H3K4 methyltransferase activity from nuclear lysates further indicated that 
this change in H3K4 methylation with Thr levels is not due to a change in the total 
amount of methyltransferase activity (Figure S4.3C), suggesting that it is changes in the 
substrate/product  ratio  (SAM/SAH)  and/or  the  exposure  of  H3K4  to  the 
methyltransferase that influences the extent of methylation at this site. 
 
To  test  if  the  Thr/Met  metabolic  flux  (Figure  4.3H)  has  functional  consequences  on 
mESC  pluripotency,  we  knocked  down  the  Tdh  enzyme.  Thr  restriction  was  less 
suitable  for  this  purpose  because  it  induces  cell  death  very  rapidly.  We  used  an 
inducible  RFP-shRNA  against  Tdh,  and  observed  a  substantial  dox-dependent 
downregulation of Tdh protein (Figure S4.3D). In the presence of 0.3X Thr media, Tdh 
knockdown led to a dramatic decrease in the growth of mESCs (Figure 4.4A). Partial 
knockdown of Tdh led to mESC differentiation and death, as revealed by staining for 
alkaline phosphatase. This phenotype could be rescued by higher levels of Thr in the 
media,  further  supporting  the notion that Thr  metabolism  is  required  for  mESC self-
renewal  (Figure  4.4B).  More  robust  knockdown  of  Tdh  abrogated  the  ability  of  Thr 
supplementation to rescue cell viability. Importantly, the presence of Thr did not affect 117 
 
Tdh expression in surviving cells (Figure S4.3F-G). Tdh knockdown led to a slower flux 
of 
13C-Thr to Gly, Met and SAM, as well as to acetyl-CoA-derived TCA intermediates 
(Figure 4C). At steady state, Tdh knockdown also led to lower levels of Gly and citrate, 
and  a  lower  SAM/SAH  ratio  (Figure  4.4D).  Again,  we  observed  a  compensatory 
upregulation of glycolysis (Figure 4.4D), consistent with our analysis of Thr restriction 
(Figure  4.2E-F).  Tdh  knockdown  also  led  to  a  downregulation  of  H3K4me3  (Figure 
S4.3E).  Expression  profiling  by  qRT-PCR  revealed  that  Tdh  knockdown  led  to  a 
decrease in expression of pluripotency factors, including Oct4, Sox2, Nanog, Rex1, and 
Blimp1, and increased expression of the differentiation markers Foxa2 and Sox17 (Fig. 
S4.4A).  Embryoid  body  differentiation  of  the  mESCs  for  3  days  showed  that  Tdh 
knockdown  leads  to  more  rapid  extinction  of  the  pluripotency  factor  Sox2,  and  an 
aberrantly  rapid  induction  of  the  differentiation  markers  Gata4  and  Sox17  (Figure 
S4.4B).  These  data  provide  evidence  that  Thr  catabolism  by  Tdh  is  required  for 
maintenance of the pluripotent epigenetic state. 
 
We then tested if enzymes downstream of Tdh in Thr/Met metabolism are genetically 
required by mESCs in a similar fashion. In particular we tested mitochondrial glycine 
decarboxylase  (Gldc)  which  produces  methylene-THF  from  Gly,  and  the  methionine 
adenosyltransferase Mat2a, which produces SAM from Met. Dox-inducible knockdown 
of  Gldc  led  to  a  drop  in  H3K4me3  (Figure  S4.4C).  Like  Tdh  knockdown,  Gldc 
knockdown  also  led  to  a  growth  defect  in  mESCs  (Figure  S4.4D),  and  a  general 
decrease in Thr/Met metabolic flux (Figure S4.4G). In contrast, transient overexpression 
of Gldc rescued mESCs from Thr restriction (Figure S4.4H-I), suggesting that Thr- 118 
 
Figure 4.4: Threonine dehydrogenase regulates the pluripotency of mESCs. (A) 
Effects of Tdh shRNA (shTdh) on mESC growth, before (No dox) and after 48 hours dox 
treatment  (Dox)  in  0.3X  Thr  media,  relative  to  a  control  shRNA  against  luciferase 
(shLuc). Images are taken at 4X magnification. (B) Feeder-free mESC colonies with 
dox-induced  shTdh or  shLuc,  seeded  at  clonal density,  after  48h  of  culture in 0.1X, 
0.3X,  and  1X  relative  concentrations  of  Thr,  as  visualized  by  alkaline  phosphatase 
staining.  (C) 
13C-labeled  metabolites  derived  from  [U-
13C]Thr  in  mESCs,  after  24h 
incubation in [U-
13C]Thr and 48h dox-induction of shTdh or shLuc (n=3).  The fraction of 
13C incorporation (
13C / total C ratio) is plotted. (D)  Relative metabolite levels of mESCs 
after  48h  dox-induction  of  shTdh  or  shLuc  (n=3).  (E)  Human  iPSC  colonies 
reprogrammed from human fibroblasts overexpressing mouse Tdh-T2A-GFP, relative to 
empty  vector,  for  18  days  with  Oct4/Sox2/Klf4/Myc  lentivirus.  Colonies  were 
immunohistochemically stained for the hESC marker Tra-160. (F) Efficiency of human 
iPSC  reprogramming  from  human  fibroblasts  overexpressing  mouse  Tdh-T2A-GFP, 
relative to empty vector (n = 5 replicates, 3 independent experiments). (G) Quantitative 
RT-PCR analysis for relative gene expression of threonine-glycine metabolic enzymes 
and  endogenous  pluripotency  factors  in  human  fibroblasts  overexpressing  Tdh-T2A-
GFP, relative to empty vector (fold change), after 6 days of iPSC reprogramming (n=3). 
(H) Immunoblot analysis of human fibroblasts overexpressing Tdh-T2A-GFP, relative to 
empty vector, for Tdh, H3K4me3, H3K27me3, and pan-methyl-lysine levels, prior to iPS 
reprogramming. (I) Metabolite profiles of human fibroblasts overexpressing Tdh-T2A-
GFP, relative to empty vector (fold change), prior to iPSC reprogramming (n=3). (J) 
13C-
labeled metabolites derived from [U-
13C]Thr after 24h of incubation in human fibroblasts 119 
 
Figure  4.4 (continued)  overexpressing  Tdh-T2A-GFP,  prior  to iPSC reprogramming 
(n=3).  The fraction of 
13C incorporation (
13C / total C ratio) is plotted across several 
metabolites. All error bars represent the s.e.m. from three independent measurements. 
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Figure 4.4 (continued)   
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derived 5-methyl-THF and SAM are necessary for mESC pluripotency. Dox-inducible 
knockdown of the downstream Mat2a also led to a drop in H3K4me3 (Figure S4.4E) 
due to a lower flux of SAM synthesis (Figure S4.4G), with an accompanying growth 
defect  in  mESCs  (Figure  S4.4F).  Conversely,  transient  overexpression  of  the  SAH 
hydrolase Ahcy, which is known to decrease SAH and increase the SAM/SAH ratio, 
rescued mESCs from Thr restriction (Figure S4.4H-I). Finally components of the H3K4 
methyltransferase  complexes,  like  Wdr5,  Dpy30,  and  Setd1a  also  partially  rescued 
mESCs from Thr restriction, suggesting that Thr/Met metabolism is affecting mESCs at 
least in part  through  effects  on  H3K4me3.  These  data  provide  further  evidence  that 
Thr/Met metabolism regulates pluripotency in mESCs. 
 
In contrast to mice, humans lack a functional form of Tdh (Edgar et al., 2002; Wang et 
al., 2009) and thus, human ESCs must utilize other metabolic pathways to maintain the 
SAM/SAH  ratio.    We  examined  the  possibility  that  introduction  of  murine  Tdh  into 
human fibroblasts might promote the epigenetic changes that maintain or establish the 
pluripotent state. We expressed murine Tdh in a lentiviral vector with a self-cleaving 
T2A  tag  followed  by  GFP,  and  observed  high  levels  of  GFP  fluorescence  and  Tdh 
expression in human fibroblasts following viral transduction, similar to levels in mESCs 
(Figure S4.4J-L). Cell proliferation was not affected (Figure S4.4M). Tdh-overexpressing 
and empty-vector control fibroblasts were then subjected to iPSC reprogramming with 
OSKM lentivirus. By 18 days, Tdh-overexpressing human fibroblasts extinguished most 
of  their  GFP  fluorescence  due  to  the  silencing  of  provirus  that  is  characteristic  of 122 
 
pluripotent stem cells. This indicated that Tdh-overexpressing fibroblasts were properly 
reprogrammed into human iPSCs (Figure S4.4L). Immunohistochemical staining with 
the definitive human iPSC and ESC marker Tra-160 showed that Tdh overexpression 
led  to  3-fold  more  human  iPSC  colonies  than  control  fibroblasts  (Figure  4.4E-F). 
Expression  profiling  by  qRT-PCR  revealed  that  the  Tdh-overexpressing  fibroblasts 
showed a more rapid upregulation of endogenous pluripotency markers Oct4, Nanog, 
Rex1 and Stella than control fibroblasts after 6 days of iPSC reprogramming (Figure 
4.4G).To further understand Tdh’s mechanism for promoting iPSC reprogramming, we 
assayed  the  effects  of  ectopic  Tdh  expression  on  histone  methylation  and  the 
metabolome.  Immunoblotting  showed  that  Tdh  leads  to  higher  H3K4me3  and  pan-
methyl-lysine levels relative to control fibroblasts, even before iPSC reprogramming was 
initiated; moreover, pluripotency factor expression was not significantly changed over 
background  levels  (Figure  4.4H,  S4.4N).    The  steady-state  metabolome  of  Tdh-
expressing fibroblasts revealed a resemblance to mESCs, with lower levels of Thr, Cys, 
folate  and  5-methyl-THF,  and  higher levels of  cystathionine  and  a  higher  SAM/SAH 
ratio,  relative  to  control  fibroblasts  (Figure  4.4I). 
13C-Thr  isotope  labeling  further 
revealed that Tdh-expressing fibroblasts were converting Thr to Gly and SAM, as well 
as  acetyl-CoA-derived  TCA  intermediates  (Figure  4.4J).  Thus,  Thr/Met  metabolism 
driven by Tdh regulates epigenetic changes to promote changes in cellular identity. 
 
Discussion 
We have demonstrated that in mESCs, Thr/Met metabolism regulates changes in SAM 
and  SAH,  amongst  other  metabolites.  Alterations  in  the  SAM/SAH  ratio  directly 123 
 
influenced the maintenance of ESC/iPSCs, in part by regulating tri-methylation of H3K4, 
thus revealing a novel mechanistic link between cellular metabolism and pluripotency. 
Previous studies have shown that Thr is uniquely required to generate both acetyl-CoA 
and Gly in mESCs, but it was unclear why Thr was uniquely required (Wang et al., 
2009) - since both acetyl-CoA and Gly are available from other nutrients. The data we 
present here suggests that the unique ability of Tdh to convert Thr into both Gly and 
acetyl-CoA in the mitochondrial matrix optimizes the ability of cells to synthesize SAM 
and  deplete  SAH  to  maintain  high  SAM/SAH  ratios.  Besides  providing  reducing 
equivalents for the synthesis of 5-methyl-THF, Thr-derived acetyl-CoA could also be 
directly activating the Gly cleavage system by increasing synthesis of its rate-limiting 
cofactor lipoate (Brody et al., 1997) or, as proteomics profiling studies suggest (Schwer 
et al., 2009), by directly acetylating proteins in the Gly cleavage complex, like Gldc. 
Future  work  will  resolve  these  possibilities.  We  also  found  that  H3K4me3  is  more 
sensitive to changes in Thr metabolism than methylation of other histone H3 lysines, 
possibly due to the high abundance of this H3 methylation mark in the euchromatin of 
mESCs (Azuara et al., 2006; Pan et al., 2007; Zhao et al., 2007; Gaspar-Maia et al., 
2011) and its rapid turnover (Deal et al., 2010; Zee et al., 2010). While previous findings 
have suggested that H3K4me3 is necessary for mESC pluripotency and self-renewal 
(Ang et al., 2011), here we provide an explanation for how the  Thr/Met pathway, by 
modulating the SAM/SAH ratio amongst other changes in metabolism, regulates murine 
ESC  self-renewal  and  promotes  fibroblast  reprogramming  to  iPSCs  at  least  in  part 
through changes in H3K4me3. It is also interesting to note that, since human ESCs lack 
a functional Tdh gene (Edgar et al., 2002; Wang et al., 2009), they must rely on other 124 
 
metabolic enzymes to maintain optimal SAM/SAH ratios for histone methylation. The 
high levels of Tdh in mouse ESCs could explain why these cells are relatively easy to 
isolate and maintain in the pluripotent state compared with human ESCs that lack Tdh. 
Indeed, we have shown that ectopic expression enhances reprogramming, suggesting 
that  adding  Tdh  to  the reprogramming  cocktail  may  facilitate  the isolation of  human 
iPSCs from cells that appear refractory to reprogramming. 
Collectively, our results establish a metabolic signaling pathway that controls epigenetic 
identity in stem cells, supporting an emerging appreciation of the role of intermediary 
metabolism in controlling histone acetylation (Wellen et al., 2009; Cai et al., 2011), and 
making a novel link between regulation of metabolite levels and maintenance of the 
stem  cell  state.  Since  other  enzymes  that  regulate  Gly  metabolism  have  also  been 
implicated in the development of cancer (Locasale et al., 2011; Possemato et al., 2011; 
Jain et al., 2012; Zhang et al., 2012), our findings provide a framework for the study of a 
metabolic signaling mechanism that might also be dysregulated in the pathogenesis of 
other diseases. 
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Chapter 5: Epilogue - Stem cell metabolism in tissue development and aging 
As the zygote develops into a multicellular organism, the evolving demands for rapid 
cell growth, tissue formation, and organogenesis place drastically different metabolic 
requirements on embryos, early pluripotent stem cells, tissue-resident adult stem cells, 
transient amplifying tissue progenitors, and ultimately mature adult tissues.  
During the 1960-70s, advances in our understanding of the metabolism of embryos led 
to  techniques  for  in  vitro  culture  of  blastocysts  and  the  development  of  in  vitro 
fertilization (IVF). More recently, advances in cancer cell metabolism have led to an 
explosion in our understanding of how aerobic glycolysis (the “Warburg effect), rather 
than  normal  glycolysis  linked  to  OxPhos  supports  rapid  cellular  growth.  This 
understanding has led to new drug targets for cancer therapy. Within the last decade, 
studies of metabolism in various stem cell populations have also highlighted a role for 
cell-specific  metabolic  pathways  that  are  modulated  during  differentiation  or  during 
reprogramming  to  pluripotency.  These  novel  insights  have  challenged  the  long-held 
assumption that all metabolic enzymes perform the same housekeeping functions in all 
cells, and have provoked a resurgence of interest in metabolism. Overall, these results 
paint a picture of tissue- and cell-specific metabolic pathways and isoenzymes, which 
are  tightly  regulated  during  development  and  perform  unique  functions  in  specific 
contexts. Such cell- and tissue-specific isoenzymes provide a therapeutic window for 
pharmacological manipulation. Hence, the application of metabolomics to the study of 
stem cells during development could lead to new breakthroughs in our understanding of 
embryogenesis and adult tissue homeostasis, with implications for ongoing efforts in 
stem cell biology, tissue regeneration, and therapies for degenerative diseases. 127 
 
In  this  Epilogue,  we  review  the  specific  metabolic  pathways  active  in  mammalian 
totipotent stem cells, pluripotent stem cells before and after differentiation, quiescent 
adult  stem  cells,  and  proliferative  stem/progenitor  cells  during  mammalian  tissue 
development. We will also discuss the role of stemness factors in governing stem cell 
metabolism, and examine the role of stem cell metabolism during aging using insights 
gleaned from invertebrate models.  
Metabolism in totipotent stem cells and the early (pre-blastocyst) embryo  
Before the morula stage of development in mammalian embryos, each individual early 
blastomere is totipotent and retains the ability to generate an entire organism and its 
placenta.  Despite  differences  between  mammalian  species  in  the  time  spent  in 
gestation, the amount of time required to develop to the blastocyst stage is remarkably 
conserved (Brinster, 1974). In the first week, blastomeres, which are considered here as 
totipotent stem cells (TSCs), undergo a few self-renewing cell divisions and rounds of 
DNA replication, but the embryo as a whole experiences no net growth (Leese, 1995). 
TSCs likely autophagize their protein reserves, which drop by 26% by the 8-cell stage 
(Brinster, 1967).  
Metabolic  studies  indicate  that  TSCs  have  a  block  at  the  rate-limiting  glycolysis 
enzymes hexokinase (HK) and phosphofructokinase-1 (PFK1), thus glycolysis rates are 
initially low (Figure 5.1A; Barbehenn et al., 1978). Instead, the only energy and carbon 
sources that TSCs can use are pyruvate analogs, a fact that is also true for primordial 
germ  cells,  oocytes  and  spermatocytes,  which  utilize  pyruvate  secreted  by  ovarian 
follicle  cells  and  lactate  secreted  by  testicular  Sertoli  cells.  The  advantages  of  this 128 
 
preference for pyruvate in TSCs remain unknown. Early embryo development is actually 
inhibited  by  high  concentrations  of  glucose  (Brinster  and  Troike,  1973).  Only  at  the 
morula stage does the relative rate of glucose oxidation rival that of pyruvate (Leese 
and Barton, 1984). Pyruvate oxidation in the mitochondria fuels the Krebs cycle, which 
in turn generates carbon intermediates and fuels OxPhos.   
 
Figure 5.1: Totipotent stem cell (TSC) metabolism. (A) Glycolysis is impaired due to 
the low activities of the rate-limiting enzymes hexokinase (HK) and phosphofructokinase 
(PFK).  TSCs  use  pyruvate  as  their  major  energy  and  carbon  source  instead,  via 
pyruvate dehydrogenase (PDH) to generate acetyl-CoA (Ac-CoA) and pyruvate  129 
 
Figure  5.1  (continued)  carboxylase  (PC)  to  generate  oxaloacetate  (OAA)  for 
anaplerosis  or  gluconeogenesis.  (B)  ATP  synthesis  is  dependent  on  mitochondrial 
OxPhos driven by the electron transport chain (ETC) and ATP synthase. However, as 
mitochondrial replication has not yet initiated, the halving of mitochondrial mass with 
each  round  of  mitosis  leads  to  a  drop  in  ATP  levels  during  embryo  cleavage.  (C) 
Simultaneously,  each  mitochondrion  matures  and  the  inner  mitochondrial  membrane 
potential (ΔΨm) increases steadily, thus turning the exponential drop in ATP into a linear 
drop.  (D)  Bicarbonate  HCO3
-  is  needed  to  buffer  the  pH  and  also  contributes  as  a 
carbon source to OAA in the Krebs cycle for anaplerosis via PC, or nucleotide synthesis 
for DNA and RNA via carbamoyl phosphate synthetase (CAD). 
Despite  the  preference  for  pyruvate  oxidation,  the  O2  consumption  rate  of  TSCs  is 
relatively  low,  comparable  to  that  of  adult  skin  or  bone  (Brinster  and  Troike,  1973). 
Consistent with the low O2 consumption rate, mitochondria are structurally immature in 
TSCs. Oocyte and TSC mitochondria are typically spherical elements ≤1 μM in diameter 
with few truncated cristae, which contain a matrix of high-electron density. By the end of 
early embryogenesis, mitochondria elongate and develop networks of cristae containing 
a  matrix  of  low-electron  density  (Van  Blerkom,  2009).  The  inner  mitochondrial 
membrane  potential  (ΔΨm)  per  mitochondrion  also  increases  with  embryo  cleavage. 
However, prior to blastocyst implantation and  mitochondrial replication, mitochondrial 
numbers  are  halved  with  each  cell  division.  Accordingly,  total  ATP  levels  and  the 
ATP/ADP  ratio  are  high  initially  in  TSCs  but  decrease  linearly  with  time  during 
development  (Figure  5.1B-C),  whereas  the NADH/NAD
+  ratio  remains relatively high 
throughout (Quinn and Wales, 1971; Wales, 1974). Considering that ATP is a potent 130 
 
allosteric inhibitor of PFK1, the decrease in ATP may play a role in activating glycolysis 
at the blastocyst stage (Johnson et al., 2003). 
The ATP generated by mitochondrial OxPhos is also used to actively transport ions into 
the  early  embryo.  For  example,  the  pH  inside  the  early  embryo  is  kept  alkaline  by 
importing high levels of bicarbonate from the oviduct and uterine fluid (Vishwakarma, 
1962). Bicarbonate is important not just for pH buffering and membrane potential - it 
also contributes significantly to the carbon pool within TSCs (Graves and Biggers, 1970; 
Brinster,  1973).  TSCs  might  utilize  bicarbonate  for  carbon  fixation  via  mitochondrial 
pyruvate  carboxylase  (PC)  to  generate  oxaloacetate  for  anaplerosis  or 
gluconeogenesis,  or  via  carbamoyl  phosphate  synthetase  (CAD)  to  generate 
nucleotides for DNA and RNA synthesis (Figure 5.1D).  
Metabolism in pluripotent stem cells and the blastocyst  
During  morula  compaction,  blastomeres  undergo  the  first  round  of  differentiation  to 
segregate into trophectoderm (which becomes the placenta) and the pluripotent inner 
cell mass (ICM, which becomes the embryo proper). Accompanying this transformation 
is a sharp increase in net growth and metabolic activity (Figure 5.2). Firstly, glucose 
uptake  rises  sharply  as  the  embryo  upregulates  the  expression  of  the  glucose 
transporters  GLUT1  and  GLUT3  (Pantaleon  and  Kaye,  1998).  Glycolytic  flux  hence 
rises sharply, leading to increased lactate synthesis (Figure 5.2A; Leese and Barton, 
1984). The importance of glycolysis to blastocysts is evident in vivo, since mutations in 
4  glycolytic  enzymes  –  glucose-6-phosphate  isomerase  (GPI),  glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), triosephosphate isomerase (TPI1) and lactate  131 
 
 
Figure 5.2: Metabolism in pluripotent stem cells. (A) Glucose flux increases with the 
increase in GLUT1/3 expression, and the HK and PFK1 enzymes become activated to 
sharply increase glycolytic flux. As a result, flux into the pentose phosphate pathway 
(PPP) for nucleotide synthesis increases. (B) ATP synthesis is more dependent on the 
reactions  carried  out  by  glycolytic  phosphoglycerate  kinases  (PGK)  and  pyruvate 
kinases (PK), and is decoupled from O2 consumption by the mitochondrial ETC. (C) 
Activation of threonine dehydrogenase (TDH), glycine C-acetyltransferase (GCAT), and 
glycine  decarboxylase  (GLDC)  promotes  Thr-Gly  catabolism  to  feed  the  folate  one-
carbon  (1C)  pool,  which  in  turn  fuels  S-adenosyl-methionine  (SAM)  and  nucleotide 
synthesis to maintain pluripotency and proliferation.  132 
 
dehydrogenase A (LDHA) - result in early postimplantation lethality (West et al., 1990; 
Pretsch,  2000;  Merkle  and  Pretsch,  1989;  Merkle  et  al.,  1992).  OxPhos  rates  also 
increase, and O2 consumption in blastocysts rises to a high rate, comparable to that 
observed in the adult brain (Brinster, 1974). However, this increase is largely due to 
mitochondria of the trophectoderm, which have a high ΔΨm. In contrast, mitochondria in 
the ICM, which is not involved in organizing the blastocyst cavity, have a lower ΔΨm 
(Van Blerkom et al., 2009).  
Consistent with the lower ΔΨm in ICM mitochondria, pluripotent embryonic stem cells 
(ESCs) derived from in vitro culture of the ICM show high rates of glycolysis (Chung et 
al., 2007; Kondoh et al., 2007; Prigione et al., 2010; Varum et al., 2011; Zhang et al., 
2011a; Panopoulos et al., 2012; Shyh-Chang et al., 2013). A switch from OxPhos back 
to  glycolysis  is  also  seen  during  the  conversion  of  differentiated  cells  into  induced 
pluripotent  stem  cells  (iPSCs),  and  reflects metabolic  reprogramming  (Folmes  et  al., 
2011; Shyh-Chang et al., 2013). However, the upregulation of glycolysis precedes the 
reactivation of pluripotency markers (Hansson et al., 2012; Shyh-Chang et al., 2013). 
This indicates that the activation of glycolysis is not necessarily specific to pluripotency 
but,  rather,  represents  the  preferred  metabolic  state  of  rapidly  proliferating  cells. 
Furthermore, cell proliferation enhances iPSC reprogramming stochastically (Hanna et 
al.,  2009),  further  confounding  the  relationship  between  glycolysis,  proliferation,  and 
pluripotency.  That  said,  promotion  of  glycolysis  enhances  iPSC  reprogramming, 
whereas pharmacological inhibition of glycolysis or stimulation of OxPhos impairs iPSC 
reprogramming  (Yoshida  et  al.,  2009;  Zhu et  al.,  2010;  Folmes  et  al.,  2011).  In  the 
Warburg effect, cancer cells are thought to shunt glycolytic intermediates into amino 133 
 
acid, lipid, and nucleotide biosynthesis for cell proliferation (Vander Heiden et al., 2009). 
Similarly,  mouse  ESCs  show  increased  activity  in  the  pentose  phosphate  pathway 
(PPP), which allows rapid nucleotide synthesis (Filosa et al., 2003; Manganelli et al., 
2012;  Varum  et  al.,  2011).  Thus,  anabolic  glycolysis  is  a  common  feature  of  the 
metabolism in both ESCs and cancer cells. 
Despite the low levels of OxPhos occurring in undifferentiated ESCs, O2 consumption is 
still important. However, ATP synthesis appears to be decoupled from O2 consumption, 
and  depends  on  glycolysis instead (Figure 5.2B;  Zhang et  al.,  2011a).  Although  the 
mechanism and reasons for this decoupling remain unclear, it is possible that ESCs 
consume  O2  through  the  electron  transport  chain  to  oxidize  NADH  into  NAD
+  and 
maintain the Krebs cycle flux. This might also allow ESCs to maintain an optimal redox 
potential  for  lipid  synthesis  from  citrate,  and  amino  acid  synthesis  from  OAA  or  ʱ-
ketoglutarate (Shyh-Chang et al., 2011). In line with this, ESCs with high ΔΨm form 
teratomas  more  efﬁciently  than  ESCs  with  low  ΔΨm  (Schieke  et  al.,  2008),  and 
blastocysts  deficient  in  mitochondrial  oxidation  enzymes,  including  the  pyruvate 
dehydrogenase  (PDH)  complex,  show  developmental  defects  (Johnson  et  al.,  1998, 
2001). 
Mouse ESCs also utilize a unique mode of amino acid metabolism to  maintain their 
pluripotent epigenetic state (Figure 5.2C). In a screen for dependence on each of the 20 
amino  acids,  restriction  of  Thr  alone  (and  to  a  lesser  extent,  Met  or  Cys)  uniquely 
abolished mouse ESC growth. In contrast, other proliferative cell lines such as HeLa, 
3T3 or MEFs were sensitive to restriction of other amino acids but not Thr restriction 
(Wang et al., 2009). Consistent with these findings, expression of the Thr catabolizing 134 
 
enzyme  threonine  dehydrogenase  (TDH)  is  dramatically  upregulated  in  early 
blastocysts  and  ESCs,  and  after  iPSC reprogramming,  relative  to  differentiated  cells 
(Wang  et  al.,  2009;  Shyh-Chang  et  al.,  2013).  TDH  is  a  mitochondrial  enzyme  that 
serves as the rate-limiting step in the metabolism of Thr into Gly and acetyl-CoA. Gly 
can be subsequently used by the mitochondrial enzyme glycine decarboxylase (GLDC) 
to  generate  1-carbon  equivalents  for  the  folate  pool.  Like  TDH,  GLDC  is  also 
upregulated in pluripotent cells relative to differentiated cells (Shyh-Chang et al., 2013). 
Furthermore, pharmacological inhibition or knockdown of TDH disrupts mESC colony 
growth (Alexander et al., 2011; Shyh-Chang et al., 2013). Collectively, these findings 
suggest that the metabolites generated by Thr degradation may be utilized specifically 
for the self-renewal of pluripotent ESCs. Indeed, it was recently demonstrated that TDH 
and  GLDC  regulate  the  synthesis  of  5-methyl-tetrahydrofolate  (5mTHF),  thereby 
modulating S-adenosylmethionine (SAM) metabolism and histone H3K4 tri-methylation 
(Shyh-Chang  et  al.,  2013;  Box  2).  H3K4  tri-methylation  is  associated  with  open 
euchromatin, which is critical for the epigenetic plasticity of pluripotent ESCs and their 
self-renewal (Azuara  et  al., 2006;  Gaspar-Maia  et  al.,  2011;  Ang  et  al.,  2011).  TDH 
regulation of the folate pool was also found to promote rapid proliferation in mESCs 
(Wang  et al.,  2009),  consistent  with  findings  that  GLDC regulates  the  folate  pool  to 
promote nucleotide synthesis and proliferation in cancer stem cells (Zhang et al., 2012). 135 
 
Figure  5.3:  Metabolism  in  differentiating  ESCs.  (A)  Glycolytic  flux  and  lactate 
production drop rapidly upon ESC differentiation. (B) Flux into the PPP decreases as a 
result. (C) O2 consumption increases sharply as the ETC again becomes coupled to 
ATP synthase, to fulfill the needs of cell differentiation. (D) Glycolysis also becomes 
more  coupled  to  the  Krebs  cycle,  as  pyruvate  is  transported  more  efficiently  into 
mitochondria. (E) Increased ETC activity leads to increased reactive oxygen species 
(ROS) and eicosanoid signaling, which promote cell differentiation.   
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Metabolism in differentiating ESCs 
When ESCs differentiate, glycolytic flux decreases dramatically (Figure 5.3A-B), Thr-Gly 
metabolism  is  extinguished,  and  mitochondrial  OxPhos  fueled  by  glucose  and  fatty 
acids increases (Figure 5.3C-D; Cho et al., 2006; Chung et al., 2007; Facucho-Oliveira 
et  al.,  2007;  Wang  et  al.,  2009).  Thus  cells  acquire  an  even  more  oxidized  state. 
Furthermore, pluripotent ESCs are enriched with unsaturated lipids such as omega-3 
and omega-6 fatty acids that contain readily oxidizable carbon-carbon double bonds 
(Yanes et al., 2010). These unsaturated lipids prime ESCs to differentiate after oxidation 
by reactive oxygen species (ROS) to form eicosanoids (Figure 5.3E). In support of this 
concept, pharmacological inhibition of enzymes in the eicosanoid synthesis pathway, 
which  oxidizes  these  unsaturated  lipids,  preserves  ESC  pluripotency  (Yanes  et  al., 
2010).  
Metabolism in quiescent adult stem cells  
Unlike the proliferative ESCs, most adult stem cells are quiescent. Such quiescent adult 
stem cells reside in various tissues and include long-term hematopoietic stem cells (LT-
HSCs)  and  mesenchymal  stem  cells  (MSCs)  in  the  bone  marrow,  neural  stem  cells 
(NSCs) in the brain, epidermal stem cells in the hair follicle bulge, and satellite cells in 
the skeletal muscles. It is thought that quiescent adult stem cells generally maintain a 
slow-cycling state to avoid cellular damage from ROS and to ensure life-long tissue 
renewal  capacity  (Rossi  et  al.,  2008;  Suda  et  al.,  2011).  One  largely  unanswered 
question is whether the metabolic program  in adult stem cells is an intrinsic feature 
required for stem cell self-renewal, or an adaptive response to the hypoxic environment.  137 
 
Figure  5.4:  Metabolism  in  quiescent  long-term  hematopoietic  stem  cells  (LT-
HSCs). (A) The HSC transcription factor MEIS1 and low O2 levels combine to activate 
HIF1a  activity,  which  in  turn  promotes  glycolysis  in  quiescent  LT-HSCs.  (B)  HIF1a-
dependent pyruvate dehydrogenase kinases (PDK1-4) prevent pyruvate oxidation by 
suppressing PDH. (C) PPARʴ-driven fatty acid oxidation in the mitochondria is required 
for LT-HSC self-renewal and quiescence. Inhibition of fatty acid oxidation leads to LT-
HSC proliferation and differentiation. 
It is known that adult LT-HSCs prefer to utilize glycolysis (Figure 5.4A), a phenotype 
that some have argued to be an adaptation to the hypoxic environment of the bone 138 
 
marrow  niche  (Suda  et  al.,  2011).  One  potential  advantage  of  hypoxia-induced 
glycolysis in LT-HSCs is the associated reduction in ROS production from mitochondria, 
that leads to LT-HSC differentiation (Figure 5.5). LT-HSCs are sensitive to ROS, and 
they either undergo differentiation or apoptosis in the presence of excessive ROS when 
the  stress  response  is  defective  (Tothova  et  al.,  2007).  NSCs  in  the  hypoxic  brain 
exhibit similar responses to ROS (Figure 5.6A; Renault et al., 2009). This suggests that 
glycolysis  is  not  simply  an  environmental  adaptation  but  an  intrinsic  necessity  for 
quiescent adult stem cells. In line with this, the pro-glycolytic phenotype of LT-HSCs 
appears to be programmed by the HSC transcription factor MEIS1 via its target hypoxia-
inducible factor 1-alpha (HIF1a; Simsek et al., 2010), which upregulates many glycolytic 
enzymes. Similar to embryonic TSCs and ESCs, adult HSCs possess low mitochondrial 
mass and immature mitochondrial morphology (Chung et al., 2007). In fact, the majority 
of LT-HSCs can be metabolically sorted by gating for low ΔΨm and low endogenous 
NADH, and the resultant cells have greater hematopoietic capacity in vivo (Simsek et 
al., 2010). The low ΔΨm could be partly because LT-HSCs express higher levels of the 
pyruvate dehydrogenase kinases PDK1 and PDK3, which inhibit PDH and mitochondrial 
pyruvate oxidation (Figure 5.4B; Klimmeck et al., 2012). Interestingly, another pair of 
PDKs  regulated  by  HIF1a,  PDK2  and  PDK4,  are  also  required  by  LT-HSCs, 
demonstrating  that  PDK-regulated  OxPhos  generally  acts  as  a  switch  for  LT-HSC 
function (Takubo et al., 2013). Overall, it appears that OxPhos capacity is reduced in 
LT-HSCs. However, PPARʴ-driven fatty acid β-oxidation has been shown to promote 
LT-HSC self-renewal (Figure 5.4C; Ito et al., 2012), suggesting that it is not the absolute 
quantity per se, but the efficiency of OxPhos that might also be important. 139 
 
 
Figure 5.5: Proliferative hematopoietic stem and progenitor cell metabolism. (A) 
Anabolic glycolysis is driven in part by the myeloid transcription factor PU.1 and the Akt 
kinase.  (B)  Increased  ROS  production  during  OxPhos,  fueled  by  PTPMT1-driven 
pyruvate oxidation, might lead to increased synthesis of eicosanoids, e.g. prostaglandin 
E2  (PGE2),  which  promote  hematopoiesis.  (C)  Insulin-PI3K-Akt  signaling  activates 
glycolysis,  promotes  ROS  production  by  repressing  the  FoxO-mediated  stress 
response, and promotes mitochondrial biogenesis by activating mTOR signaling. This 
leads to HSC proliferation, differentiation, and aging. 140 
 
 
Figure 5.6: Metabolism in neural stem cells and progenitors. (A) Neural stem cells 
(NSCs)  remain  quiescent  in  a  hypoxic  niche  with  low  O2.  NSCs  require  FoxO3  to 
suppress ROS. (B) Neural progenitors, which exist under normoxia, upregulate both 
glycolysis and OxPhos. In normoxia, FoxO3 is repressed and leads to increased ROS, 
which prime NSCs for differentiation. Activation of acetyl-CoA carboxylase (ACC) and 
fatty  acid  synthase  (FASN)  increase  fatty  acid  synthesis  from  Ac-CoA  to  fuel 
phospholipid membrane synthesis. 
 
MSCs also reside in hypoxic conditions in vivo (Figure 5.7A). Relative to the more 
differentiated osteoblasts within the bone marrow niche, MSCs express higher levels of 
glycolytic enzymes and lower levels of OxPhos proteins, suggesting that MSCs rely 
more on glycolysis than do osteoblasts (Chen et al., 2008a). Nevertheless, MSCs 
expanded under normoxia can still utilize OxPhos with a high O2 consumption rate, 
suggesting that glycolysis may be an environmental adaptation for MSCs (Pattappa et 141 
 
Figure 5.7: Metabolism in mesenchymal stem cell (MSCs) and progenitors. (A) 
Bone marrow MSCs remain quiescent in a hypoxic niche, and utilize glycolysis. (B) Pre-
adipocytes upregulate OxPhos, and ROS production from the ETC complex III is highly 
active, to prime adipocyte differentiation. (C) Adipocytes upregulate glycolysis and ATP 
citrate lyase (ACL), which leads to increased cytosolic acetyl-CoA synthesis and hence 
an increase in histone H3 acetylation (H3ac) and also lipid synthesis. H3ac, in turn, 
leads to activation of the ChREBP transcription factor to promote GLUT4-mediated 
glucose uptake and glycolysis in order to generate the acetyl-CoA needed. (D) In 
osteoblasts, which give rise to bone, OxPhos and O2 consumption are upregulated, but 
ROS is suppressed via superoxide dismutase (SOD) and catalase (CAT). (E) Glycolysis 
is further upregulated in chondroblasts during chondrogenesis, which give rise to 
cartilage. 142 
 
al.,  2011).  In  fact,  MSC  proliferative  and  colony  formation  capacity  is  significantly 
increased in normoxia (Pattappa et al., 2013). The switch to OxPhos comes at a cost 
however,  since  MSCs  expanded  under  normoxia  show  a  3-4  fold  increase  in 
senescence,  suggesting  that  hypoxia-induced  glycolysis  limits  MSC  proliferation  to 
prevent oxidative stress-induced senescence and preserve MSC long-term self-renewal 
(Pattappa et al., 2013). Thus, in at least three types of adult stem cells, namely LT-
HSCs (Tothova et al., 2007), MSCs (Chen et al., 2008a), and NSCs (Renault et al., 
2009), the induction of ROS forces adult stem cells out of quiescence in hypoxia, and 
into  a  more  proliferative  state  in  normoxia.  This  may  be  a  common  mechanism  for 
priming stem cell differentiation.  
Metabolism in proliferative adult stem/progenitor cells  
In  addition  to  long-lived  quiescent  stem  cells,  a  number  of  adult  tissues  contain 
proliferative  stem  and  progenitor  cells  that  contribute  to  tissue  homeostasis  and 
renewal.  These  include  hematopoietic  progenitors,  neural  progenitors,  mesenchymal 
progenitors, skeletal myoblasts, cardiomyocyte progenitors, intestinal stem cells (ISCs), 
and germline stem cells (GSCs). As we discuss below, these are all highly proliferative 
undifferentiated cells that rely on different combinations of glycolysis and OxPhos for 
proliferation (summarized in Table 5.1).  
Hematopoietic progenitors 
The metabolic switch from anaerobic glycolysis under hypoxia for quiescent adult stem 
cells,  to  a  mixture  of  aerobic  glycolysis  and  OxPhos  for  proliferative  adult 
stem/progenitor cells is well exemplified in hematopoiesis. A proteomics study of the  143 
 
Table 5.1: Summary of Metabolic Pathways in Various Stem and Progenitor Cells 
 
transition  from  HSCs  to  myeloid  progenitors  showed  that  among  the  hexokinase 
isoforms, HK1 expression is higher in HSCs, whereas HK2 and HK3 expression levels 
were higher in myeloid progenitors (Klimmeck et al. 2012). HK1 is primarily associated 
with catabolism, whereas HK2 and HK3 have anabolic roles (Wilson, 2003), suggesting 
that HSCs rely on glycolysis for energy whereas myeloid progenitors use glycolysis for 
anabolic  growth  (Figure  5.5A).  In  fact,  myeloid  cells  express  high  levels  of  the 
transcription factor PU.1, which transactivates HK3 to drive myeloid differentiation and 
maintain  myeloid  identity  (Federzoni  et  al.,  2012).  Myeloid  progenitors  also  express 
lower levels of PDKs, suggesting that PDK-mediated suppression of OxPhos in HSCs is 
relieved  upon  myeloid  commitment  (Klimmeck  et  al.,  2012;  Takubo  et  al.,  2013).  In 
addition,  the  mitochondrial  phosphatase  PTPMT1,  which  dephosphorylates 
phosphatidylglycerol  phosphate  during  cardiolipin  synthesis  (Zhang  et  al.,  2011b), 
appears to be another master regulator of the OxPhos switch (Figure 5.5B; Yu et al., 
2013).  144 
 
Concomitant  with  the  increase  in  OxPhos  activity  as  HSCs  differentiate,  ROS  also 
increases  (Figure  5.5B;  Tothova  et  al.,  2007).  In  the  Drosophila  larval lymph  gland, 
hematopoietic  cells  resembling  mammalian  myeloid  progenitors  require  ROS  to 
differentiate into mature blood cells (Owusu-Ansah and Banerjee, 2009). The targets of 
ROS  that  prime  HSC  differentiation  still  remain  unknown,  but  it  is  possible  that 
components  of  the  eicosanoid  biosynthesis  pathway,  which  oxidizes  lipids  in  ESCs 
(Yanes et al., 2010), may be involved. In fact, the eicosanoid product prostaglandin-E2 
has  been  shown  to  significantly  enhance  HSC  proliferation,  hematopoietic  colony 
formation,  and  hematopoiesis  in  vivo  by  activating  Wnt  signaling  (Goessling  et  al., 
2009),  suggesting  that  eicosanoids  might  be  important  for  HSC  proliferation  and 
differentiation. 
Neural progenitors 
Like  hematopoietic  progenitors,  proliferative  neural  progenitors  show  high  levels  of 
glycolysis mediated by HK2 (Gershon et al., 2013). And like hematopoietic progenitors, 
the  directed  differentiation  of  ESCs  into  neural  progenitors  is  stimulated  by  the 
eicosanoid pathway, and also fatty acid metabolism (Yanes et al., 2010). However, it is 
unclear if these effects of fatty acids are due to mitochondrial fatty acid β-oxidation, or 
fatty acid utilization in lipogenesis, or both. On one hand, the oxidative stress response 
mediated by FoxO3 becomes rapidly deactivated upon NSC differentiation, suggesting 
that mitochondrial oxidation-induced ROS is required in neural progenitors (Figure 5.6A; 
Renault et al., 2009). In fact, deficiency in FoxO3 causes depletion of adult brain NSCs, 
and an expansion of oligodendrocytes in the corpus callosum (Renault et al., 2009). On 
the other hand, Nestin
+ neural progenitors require lipogenesis, mediated by fatty acid 145 
 
synthase (FASN) and acetyl-CoA carboxylase (ACC), for lipid membrane synthesis and 
neural progenitor proliferation (Knobloch et al., 2013). These results suggest that both 
fatty acid synthesis and oxidation-induced ROS might be critical for neural progenitors 
(Figure 5.6B). Alternatively, it is possible that fatty acid β-oxidation is only required in 
quiescent NSCs, resembling the situation observed in LT-HSCs (Ito et al. 2012). Upon 
differentiation into neural progenitors, the ACC-mediated increase in malonyl-CoA could 
then  allosterically inhibit  fatty  acid  β-oxidation  and  promote  fatty  acid  synthesis.  Yet 
another  possibility  is  that  fatty  acid-derived  lipids  are  oxidized  via  the  eicosanoid 
pathway to promote neurogenesis. More work is required to resolve these questions.  
Mesenchymal progenitors 
During  adipogenesis,  mesenchymal  pre-adipocytes  activate  a  lipogenic  program 
involving ATP citrate lyase (ACL) to increase glucose metabolism and to synthesize 
lipids for fat storage. Adipocytes also rely upon ACL to increase their supply of acetyl-
CoA  for  increased  histone  acetylation  during  adipogenesis  (Figure  5.7B-C).  This  is 
necessary for transactivation of key metabolic proteins such as the glucose transporter 
GLUT4, HK2, PFK1, LDHA, and the carbohydrate-responsive element-binding protein 
(ChREBP)  in  the  lipogenic  program  (Wellen  et  al.,  2009).  Directed  adipogenesis  of 
MSCs also increases mTORC1-dependent mitochondrial biogenesis, OxPhos and ROS 
(Figure 5.7B). Endogenous ROS generated from the mitochondrial ETC complex III is 
required to initiate adipogenesis, suggesting that OxPhos and ROS are not simply a 
consequence of adipogenesis but are a causal factor in promoting it (Tormos et al., 
2011). Similarly, directed osteogenesis of MSCs leads to an increase in mitochondrial 
biogenesis  and  OxPhos  in  osteoblasts  (Chen  et  al.,  2008a).  Unlike  adipogenesis, 146 
 
however, osteogenesis cannot tolerate ROS (Figure 5.7D). In fact, antioxidant enzymes 
such  as  superoxide  dismutase  (SOD)  and  catalase  (CAT)  are  simultaneously 
upregulated  with  OxPhos  in  osteoblasts  to  prevent  ROS  accumulation  (Chen  et  al., 
2008a).  In  contrast  to  adipogenesis  and  osteogenesis,  MSCs  undergoing 
chondrogenesis have signiﬁcantly reduced O2 consumption and OxPhos, indicating a 
shift  towards increased  glycolysis (Figure  5.7E;  Pattappa  et  al.,  2011).  Furthermore, 
hypoxia inhibits MSC osteogenesis, while chondrogenesis is unaffected (Pattappa et al. 
2013). Taken together, these studies demonstrate that careful manipulation of oxidative 
metabolism can direct the differentiation of MSCs either into adipocytes, osteoblasts or 
chondroblasts. 
Skeletal myoblasts 
Myogenesis during muscle regeneration is mediated by the proliferation of myoblasts 
derived from satellite cells, which undergo fusion to form myotubes. The expression of 
glucose transporters is tightly regulated during this process. GLUT1, for example, is 
expressed  only  in  satellite  cells  and  myoblasts  (Figure  5.8A).  The  higher  affinity 
transporter GLUT3 increases markedly in myoblasts during myogenesis, and decreases  
in myotubes. In contrast, the high affinity and insulin-sensitive GLUT4 is expressed only 
in myotubes (Figure 5.8B). Accordingly, the rate of glucose transport rises significantly 
during  myogenesis,  suggesting  a  switch  in  glucose  metabolism  during  this  process  
(Guillet-Deniau  et  al.,  1994).  This  switch  is  supported  by  findings  that  myoblast 
differentiation leads to a dramatic switch in the expression of pyruvate kinase isoforms, 
mediated  by  RNA-binding  proteins,  from  the  pro-glycolytic  PKM2  to  the  pro-OxPhos 
PKM1 (Figure 5.8A-B; Clower et al., 2010; David et al., 2010). In fact, myoblasts require  147 
 
 
Figure 5.8: Metabolism in skeletal myoblasts and myotubes. (A) Myoblasts utilize 
GLUT1 and GLUT3 for glucose uptake. Glycolysis mediated by PGK1 is necessary for 
myoblast  self-renewal.  The  low  activity  pyruvate  kinase  isoform  M2  (PKM2)  then 
facilitates  accumulation  of  glycolytic  intermediates  for  anabolic  metabolism  in 
myoblasts. For example the pentose phosphate pathway (PPP), mediated by hexose-6-
phosphate dehydrogenase (H6PD), shunts glucose-6-phosphate (G6P) into ribose and 
NADPH synthesis. ACL, which generates acetyl-CoA from citrate, is also necessary for 
myoblast self-renewal. (B) Upon cell fusion and differentiation into myotubes, glucose 
uptake  and  glycolysis  are  increased  by  GLUT4,  which  is  sensitive  to  regulation  by 
insulin-PI3K-Akt signaling. Mitochondrial OxPhos increases as well, partly due to the 
switch to the high activity pyruvate kinase isoform M1 (PKM1). 
 
glycolytic  phosphoglycerate  kinase-1  (PGK1)  for  self-renewal  (Bracha  et  al.,  2010). 
Hexose-6-phosphate dehydrogenase (H6PD) in the pentose phosphate pathway, and 148 
 
ACL-driven acetyl-CoA synthesis also appear to be required for myoblast self-renewal 
in vitro (Bracha et al., 2010). 
Cardiomyocyte progenitors 
In  the  fetal  heart,  cardiomyocyte  progenitors  prefer  to  use  lactate  to  fuel  OxPhos 
(Werner  and  Sicard,  1987).  Knowledge  of  these  metabolic  features  has  aided  the 
efficient  derivation  of  cardiomyocytes  from  ESCs  and  iPSCs  during  directed 
differentiation. Lactate media without glucose effectively eliminates human ESCs and 
iPSCs from differentiating embryoid bodies, while stimulating the rapid proliferation of 
cardiomyocyte  progenitors.  The  resultant  human  cardiomyocytes  showed 
physiologically relevant action-potential conﬁgurations and drug responses, and can be 
transplanted without forming tumors (Tohyama et al., 2013). These results demonstrate 
how understanding stem cell metabolism can lead to effective strategies for directed 
differentiation and mass production of functional cells and tissues. 
Metabolism and “stemness” factors: establishing a link 
After decades of research in stem cell biology, candidate factors that define “stemness” 
across  the  myriad  of  tissue lineages  and  stem  cells  are  emerging.  One  outstanding 
question  in  stem  cell  biology  is  whether  such  a  stemness  factor,  if  it  exists,  drives 
particular  cellular  functions  such  as  metabolism  in  a  specific  manner  to  maintain 
stemness. One such candidate factor is Lin28, an RNA-binding protein first identified in 
C.  elegans  through  mutagenesis  screens  for  regulators  of  developmental  timing,  or 
heterochrony (Ambros and Horvitz, 1984; Shyh-Chang and Daley, 2013). In mammals, 
Lin28a/b have been found to be regulators of pluripotent ESCs and iPSCs, fetal HSCs, 149 
 
neural  crest  progenitors,  skeletal  myoblasts  during  muscle  regeneration,  and 
spermatogonia (Viswanathan et al., 2008; Yu et al., 2007; Yuan et al., 2012; Molenaar 
et  al.,  2012;  Polesskaya  et  al.,  2007;  Zheng  et  al.,  2009).  Interestingly,  Lin28a/b 
regulate glucose metabolism in vivo by modulating insulin-PI3K-mTOR signaling via the 
let-7  microRNA  (Zhu  et  al.,  2011).  Furthermore,  transcripts  encoding  glycolysis  and 
mitochondrial enzymes are amongst the top mRNA targets directly bound by Lin28a in 
human ESCs (Peng et al., 2011). These findings suggest that the effects of Lin28 on 
stem/progenitor cell self-renewal across multiple lineages might be mediated in part by 
metabolic programming – a hypothesis that awaits testing.  
Stem cell metabolism and aging 
Several lines of evidence support the notion that enhanced tissue regeneration by adult 
stem cells can delay aging, whereas a decline in adult stem cell numbers and function 
drives  aging-related  syndromes  (Sahin  and  DePinho,  2010).  Accumulating  damage 
from  ROS,  for  example,  can  compromise  stem  cell  self-renewal  and  promote  aging 
(Rossi et al., 2008; Sahin and DePinho, 2010). Nutrient-sensitive signaling pathways 
that regulate organismal aging, such as the insulin-PI3K, Akt-FoxO, mTOR, and AMPK 
pathways, also regulate the balance between quiescence and proliferation of stem cells 
during aging (Chen et al., 2009; Jasper and Jones, 2010; Kharas et al., 2010; Kalaitzidis 
et al., 2012; Magee et al., 2012). As one example of the cross-talk between nutrient-
sensitive signaling and ROS in mammals, deficiency in the FoxO transcription factors 
dampens the oxidative stress response and depletes mouse LT-HSCs (Tothova et al., 
2007). Likewise, deletion of the AMPK regulator LKB1 leads to loss of mouse LT-HSC 
quiescence,  depletion  of  LT-HSC  pools,  and  impaired  hematopoiesis,  likely  due  to 150 
 
mitochondrial defects (Gan et al., 2010; Gurumurthy et al., 2010; Nakada et al., 2010). 
The mTOR signaling pathway also plays a major role in governing stem cell fate. For 
example, deletion of the metabolic sensor TSC1, which upregulates mTORC1 signaling, 
drives  mouse  LT-HSCs  into  proliferation  due  to  increased  mitochondrial  biogenesis, 
ultimately  depleting  the  LT-HSCs and  impairing  hematopoiesis  (Chen  et  al.,  2008b). 
Consistently,  mTORC1  inhibition  with  rapamycin  delays  mouse  LT-HSC  aging  by 
preserving adult LT-HSC self-renewal and hematopoietic capacity (Chen et al., 2009). 
Excessive  mTOR  signaling  also  leads  to  adult  epidermal  stem  cell  exhaustion  and 
progressive hair loss in mice – a phenomenon that rapamycin can delay (Castilho et al., 
2009).  Perhaps  more  strikingly,  rapamycin  treatment  late  in  adulthood  can  extend 
organismal longevity in mice (Harrison et al., 2009). These mechanisms appear to be 
well-conserved  in  Drosophila  too,  since  insulin-PI3K  signaling  also  regulates  the 
proliferative  capacity  of  fruit  fly  hematopoietic  progenitors  (Shim  et  al.,  2012), 
neuroblasts (Chell and Brand, 2010; Sousa-Nunes et al., 2011), intestinal stem cells 
(ISCs; Biteau et al., 2010; Choi et al., 2011; O’Brien et al., 2011), and germline stem 
cells (GSCs; McLeod et al., 2010). Thus, metabolic signaling pathways that regulate 
aging might do so via stem cell metabolism, by acting as nutrient-sensors that modulate 
regenerative capacity during aging (Figure 5.5C).  
Drosophila models of ISCs provide strong evidence that efficient oxidative metabolism 
can enhance stem cell self-renewal during aging and contribute to organismal longevity. 
One example is the demonstration that intestine-specific upregulation of the Drosophila 
PGC-1 homolog (dPGC-1/spargel), a master regulator of mitochondrial biogenesis, can 
delay  ISC  aging  and  the  consequent  accumulation  of  mis-differentiated  cells  during 151 
 
aging by enhancing the efficiency of OxPhos. Moreover, dPGC-1 upregulation in ISCs 
improves intestinal integrity and extends adult organismal longevity in old ﬂies (Rera et 
al.,  2011).  In  the  same  vein,  it  is  well-known  that  redox  balance  regulates  ISC 
proliferation.  In  the  Drosophila  intestine,  high  levels  of  ROS  are  produced  by 
enterocytes to control bacterial populations. ISCs respond to this oxidative stress by 
proliferating,  as  part  of  a  regenerative  response.  But  over  time,  this  can  lead  to 
hyperproliferation, stem cell exhaustion and epithelial degeneration in the aging animal. 
In fact, ROS-induced hyperproliferation can be prevented with antioxidants (Hochmuth 
et al., 2011). Moreover, organismal longevity can be increased upon gain-of-function of 
NRF2  or  its  C.  elegans  homolog  SKN1,  master  regulators  of  the  oxidative  stress 
response  (Hochmuth  et  al.,  2011).  In  contrast,  tissue-specific  loss  of  NRF2  in  ISCs 
causes  accumulation  of  ROS  and  accelerates  aging-related  degeneration  of  the 
intestine  (Hochmuth  et  al.,  2011).  Interestingly, loss  of  the  NRF2  regulator,  KEAP1, 
leads to hyperkeratosis in the gastrointestinal tract in mice (Wakabayashi et al., 2003), 
suggesting that NRF2 might also control ISC proliferation and aging in mammals.  
Although very little is known regarding GSC metabolism, GSC proliferation is known to 
be regulated by the availability of various nutrients. GSCs in the Drosophila ovary adjust 
their  proliferation  rates  to  nutritional  conditions  (Drummond-Barbosa  and  Spradling, 
2001), and the nutrient-sensitive insulin/IGF1 and TOR signaling pathways are required 
for this response (LaFever and Drummond-Barbosa, 2005; Hsu et al., 2008; Ueishi et 
al., 2009; LaFever et al., 2010). Given that studies in  C. elegans have shown GSCs 
regulate C. elegans longevity (Arantes-Oliveira et al. 2002; Wang et al., 2008), it will be 152 
 
interesting  to  see  if  GSC  metabolism  plays  a  role  in  regulating  C.  elegans  and 
mammalian longevity.  
Calorie restriction might also promote longevity in part by promoting the self-renewal of 
stem cells. Calorie restriction not only extends longevity but also prolongs the health of 
organisms,  ranging  from  worms  and  flies  to  rodents  and  primates,  by  improving 
metabolic  homeostasis  and  decreasing  the  incidence  of  degenerative  diseases  and 
cancer (Barger et al., 2003). However, the detailed mechanisms underlying the benefits 
of  calorie  restriction  in  specific  tissues  had  remained  unclear  until  recently.  In 
Drosophila,  calorie  restriction  conditions  that  extend  longevity  also  delay  the loss  of 
male GSCs over the course of aging (Mair et al., 2010). In mammalian muscles, calorie 
restriction  boosts  the  number  and  myogenic  function  of  skeletal  satellite  cells,  by 
increasing mitochondrial biogenesis and enhancing  OxPhos (Cerletti et al., 2012). In 
fact,  the  pro-myogenic  effect  of  calorie  restriction  can  be  recapitulated  in  vitro  by 
replacing glucose in satellite cell media with galactose to force the use of fatty acid 
oxidation  and  OxPhos.  In  the  intestinal  villus  crypts,  calorie  restriction  leads  to 
upregulation of cyclic ADP-ribose (cADPR) signaling in the intestinal niche Paneth cells 
by inhibiting mTOR signaling. As a result, cADPR signaling induces the proliferation of 
Lgr5
+ ISCs during calorie restriction (Yilmaz et al., 2012). Thus, calorie restriction can 
lead  to  complex  effects  in  niche  and  stem  cells  to  promote  stem  cell  function  and 
counteract aging-related degeneration. 
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Conclusion 
By the end of the 20
th century, early seminal discoveries of metabolism in early embryos 
led to the perfection of techniques in blastocyst culture and IVF. More recent insights 
into the metabolism in human ESCs have also led to rapid advances in chemically-
defined  conditions  for  human  ESC  culture,  iPSC  reprogramming,  and  their  use  in 
human disease models. As we move forward, a deeper understanding of human stem 
and  progenitor  cell  metabolism  could  lead  to  similar  breakthroughs  in  our  efforts  to 
define conditions to culture functional human tissues in vitro via directed differentiation 
of human ESCs. Furthermore, it is clear that our understanding of stem cell metabolism 
could  also  be  useful  in  fighting  aging-related  degeneration  in  patients.  Studies  of 
metabolism in stem cells thus harbor enormous potential for the field of regenerative 
medicine.  One  recent  example  is  the  mass  production  of  functional  human 
cardiomyocytes from human ESCs achieved by changing the primary carbon source in 
growth media from glucose to lactate (Tohoyama et al. 2012), thus yielding a source of 
cells that could help treat degenerative heart diseases in the future. But progress is slow 
elsewhere. Much remains unclear about metabolism in quiescent adult stem cells. This 
gap in our knowledge represents a critical barrier in our ability to grow, study, and utilize 
adult  stem  cells  ex  vivo,  and  to  derive  transplantable  adult  stem  cells  from  human 
ESCs.  A  case  in  point  is  that  highly  desired  methods  for  long-term  culture  and 
expansion of LT-HSCs do not yet exist. Similarly, much remains unknown about the 
metabolic requirements of various adult progenitor cells and their differentiated progeny, 
such that we are still unable to properly differentiate many adult stem and progenitor 
cells into fully functional, terminally differentiated cells that we can grow or maintain in 154 
 
vitro (Lyssiotis et al., 2011; Lairson et al., 2013). Although the traditional focus in this 
regard  has  been  on  growth  factors  and  transcription  factors,  it  would  be  critical  to 
discover  the  necessary  metabolic  conditions  as  well.  In  fact,  optimal  metabolic 
conditions need not just be permissive for the directed differentiation of cells, but could 
also serve as instructive regulatory signals (see Box 1). Drugs could even be developed 
to pharmacologically manipulate the relevant enzymes, which have historically proven 
to be one of the most druggable classes of proteins in humans.  
To  achieve  these  goals,  further  advances  in  metabolomic  technologies  might  be 
necessary. Much of the extant literature on stem cell metabolism is based on steady-
state measurements of lysed cells. Given the rapid kinetics of metabolic reactions, it will 
be critical to measure metabolic fluxes inside cells. Isotope-tracing methods in gas or 
liquid chromatography mass spectrometry (GC-MS or LC-MS) represent the state-of-
the-art in this area with their high levels of sensitivity, but still suffer from the inability to 
track real-time changes in vivo. Nuclear magnetic resonance (NMR) detection methods 
could  potentially  overcome  this  barrier,  but  they  currently  show  poorer  sensitivity 
compared to  mass spectrometry. Another important barrier to advances in stem cell 
metabolism is the current lack of reliable methods for metabolomic profiling at a single-
cell level. Current methods are limited to single fluorescent reporters of a few metabolic 
indicators,  such  as  the  ATP/AMP  ratio,  the  NADH/NAD  ratio,  or  ROS  abundance, 
instead of the hundreds of metabolites measurable by metabolomics. In addition, the 
intercellular  metabolism  and  subcellular  metabolism  of  stem  cell  niches  in  vivo  also 
await  further  exploration.  Therefore,  we  emphasize  the  need  to  explore  beyond  the 155 
 
current paradigm of in vitro stem cell metabolism to one that also encompasses the 
real-time changing metabolic needs of stem cells in vivo. 
 
Another tradition among extant metabolic studies is the focus on the carbon and energy 
source of cells. This focus has led to numerous studies on key common pathways in 
glucose metabolism, i.e. glycolysis, OxPhos and ROS. However, insufficient attention 
Box 1: Metabolic regulation of epigenetics during stem/progenitor cell differentiation 
Acetyl-CoA,  besides  being  a  Krebs  cycle  substrate,  is  important  for  protein  acetylation 
(Choudhary et al. 2009; Kaelin and McKnight, 2013) - which is known to impact protein 
function  and  gene  expression.  In  particular,  histone  H3  acetylation  leads  to  an  open 
euchromatin conformation that regulates gene expression in stem cells. Reduction of acetyl-
CoA  by  knockdown  of  ATP  citrate  lyase  (ACL,  the  enzyme  responsible  for  acetyl-CoA 
synthesis)  induces  myoblast  differentiation  (Bracha  et  al.,  2010),  whereas  inhibition  of 
histone  deacetylases  promotes  iPSC  reprogramming  (Huangfu  et  al.,  2008).  In  addition, 
glycolysis fuels the rise in acetyl-CoA and histone acetylation required for pre-adipocyte 
differentiation (Wellen et al., 2009).  
Akin to the role of acetyl-CoA in histone acetylation, S-adenosylmethionine (SAM) is critical 
for histone methylation (Shyh-Chang et al., 2013). Like histone acetylation, histone H3K4 di- 
or tri-methylation leads to euchromatin formation. Reduction  in the ratio of SAM to  S-
adenosylhomocysteine (SAH), induced by the SAH hydrolase inhibitor DZA, leads to rapid 
loss of H3K4 tri-methylation in ESCs and causes ESCs to differentiate and die (Shyh-Chang et 
al., 2013). Thr-Gly-Ser metabolism was shown to fuel SAM synthesis in mouse ESCs, thus 
maintaining the high levels of H3K4 tri-methylation critical to mouse ESC pluripotency and 
reprogramming. This demonstrates that changes in amino acid metabolism can regulate 
histone methylation via SAM, thereby influencing epigenetic control of stem cell fate (Shyh-
Chang et al., 2013).  
The Krebs cycle intermediate α-ketoglutarate (αKG) is also an important cofactor for the 
Fe
2+-dependent  Jumonji  (JmjC)  family  of  dioxygenases,  which  mediate  histone 
demethylation, and the TET family of dioxygenases, which mediate DNA demethylation. 
Somatic  mutations  in  isocitrate  dehydrogenases  IDH1/2  lead  to  reduced  αKG,  thus 
disrupting normal histone demethylation and consequently HSC differentiation (Figueroa et 
al., 2010; Sasaki et al., 2012), as well as pre-adipocyte and neural progenitor differentiation 
(Lu et al., 2012). This leads to cellular transformation and cancer. Interestingly, another 
cofactor for Fe
2+-dependent dioxygenases, ascorbate or vitamin C, has also been shown to 
improve iPSC reprogramming, thereby promoting DNA and H3K36 demethylation (Chung et 
al., 2010; Stadtfeld et al., 2012; Wang et al., 2011). 156 
 
has  been  dedicated  to  amino  acid  and  lipid  metabolism.  Recent  studies  are  just 
beginning  to  show  that  Thr-Gly-Ser  metabolism  is  important  to  the  folate  pool  and 
SAM/Met metabolism, with implications for nucleotide synthesis during proliferation and 
histone  methylation  for  epigenetic  regulation  in  stem  cells  (see  Box  1).  Acetyl-CoA 
metabolism  is  also  beginning  to  emerge  as  a  major  regulator  of  protein  (including 
histone) acetylation to regulate stem cells epigenetically. Furthermore, lipogenesis is 
emerging  as  a  key  pathway  that  sustains  membrane  synthesis  and  proliferation, 
whereas lipid oxidation via the eicosanoid pathway might generate a diversity of tissue-
specific  signaling  molecules  necessary  to  guide  stem  cell  differentiation.  An  entire 
universe  of  cell-  or  tissue-specific  metabolic  pathways  might  be  awaiting  future 
discovery – with the potential to revolutionize regenerative medicine.     
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Appendix 
Supplemental Materials 
Figure S2.1
  
Figure S2.1. Further characterization of Lin28a/b gain and loss of function mice. Over 96 
hours,  there  were  no  horizontal  activity  (A),  O2/CO2  exchange,  or  food/water  intake  (B) 
differences between wild-type and Lin28a Tg mice. (C) Weight and (D) GTT of uninduced wild-
type and LIN28B Tg containing mice. (E) Mature let-7 miRNA expression in E12.5 wild-type and 
Lin28a muscle-specific knockout embryos. 
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Figure S2.2 
 
Figure S2.2. Further characterization of iLet-7 transgenic mice. (A) Relative organ weights 
of iLet-7 mice induced for 8 weeks. (B) Mature let-7g expression in tissues of uninduced iLet-7 
or  Let-7  Tg  carrying  mice.  (C)  Weight  and  (D)  GTT  of  uninduced  wild-type  and  iLet-7  Tg 
containing mice.  
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Figure S2.3 
 
Figure  S2.3.  Lin28a  increases  PI3K-mTOR  signaling  in  differentiated  myotubes,  the 
MAPK/Erk inhibitor does not abrogate Lin28a-induced glucose uptake, and rapamycin 
does  not  alter  let-7  levels  in  myoblasts.  (A)  Western  blot  showing  Akt  and  S6 
phosphorylation in C2C12 cells differentiated into myotubes for 3 days, expressing either Lin28a 
or the pBabe empty vector. (B) Glucose uptake in 3-day-differentiated C2C12 myotubes after 24 
hr treatment with 10 µM of the MAPK/Erk inhibitor PD98059, or DMSO. (C) Effect of rapamycin 
on mature let-7a levels in C2C12 myoblasts.  (D) Mature let-7 miRNA expression in C2C12 
myoblasts. NC = negative control.  
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Figure S2.4 
Figure S2.4. Lin28a promotes insulin-PI3K-mTOR pathway genes and Igf2 is dispensable 
for  Lin28a’s  functions  in  vitro  and  in  vivo.  (A)  Quantitative PCR for  components  of the 
insulin-PI3K-mTOR signaling pathway in C2C12 myoblasts, normalized to Gapdh, after Lin28a 
overexpression.  (B)  Igf2  mRNA  expression  in  C2C12  myoblasts.  (C)  S6  and  4EBP1 
phosphorylation in C2C12 myoblasts after overexpression of let-7a and knockdown of Igf2. (D) 
Glucose uptake in 3-day-differentiated C2C12 myotubes after siRNA knockdown of  Igf2 and 
overexpression of let-7a duplex. (E) GTT and (F) ITT of Igf2-/+; Lin28a Tg vs. Igf2-/+ mice. 
Since Igf2 is imprinted and silenced on the maternal allele, all of the heterozygous offspring 
(labeled Igf2-/+) of a homozygous null father are functionally Igf2 null. (G) Inguinal fat pads 
dissected from 1-year-old Igf2-/+; Lin28a Tg and Igf2-/+ mice. (H) Weight in grams of these fat 
pads.  192 
 
Figure S2.5 
 
Figure  S2.5.  Constructs  used  to  make  inducible  transgenic and  conditional knockout 
mice. (A) Tetracycline inducible mouse constructs for iLin28a, iLIN28B, and iLet-7 mice. (B) 
Design of conditional Lin28a knockout mice. Upper: Genomic map of the Lin28a locus shows 
exons, restriction sites. Middle: Lin28a conditional targeting construct. Exon 2 is flanked by loxP 
sites. PGK-Neo cassette is flanked by a frt site. Lower: Targeted allele following a homologous 
recombination. As=Asp718, EV=EcoRV. (C) Southern blot showing ESC clones with the floxed 
allele. (D) PCR genotyping showing wild-type (wt), floxed and deleted (null) alleles. 
 193 
 
Figure S3.1 
 
 
Figure S3.1: Lin28a reactivation promotes hair regrowth. (A) Relative skin thickness 
of WT vs. iLin28a Tg mice over time. Measurements included the epidermis and dermis. 
(B)  Number  of  hair  follicles  per  10x  magnification  field.  (C)  Relative  follicle  bulb 
diameters were measured. (D) WT and iLin28a Tg mice underwent wax depilation at 
age  p44  and  images  were  taken  11  days  later.  (E)  Phospho-histone  H3 
immunohistochemistry staining performed on p24 WT and iLin28a Tg mice, which were 
both in anagen.  
   194 
 
Figure S3.2: Local Lin28a overexpression does not promote adult digit 
regeneration after distal amputation.  
 
 
 
Figure  S3.3:  Topical  LIN28B 
overexpression  does  not  promote 
pinnal tissue repair. 
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Figure  S3.4:  Lin28a  alters  the  bioenergetic  state  during  tissue  repair.  (A)  LC-
MS/MS  selected  reaction  monitoring  (SRM)  analysis  of  abundance  in  glycolysis 
intermediates in Lin28a
+/+;Lin28b
-/- (n=7), Lin28a
+/-; Lin28b
-/- (n=8) and Lin28a
-/-; Lin28b
-
/- (n=5) embryos at E10.5 post-coitum. * P<0.1 (B) SRM analysis of several metabolic 
indicators  in  Lin28a
+/+;Lin28b
-/-  (n=7),  Lin28a
+/-;  Lin28b
-/-  (n=8)  and  Lin28a
-/-;Lin28b
-/- 196 
 
Figure S3.4 (continued) (n=5) embryos at E10.5 post-coitum. * P<0.1, ** P<0.01 (C) 
Mitochondrial DNA (mtDNA) content analyzed by means of qRT-PCR. Relative amounts 
were  normalized  to  WT  MEFs.  (D)  Mitochondrial  distribution  in WT  and  iLin28a  Tg 
MEFs, as visualized by MitoTracker Red CMXRos staining.  
 
 
 
Figure S3.5: Lin28a enhances mitochondrial oxidation enzymes to promote tissue 
repair. (A) Schematic of glucose catabolism through glycolysis, the Krebs cycle and 
oxidative phosphorylation, and the drug inhibitors that modulate this pathway. 2DG, 2-
deoxy-D-glucose.  3BP,  3-bromopyruvate.  ROS,  reactive  oxygen  species.  GSH, 
glutathione. GSSG, glutathione disulfide. NAC, N-acetyl-cysteine. Anti-A, antimycin-A. 
Pfkp,  phosphofructokinase,  platelet  type.  Pdha1,  pyruvate  dehydrogenase  alpha  1. 
Idh3b, isocitrate dehydrogenase 3 NAD(+)-specific, mitochondrial, beta subunit. Sdha, 
succinate  dehydrogenase  complex  subunit  A,  flavoprotein.  Ndufb3/8,  NADH 
dehydrogenase  (ubiquinone)  1  beta  subcomplex  3/8.  (B)  Western  blots  showing 
efficacy of siRNA knockdown of metabolic enzymes in WT and iLin28a Tg MEFs. (C) 
qRT-PCR  showing  efficacy  of  siRNA  knockdown  of  metabolic  enzymes  in  WT  and 
iLin28a  Tg  MEFs.  (D) 
13C-glucose  flux  analysis  of  glycolytic  and  Krebs  cycle 
intermediates in WT and iLin28a Tg MEFs treated with siRNAs against glycolysis and 
Krebs cycle enzymes. (E) SRM analysis of the ATP/AMP and GSH/GSSG ratios in WT 
and iLin28a Tg MEFs treated with siRNAs against electron transport chain enzymes. (F) 
Primary MEF proliferation over 5 days with and without antimycin-A treatment.  197 
 
Figure S3.5 (continued) 
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Figure S3.5 (continued) 
 
 
 
 
 
 
 199 
 
Figure S3.6 
 
Figure S3.6: iLin28a Tg mice do not exhibit improved regeneration after cardiac 
cryoinjury. (A) Images of the adult heart 2 weeks after cryoinjury with metal probes 
cooled in liquid N2. (B) Injured hearts 8 weeks after cryoinjury. (C) H+E and trichrome 
images of the injured region of the heart at 8 weeks.  200 
 
Figure S4.1
 
Figure S4.1: Characterization of iOSKM, iLin28, and iLet-7 cells 
(A)  Top  metabolite  changes in iOSKM  MEFs  after  reprogramming  for  18  days,  and 
isolated as iPSCs (P < 0.05). (B) Cell cycle profiles ofiLin28a and iLet-7 mESCs after 2 
days of dox induction.  
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Figure S4.2 
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Figure S4.2 (continued) 
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Figure  S4.2  (continued): 
13C-metabolomics  of  mESCs.  (A)  HPLC  analysis  of 
radioactive 
14C-labeled  amino  acids  derived  from  [U-
14C]Thr  in  MEFs,  after  24h 
incubation. Thr, threonine. Gly, glycine. Ser, serine. Glu, glutamate. (B) Quantitation of 
spike-ins  of  0.1mM  and  0.3  mM  threonine  into  mESC  samples.  (C)  Quantitation  of 
spike-ins of 0.1 – 0.3 mM [U-
13C]Thr into mESC samples. (D) Quantitation of spike-ins 
of 0.5 – 1.5 mM glycine into mESC samples. (E) Quantitation of spike-ins of 0.4 – 1000 
uM S-adenosyl-methionine into mESC samples. (F) Time-course of intracellular 
13C-Thr 
flux in mESCs, measured by LC/MS/MS (n=3). (G) Effects of cycloheximide (CHX) and 
DMSO vehicle on mESC colony density, as measured by alkaline phosphatase staining 
(AP),  under  normal  (Thr)  or  Thr-restricted  (No  Thr)  conditions.  (H)  Effect  of 
cycloheximide  on  mESC  growth  is  independent  of  Thr  restriction.  (I) 
13C-labeled 
metabolites in glucose metabolism derived from [U-
13C]-glucose, [U-
13C]Thr, [U-
13C]Ser 
or [U-
13C]Gln, after 48h incubation of mESCs (n=3). The fraction of 
13C incorporation 
(
13C  /  total  C ratio)  is  plotted  across  several  metabolites.  The  +2  citrate  and  +2  ʱ-
ketoglutarate isotopomers are shown for glucose- and Thr-labeling via acetyl-CoA, while 
the  +4  citrate  and  +5  ʱ-ketoglutarate  isotopomers  are  shown  for  Gln-labeling  via 
anaplerosis. (J) 
13C-labeled metabolites in Thr/Met metabolism derived from [U-
13C]-
glucose,  [U-
13C]Thr,  [U-
13C]Ser  or  [U-
13C]Gln,  after  48h  incubation  of  mESCs  (n=3).  
The  fraction  of 
13C  incorporation  (
13C  /  total  C  ratio)  is  plotted  across  several 
metabolites. The +2 glycine isotopomer, +3 serine and phosphoserine isotopomers, and 
the +1 SAM isotopomer, are shown for all experiments. (K) Colorimetric enzyme-based 
assay for the total NADH/NAD ratio in mESCs after Thr restriction (0X) for 6h, then re-
fed for 6h with 0X Thr or 1X Thr. (L) Colorimetric enzyme-based assay for the total 204 
 
Figure S4.2 (continued) NADPH/NADP ratio in mESCs after Thr restriction (0X) for 6h, 
then re-fed for 6h with 0X Thr or 1X Thr. (M) SRM analysis of the SAM/SAH ratio in 
mESCs after 24h treatment with 20µM DZA. Corresponding samples were stained for 
alkaline phosphatase. 
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Figure S4.3        
     
Figure S4.3 (continued): Thr restriction and Tdh knockdown of mESCs. (A) Size 
and morphology of mESC colonies when exposed to 3X and 0.3X Thr concentrations in 
the  media  for  48h.  (B)  Immunoblot  analysis  of  mESCs  for  H3K4me3,  after  Thr 
restriction (0X) for 6h, then re-fed for 6h with varying Thr concentrations in the media.  206 
 
Total tubulin is used as a loading control. (C) Colorimetric enzyme-based assay for the 
total H3K4 methyltransferase activity in nuclear lysates of mESCs after exposure to 3X 
and  0.3X  Thr.  The  mESCs  overexpressing  Wdr5,  an  H3K4  methyltransferase 
component, were used as a positive control. (D) Immunoblot of Tdh in mESCs after 
dox-induced shRNA knockdown of Tdh with 2 different hairpins (shTdh), relative to a 
control shRNA against luciferase (shLuc).  (E) Size and morphology of mESC colonies 
with  inducible  shTdh,  when  exposed  to  increasing  concentrations  of  dox  in  1X  Thr 
media for 48h. Images were taken at 4X magnification. (F) Epifluorescence images of 
mESC colonies with dox-induced shTdh, when exposed to 1X or 0.1X Thr media for 
24h. Images were taken at 4X magnification. (G) Immunoblot of mESCs grown in 0.1X 
Thr  media  for  Tdh,  H3K4me3,  H3K27me3,  and  pan-methyl-lysine  levels,  after  dox-
induced shRNA knockdown of Tdh with 2 different hairpins (shTdh), relative to a control 
shRNA against luciferase (shLuc). 
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Figure S4.4 
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Figure S4.4 (continued) 
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Figure S4.4 (continued): Tdh knockdown in mESCs and Tdh overexpression in 
human  fibroblasts.  (A)  Quantitative  RT-PCR  for  threonine-glycine  metabolism 
enzymes  and  pluripotency  markers  in  mESCs  with  dox-induced  shTdh,  relative  to 
shLuc,  in  0.3X  Thr  media  (n=3).  (B)  Quantitative  RT-PCR  for  pluripotency  and 
differentiation markers in 3-day old embryoid bodies (EB) differentiated from  mESCs 
with dox-induced shTdh, relative to shLuc (n=3). (C) Immunoblot of Gldc, H3K4me3, 
H3K27me3, and pan-methyl-lysine in mESCs after dox-induced shRNA knockdown of 
Gldc with 2 different hairpins (shGldc), relative to a control shRNA against luciferase 
(shLuc). (D) Growth of mESCs with dox-induced shGldc, relative to shLuc, as visualized 
with alkaline phosphatase staining. (E) Immunoblot of Mat2a and H3K4me3 in mESCs 
after  dox-induced  shRNA  knockdown  of  Mat2a  with  2  different  hairpins  (shMat2a), 
relative to a control shRNA against luciferase (shLuc). (F) Growth of mESCs with dox-
induced shMat2a, relative to shLuc, as visualized with alkaline phosphatase staining. 
(G) 
13C-labeled  metabolites  derived  from  [U-
13C]Thr,  after  48h  incubation  of  mESCs 
(n=3).    The  relative  fraction  of 
13C  incorporation  (
13C  /  total  C  ratio)  is  plotted.  (H) 
Quantitative  RT-PCR  (Fold  change)  of  mRNA  for  each  respective  gene  after 
overexpression in feeder-free mESCs by transfection, relative to overexpression of the 
GFP  control  (n=2).  (I)  Threonine  restriction  and  rescue  by  gene  overexpression  in 
mESCs. After overexpression of each gene by transfection, feeder-free mESCs were 
deprived of Thr in the media for 12h, then supplemented for 36h with 0.3X Thr. Alkaline 
phosphatase-positive colonies were quantified and normalized to the GFP control (n=2). 
mESCs supplemented with 0.3X and 1X Thr without transfections, served as negative 
and  positive  controls  respectively.  (J)  Quantitative  RT-PCR  for  Tdh  expression  in 210 
 
Figure S4.4 (continued) human fibroblasts expressing mouse Tdh, relative to control 
human  fibroblasts,  prior  to  iPSC  reprogramming  (n=3).  (K)  Immunoblot  for  Tdh 
expression in human fibroblasts expressing mouse Tdh with the cleaved T2A tag (Tdh-
T2A),  relative  to  control  human  fibroblasts  and  mESCs  with  endogenous  Tdh.  (L) 
Epifluorescence images of human fibroblasts expressing mouse Tdh-T2A-GFP, and a 
representative human iPSC colony reprogrammed from these fibroblasts for 18 days 
with  Oct4,  Sox2,  Klf4,  Myc  lentivirus.  Images  were  taken  at  10X  magnification.  (M) 
Proliferation kinetics of human fibroblasts expressing mouse Tdh-T2A-GFP relative to 
empty vector, with or without Thr in the media (n=3). (N) Quantitative RT-PCR profiling 
of  human  fibroblasts  expressing  mouse  Tdh,  relative  to  empty  vector,  prior  to iPSC 
reprogramming (n=3).  
All error bars represent the s.e.m. from three independent measurements. 
 
 